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ABSTRACT 
 
Porcine epidemic diarrhea virus (PEDV) was first identified in 1971 in England, and 
it then spread to Asian countries. It did not cause severe outbreaks until the 1990s in Asia. 
There was no PEDV reported in American countries prior to the first United States (U.S.) 
outbreak that started in April 2013.  
The goals of this dissertation are to better characterize the features of U.S. PEDVs, 
particularly cell culture isolation methods, genetic phylogeny, pathogenesis, and immunity, 
to aid the PEDV diagnosis and control. Genetic analyses showed that two major PEDV 
strains are currently circulating in the U.S, designated as U.S. prototype strain and U.S. S-
INDEL-variant strain. Initially, multiple U.S. PEDV prototype isolates and one U.S. PEDV 
S-INDEL-variant isolate were successfully isolated in Vero (ATCC CCL-81), which 
provided sustainable pure viral materials for various applications. Subsequently, two-way 
cross-reactivity and cross-neutralization between the two U.S. PEDV strains were evaluated 
in vitro. It was found that PEDV serological assays including indirect fluorescent antibody 
(IFA) assay, enzyme-linked immunosorbent assays (ELISA) and virus neutralization assay 
(VN) with either virus strain as indicator virus were able to detect antibodies against both 
U.S. PEDV strains. Pathogenesis difference was then compared amongst different U.S. 
PEDV strains and clades in 5-day-old neonatal pigs, 3-week-old and 7-week-old weaned 
pigs. The results revealed that U.S. prototype PEDV strain was more virulent than U.S, S-
INDEL-variant PEDV strain in 5-day-old and 3-week-old pigs, but U.S. S-INDEL-variant 
was more virulent than U.S, prototype PEDV strains in 7-week-old weaned pigs. In vivo 
cross-protection efficacy evaluation in weaned pig models indicated that immunization with 
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U.S. PEDV prototype strain provided similar protection against challenge with U.S. 
prototype strain or U.S. PEDV S-INDEL-variant strain. Immunization with U.S. PEDV S-
INDEL-variant strain provided efficient protection against challenge with U.S. PEDV S-
INDEL-variant strain and provided at least partial cross-protection against U.S. prototype 
PEDV challenge. In summary, in this dissertation, isolation of circulating U.S. PEDVs in cell 
cultures was successfully obtained and pathogenicity and cross-protective immunity of U.S. 
PEDVs were characterized.     
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CHAPTER 1. INTRODUCTION: DISSERTATION ORGANIZATION 
  
This dissertation composes seven chapters. Chapter 1 is the introduction of the 
dissertation organization. Chapter 2 reviewed literature related to PEDV virus etiology and 
characterization, epidemiology, disease features, infection diagnoses, and disease control 
strategies. Chapter 3 is an in vitro study describing the isolation and characterization of 
PEDV during the initial U.S. outbreak in 2013; the article “Isolation and characterization of 
porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in 
the United States” has been published in Journal of Clinical Microbiology in 2014. Chapter 4 
evaluated in vitro cross-reactivity and cross-neutralization between the two major U.S. 
PEDV strains (prototype and S-INDEL-variant), and the article “Evaluation of serological 
cross-reactivity and cross-neutralization between the United States porcine epidemic diarrhea 
virus prototype and S-INDEL-variant strains” has been published in BMC Veterinary 
Research in 2016. Chapter 5 compared pathogenesis differences between the two major U.S. 
PEDV strains in 5-day-old neonatal piglets, and the paper “Pathogenesis comparison between 
the United States porcine epidemic diarrhea virus prototype and S-INDEL-variant strains in 
conventional neonatal piglets” has been published in Journal of General Virology in 2016. 
Chapter 6 further evaluated pathogenesis differences of two U.S. PEDV strains in 3-week-old 
and 7-week-old weaned pig model and also evaluated the cross-protection efficacy of these 
two strains in weaned pig model in vivo, and the manuscript “Evaluation of the pathogenesis 
differences and two-way cross-protection efficacy of the U.S. PEDV prototype and S-
INDEL-variant strains in weaned pigs” has been submitted to Virology journal for 
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publication. Chapter 7 drew general conclusions based on all the research in this entire 
dissertation. 
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CHAPTER 2. GENERAL REVIEW OF PEDV: VIRUS FEATURES, DIAGNOSIS, 
AND DISEASE CONTROL  
 
2.1 Discovery of Porcine Epidemic Diarrhea Virus 
Porcine epidemic diarrhea (PED) was named from a non-transmissible gastroenteritis 
virus (TGEV) enteric disease outbreak in multiple sow herds in the region of Yorkshire, 
England in March 1971. The diseases were manifested as watery diarrhea in sows, but caused 
lower piglet mortality or impact as compared to TGE at that time (Oldham, 1972). In 
addition to TGEV and porcine hemagglutinating encephalomyelitis virus (PHEV), a novel 
porcine coronavirus was identified in 1978 from Belgium swine breeding farms with electron 
microscope (EM), named as CV777 (Pensaert & De Bouck, 1978). CV777 was shown to 
cause similar watery diarrhea to the clinical diseases caused by TGEV and rotavirus 
(Pensaert & De Bouck, 1978). Later, the virus was renamed as porcine epidemic diarrhea 
virus (PEDV), and CV777 as the prototype strain of PEDV was isolated in cell culture and 
subsequently, the viral sequence was determined (Bridgen et al., 1993; Duarte & Laude, 
1994; Duarte et al., 1994; Hofmann & Wyler, 1988). 
 
2.2 Virus Etiology and Characterization 
2.2.1 Virus classification 
PEDV belongs to the order Nidovirales, family Coronaviridae, subfamily 
Coronavirinae, genus Alphacoronavirus (ICoTo, 2014). In the Coronaviridae family, 5 other 
viruses infecting porcine have also been identified: TGEV and porcine respiratory corona 
virus (PRCV), belonging to the genus Alphacoronavirus, were identified in 1946 and 1984, 
respectively; porcine hemagglutinating encephalomyelitis virus (PHEV), belonging to the 
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genus Betacoronavirus, was identified in 1962; porcine deltacoronavirus (PDCoV), 
belonging to the genus Deltacoronavirus, was identified in 2012; and a swine enteric 
coronavirus (SECoV) resulting from the recombination of S gene of PEDV CV777 and 
TGEV, was discovered in Italy in 2016 (Boniotti et al., 2016; Doyle & Hutchings, 1946; 
Greig et al., 1962; Pensaert et al., 1986; Wang et al., 2014c; Werdin et al., 1976). PEDV, 
TGEV, and PDCoV all produce similar enteric diseases in pigs, and PRCV, an S gene 
deletion mutant from TGEV, primarily infects the respiratory tract with the capacity to cause 
enteric disease (Chen et al., 2015a; Costantini et al., 2004). The pathogenesis of SECoV is 
not well assessed yet; however, as compared to TGEV and PEDV, similar diarrhea with 
lower piglet mortality was observed in the field associated with SECoV (Boniotti et al., 
2016). PHEV can spread to the central nervous system (CNS) from site of entry and cause 
encephalomyelitis or systemic syndromes known as “vomiting and wasting disease (VWD)” 
(Greig et al., 1962; Saif et al., 2012). 
2.2.2 Virus organization 
PEDV is an enveloped, positive-sense, single-stranded RNA virus. The genome of 
PEDV is approximately 28 kb, including 2 untranslated regions (UTR) on 5’ and 3’ ends and 
7 known open reading frames (ORFs) (Song et al., 2015). The 5’ two-thirds of the genome 
are occupied by ORF1a and ORF1b encoding replicase polyprotein pp1a and pp1ab, which 
can be further cleaved into 16 non-structural proteins (nsp). As a member of coronaviruses, 
the expression of pp1ab of PEDV is also the result of a -1 ribosomal frameshift during the 
genomic RNA translation (Ziebuhr, 2005). The 3’ one-third of the genome includes 4 
structural protein genes encompassing spike (S), envelope (E), membrane (M), and 
nucleocapsid (N), and one accessory protein gene ORF3 (Bridgen et al., 1993; Duarte et al., 
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1993; Kocherhans et al., 2001). These genes were aligned in the PEDV viral genome in the 
order of 5’-UTR-ORF1a-ORF1b-S-ORF3-E-M-N-UTR-3’ (Chen et al., 2012a; Duarte et al., 
1993; Duarte & Laude, 1994). The ORF1 gene and S gene N-terminal are found to have high 
levels of variation, and S gene also has high recombination rates over the whole genome 
(Jarvis et al., 2016; Sun et al., 2015b).  
2.2.3 Protein primary putative functions 
Nsp1 has been demonstrated to aid in suppressing the innate immune response 
through acting as type I interferon (IFN-β) antagonist and interfering with host protein 
synthesis (Huang et al., 2011; Masters & Perlman, 2013). Nsp3 includes acidic domain (Ac), 
papain-like protease 1 (PL1pro), X domain with adenosine diphosphate-ribose 1’’-
phosphatase (ADRP) activity, papain-like protease 2 (PL2pro) and a highly conserved 
domain (Y) with metal-binding function (Putics et al., 2006; Ziebuhr et al., 2001). PL1pro 
and PL2pro cleave off nsp1, nsp2, and nsp3 from pp1a (Putics et al., 2006; Ziebuhr et al., 
2001). PL2pro also antagonizes type I IFN-β production (Xing et al., 2013). Nsp5, also 
known as 3C-like protease (3CLpro), is the main protease (Mpro) cleaving nsp4 to nsp16 
from pp1a or pp1ab (Masters & Perlman, 2013). Transmembrane domains (TM) I, II, and III 
were located in nsp3, nsp4, and nsp6 and anchor replication complex to intracellular 
membranes (Ziebuhr et al., 2001). Nsp7 and nsp8 jointly compose a hexadecameric complex 
structure with a central channel to encircle double-stranded RNA and initiate the RNA 
synthesis (Xiao et al., 2012). Nsp8 may also function as a primase (Xiao et al., 2012). Nsp9 
binds to single-stranded RNA as RNA-binding protein (RBP) (Egloff et al., 2004).  Nsp10 
harbors Zinc-binding domain (ZBD) and also functions as a co-factor (activator) of nsp16 
(Bouvet et al., 2010; Masters & Perlman, 2013). Nsp12 is the viral RNA-dependent RNA 
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polymerase (RdRP). Nsp13 also contains a ZBD and the activities of RNA helicase, NTPase, 
and RNA 5’ triphosphatase (Ziebuhr, 2005). Nsp14 harbors 3’-5’ exonuclease (ExoN) and 7-
methyltransferase (7MT) from N- to C-terminal, and nsp16 is identified acting as 2’-O-
methyltransferase (2’-O-MT) (Ziebuhr, 2005). The interactions between nsp10, nsp14 and 
nsp16 are crucial for viral replication fidelity and mRNA cap methylation. Uridylate-specific 
endoribonuclease (NendoU) resides in nsp15, and this unique motif is only found in 
nidovirales (Ivanov et al., 2004). The putative function of nsp2, nsp4, and nsp11 is not well 
studied and remains unclear. S glycoprotein has the size around 1400 amino acids (aa), and 
can be functionally divided into S1 and S2 domains. S is the major surface protein playing a 
pivotal role in virus binding to host cell receptor and mediating virus-host cell fusion (Bosch 
et al., 2003). In addition, S also comprises multiple neutralizing epitopes at amino acid 
residues 201-212, 499-638, 744-759, 756-771, and 1368-1374 (Br1/87 strain as reference), as 
identified so far (Cao et al., 2015; Chang et al., 2002; Cruz et al., 2008; Kang et al., 2005; 
Song & Park, 2012; Sun et al., 2008). The activation of S can be achieved by trypsin 
cleavage at the junction of S1 and S2 domains (Li et al., 2015; Millet & Whittaker, 2015), 
and the cleavage occurs after the virus binds to cell receptors (Park et al., 2011; Wicht et al., 
2014). M protein, the most abundant structural protein, and E, an integral membrane protein, 
are essential for viral particle assembling (Vennema et al., 1996). N protein wraps viral 
genomic RNA into nucleocapsid with a helical structure, which is incorporated into the viral 
particle during the budding step and additionally, it is involved in viral RNA synthesis and 
virion assembling (Verheije et al., 2010). N is also an antagonist of IFN-β by interacting with 
TBK1 and further sequestering the association between IRF3 and TBK1 (Ding et al., 2014). 
Accessory protein ORF3 may be associated with the virus adaption in cell culture, and it also 
7 
 
 
prolongs the S phase of host cell cycle progression and affects host cell subcellular structure 
(Song et al., 2003; Ye et al., 2015).  
2.2.4 Cellular factors 
Heparan sulfate on cell surface functions as an attachment factor that mediates initial 
attachment between PEDV and susceptible cells (Huan et al., 2015). An in vitro study 
showed that both treating PEDV with heparin (an analogue of heparan sulfate), and digesting 
cell-surface heparin sulfate with heparinase I resulted in reduced PEDV infection efficiency 
(Huan et al., 2015). Porcine aminopeptidase N (pAPN, CD13), naturally expressed on swine 
enterocytes, was identified as a cell receptor for PEDV S1 binding and entering cells (Cong 
et al., 2015; Liu et al., 2015; Oh et al., 2003). Furthermore, it is revealed that intestinal 
epithelial cells form polarized membranes with apical and basolateral sites, and PEDV only 
infects and is released from apical site expressing pAPN (Cong et al., 2015). PEDV may 
require high level of pAPN to efficiently infect cells, since ST cells expressing relatively low 
level of natural porcine pAPN is not susceptible to PEDV infection (Nam & Lee, 2010). ST 
cells overexpressing pAPN and MDCK (Non-PEDV permissive) cells transfected with pAPN 
cDNA can both support PEDV replication, even when the pAPN protease loses its activity 
(Li et al., 2007; Nam & Lee, 2010). Porcine epidemic diarrhea virus S1 also has the favor of 
binding to Neu5Ac sugar, which was hypothesized as a co-receptor of pAPN (Liu et al., 
2015). Use of the Neu5Ac as co-receptor may further determine the enteric tropism of PEDV 
(Liu et al., 2015). However, the necessity of Neu5Ac as a co-receptor of pAPN for PEDV 
infection has not been confirmed and the interactions among PEDV S1, Neu5Ac and pAPN 
have not been demonstrated. Cell adapted PEDV can also grow in Marc-145 cells and 
genetic changes on S gene during the first 10 passages in Marc-145 cells were observed 
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(Lawrence et al., 2014). The fact that both Vero cells supplemented with trypsin and Marc-
145 cells, which lack pAPN, support PEDV growth indicates that alternative receptors or 
receptor independent pathways may be used by PEDV for in vitro entry into cells (Lawrence 
et al., 2014; Oh et al., 2003). Exact locations of PEDV S domains binding to heparan sulfate, 
pAPN and Neu5Ac sugar have not been identified yet. Since PEDV has higher tropism 
infecting small intestine villus than small intestine crypt, cecum, and colon epithelial cells, it 
is also worthy to determine whether small intestine villi express higher level of pAPN than 
epithelial cells at the other sites. Therefore, more investigations to discover PEDV cellular 
receptors and to understand the viral-cell interaction are still necessary. 
 
2.3 Epidemiology 
2.3.1 Virus dispersion and temporal spread  
Between the 1970s and 1990s, PEDV spread to multiple European countries 
endemically (Carvajal et al., 1995b; Nagy et al., 1996; Pensaert & De Bouck, 1978; Van 
Reeth & Pensaert, 1994), and the prevalence of virus has become low in Europe since then 
with only occasional outbreaks reported (EFSA AHAW Panel, 2014; Martelli et al., 2008). 
As a result, the current PEDV-induced immunity in European pig populations may be low 
and Europe is at high risk for facing potential outbreaks. Since 2014, PEDV has started to 
draw attention again in Europe and PEDV infections have been reported in multiple 
European countries after the U.S. outbreak in 2013. 
The first recognition of PEDV in Asian countries was in China in 1973 associated 
with similar disease observed in Europe, with sporadic or local endemic infections without 
large-scale outbreak (Li et al., 2012a; Sun et al., 2015a). It was then reported in nearby 
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countries, for instance Japan in 1983, and Korea in 1987 (Lee et al., 2010; Srinuntapunt et 
al., 1995; Takahashi et al., 1983). Nevertheless, starting from the 1990s until now, severe 
and widespread epidemics caused by PEDV were frequently reported in Asian countries, 
even from farms vaccinated with PEDV vaccines, specifically in China, South Korea, 
Thailand, and Vietnam (Chae et al., 2000; Chen et al., 2010; Olanratmanee et al., 2010; 
Puranaveja et al., 2009; Sun et al., 2015b; Vui et al., 2015). Japan only had relatively 
isolated and insignificant outbreaks before 2013, but since then PEDV has been detected, 
spread nationwide and caused vast economic loss (Sasaki et al., 2016). The virus causing the 
recent epidemic outbreaks in Asian countries showed high virulence characterized by high 
morbidity and high neonatal pig mortality (Lee et al., 2010; Li et al., 2012a; Sun et al., 
2012). These highly virulent Asian strains are highly genetically homologous and have 
similar genetic deletion and insertion patterns when compared to classical European/Asian 
strains (Chen et al., 2012a; Lee et al., 2010; Luo et al., 2012).  
PEDV was not detected in North America and South America until the sudden wide 
outbreak in the U.S. starting from April 2013 (Stevenson et al., 2013), except a non-
confirmed outbreak report in baby pigs with PEDV like diarrhea in Canada (Turgeon et al., 
1980). A high virulent PEDV strain (designated as U.S. prototype strain) was first identified 
from the initial U.S. PEDV outbreak in April 2013 (Stevenson et al., 2013). In January 2014, 
a second U.S. PEDV strain with relatively milder virulence (designated as U.S. S-INDEL 
variant strain) was also recognized in the U.S. (Wang et al., 2014a). The U.S. S-INDEL-
variant strain was retrospectively detected as early as June 2013 in the U.S., but with low 
prevalence of ~10-14% (Vlasova et al., 2014). Up to January of 2015, PEDV has invaded pig 
farms in 36 U.S. states and the states raising largest number of pigs lead the numbers of 
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PEDV infected farms, including Iowa, Minnesota, and North Carolina (Disease Bioportal, 
2016). Regionally, highly significant spatial and spatio-temporal clustering patterns were 
demonstrated in two studied regions (Midwest and Southeast) in the U.S., suggesting that 
PEDV positive farms are likely to locally transmit PEDV to neighbor farms (Alvarez et al., 
2016). Passively collected data from U.S. national animal health laboratory network 
(NAHLN) revealed that, from March 2015 to December 2015, the number of premises that 
became PEDV positive each month has decreased dramatically and maintained relatively low 
in winter season, as compared to winter of 2014 (USDA-APHIS). Yet, of the 1857 
cumulative PEDV positive premises since 5 June 2014, 1642 premises were still positive by 
10 Dec 2015. Positive accession numbers and positive accession percentage of all tested 
accessions of each month did not decrease dramatically. Taken together, these indicate that 
PEDV is still actively circulating in the U.S., and the low incidence of new PEDV positive 
premises since March 2015 may be due to only a small number of pig farms in the U.S. 
remaining PEDV naïve. Additionally, the distribution of new PEDV positive premises in 
2014 reveals that more new PEDV positive premises clustered around winter season than 
summer, which implies PEDV disseminated easier and faster when the temperature is lower. 
Similar season related prevalence difference was also observed in other reports (Martelli et 
al., 2008; Sun et al., 2015a) and the role of temperature as a factor will be discussed below. 
In 2014, U.S.-like PEDV spread to other American countries such as Canada, Mexico, 
Colombia, Ecuador, and Dominican Republic (EFSA AHAW Panel, 2014; Jarvis et al., 
2016; Ojkic et al., 2015; Vlasova et al., 2014). 
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2.3.2 Molecular epidemiology 
Globally, all PEDV sequences form two major clusters (genogroup I and genogroup 
II) based on phylogenetic analysis; group I viruses can be further phylogenetically divided 
into Ia and Ib and group II viruses can be further phylogenetically divided into IIa and IIb 
(Lee, 2015). The recent highly virulent Asian-U.S. strains emerged after 2010 belong to IIb 
while the classical Euro-Asian strains belong to group Ia (Lee, 2015). The cluster affiliation 
of the recent U.S. S-INDEL-variant-strain is ambiguous depending on which gene(s) is used 
for phylogenetic analysis and this will be discussed below.  
PEDV strains circulating in Europe prior to 2014 were solely Ia strains. The evolution 
of PEDVs from group I to group II possibly occurred in Asia, and IIa viruses can be found as 
early as late 1990s in Korea. Interestingly, prior to 2008, IIa PEDVs were already identified 
in Asia although group I PEDVs still remained dominant (Chen et al., 2008; Puranaveja et 
al., 2009; Sun et al., 2015b). After 2008, acute large-scale outbreaks caused by group II 
PEDVs continually attacked pig farms in Asia and caused dramatic economic loss (Park et 
al., 2013; Sun et al., 2015b; Wang et al., 2013), with group I PEDVs still co-circulating in 
Asia (Cheun-Arom et al., 2015; Sun et al., 2015a; Temeeyasen et al., 2014). Genetic 
analyses indicate that group II PEDVs have been continuously evolving over the last two 
decades in Asia (Sun et al., 2015b; Vui et al., 2015). The decade of 2000 to 2010 can be 
hypothesized as a period that group II viruses were continuously evolving, incubating and 
gradually increasing in prevalence in Asia. Even though both group II and group I PEDVs 
were detected in Japan prior to 2013, nationwide outbreaks did not occur until U.S. PEDV 
prototype-like strain (IIb) was detected in Japan (Sasaki et al., 2016; Sun et al., 2015a; Van 
Diep et al., 2015). Although the circulation of both group I and group II PEDVs in Asia has 
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been confirmed by molecular epidemiology studies, the prevalence of group I and II viruses 
needs further assessment. The group I PEDVs seem to have less impact on pig production 
compared to the group II PEDVs. 
The major strain of PEDV (U.S. prototype strain) currently circulating in the U.S. 
belongs to IIb, and is genetically closely related to Chinese strains detected after 2010 
(Hoang et al., 2013). U.S. prototype strain possibly originated from China (Huang et al., 
2013). The minor strain (U.S. S-INDEL-variant strain) has distinct differences in the S gene, 
especially the first 1,170 nucleotides (nt) of the S1 region, when compared to U.S. prototype 
strain: 1) 3 deletion regions include 1-nt deletion at position 167, 11-nt deletion at position 
176, and 3-nt deletion at position 416; 2) 1 region of a 6-nt insertion between position 474 
and 475; and 3) a number of pointed mutations (Wang et al., 2014a). Classical Euro-Asian 
PEDVs that belong to Ia also have the same insertion and deletion patterns in S gene as U.S. 
S-INDEL-variant strain. When whole genome sequences are used for phylogenetic analyses, 
the U.S. S-INDEL-variant-like PEDVs form a clade within group II; when the S gene 
sequences are used for phylogenetic analyses, the U.S. S-INDEL-variant-like PEDVs belong 
to Ib (Lee, 2015). Comparative sequence analysis also indicates that S gene of U.S. S-
INDEL-variant strain was more genetically homologous to group I strains, but other genes of 
U.S. S-INDEL-variant strain were more genetically homologous to group II strains, including 
U.S. prototype strain (Collin et al., 2015). Concatenated alignment supports that U.S. 
prototype and S-INDEL-variant strains evolved prior to entry into the U.S. and were 
introduced to the U.S. independently (Jarvis et al., 2016). 
After PEDV emergence in U.S., PEDV outbreaks or re-outbreaks were also reported 
in other North American countries, Europe, South America and Asia. The U.S. highly 
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virulent prototype-like PEDV was detected in Ukraine for the first time, which was also the 
index case of U.S. PEDV prototype-like strain outbreak in Europe (Dastjerdi et al., 2015). 
Interestingly, the following European countries including Belgium, France, Germany, 
Portugal, Austria, Slovenia, and Italy are all located in mid-west Europe and reported the 
detection of U.S. PEDV S-INDEL-variant-like strain after 2014 (Boniotti et al., 2016; 
Grasland et al., 2015; Hanke et al., 2015; Mesquita et al., 2015; Steinrigl et al., 2015; Theuns 
et al., 2015). Multiple countries close to the U.S. also reported the detection of U.S. 
prototype-like strain of PEDV in 2014, including Canada, Mexico, Colombia, Ecuador, and 
Dominican Republic (EFSA AHAW Panel, 2014; Jarvis et al., 2016; Ojkic et al., 2015; 
Vlasova et al., 2014). In addition, U.S. S-INDEL-variant strain was also detected in Mexico 
(Vlasova et al., 2014). In Asia, China Taiwan, Japan, and South Korea have reported PEDV 
sequences more homologous to U.S. prototype strain than to Asian sequences after the initial 
U.S. outbreak (Choi et al., 2014; Deng et al., 2014; Lee & Lee, 2014; Van Diep et al., 2015). 
South Korea and Japan also reported the detection of PEDV with sequences similar to U.S. 
S-INDEL-variant strain (Lee et al., 2014; Yamamoto et al., 2015). However, U.S. prototype 
strain also shows high genetic identity to some China/2011-2013 strains, Thailand/2007–
2008 strains, and Korea/2008–2009 strains (Deng et al., 2014). Thus, it is not certain where 
such U.S. PEDV prototype-like strains emerged in these countries, or what the evolutionary 
relationship is between these U.S. PEDV-like strains found in Asia and the U.S. 
Interestingly, despite that China PEDV strains still have a wide range of genetic diversity, 
none of the sequences reported from Mainland China after 2013 are genetically most 
homologous to U.S. prototype strain (Sun et al., 2015b).  
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A PEDV sequence (USA/Minnesota188/2014) with 2aa deletion in S gene has been 
proposed as a third U.S. PEDV strain (Marthaler et al., 2014); this also raises a question of 
how to define a new PEDV strain. Since the case USA/Minnesota188/2014 is genetically 
closely related to U.S. prototype strain cluster, and it has not shown significant virulence 
difference from U.S. prototype strain, it may not have the convincing importance to be 
classified as a distinct strain at the current stage. In contrast, researchers reported strains 
collected in the U.S. (PC177/US/2013) and in Japan (Tottori2/JPN/2014), with large 
deletions (582nt-591nt) at the S gene N-terminal, associated with low neonatal piglet 
mortalities in field observation, but they still cluster together with U.S. prototype strain based 
on whole sequence and S gene phylogenetic analysis (Masuda et al., 2015; Murakami et al., 
2015; Oka et al., 2014). 
 
2.4 The Disease 
2.4.1 Clinical disease 
PEDV has been causing enteric disease in pigs of all ages, characterized by acute 
watery scour without the presence of mucus or blood in feces, and vomiting and anorexia can 
also be observed in some pigs (Kim & Chae, 2003; Martelli et al., 2008). Morbidity in an 
acute PEDV outbreak is usually very high on the farm (ranged 20% to 100%) (Martelli et al., 
2008). Dehydration is usually seen in neonatal pigs which is probably the major reason 
contributing to pig death (Debouck et al., 1981). However, mortality rates in neonatal pigs 
vary when infected with different PEDV strains. U.S. prototype strain usually causes high 
mortalities (up to 100%) in suckling pigs, while U.S. S-INDEL-variant strain and classical 
Euro-Asian strains are usually associated with low mortalities in suckling pigs and various 
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mortalities in finishing pigs (Bowman et al., 2015a; Grasland et al., 2015; Lin et al., 2015; 
Stadler et al., 2015; Stevenson et al., 2013; Wang et al., 2014a). PC177/US/2013 and 
Tottori2/JPN/2014 were also observed to cause less mortality in suckling pigs (Masuda et al., 
2015; Oka et al., 2014). Surviving pigs generally recover in 1 or 2 weeks without latent 
infection, although low level of virus shedding can be prolonged. Since naïve pigs introduced 
to a herd are highly susceptible to PEDV, persistent circulating of the virus can occur. 
PEDV infection in pregnant gilts and sows also cause reproduction performance 
reduction, including decreased farrowing rate and return rate, increased abortion rate, and 
stillborn piglets and mummified fetus (Olanratmanee et al., 2010). Such impact is even more 
severe in pregnant gilts than in pregnant sows (Olanratmanee et al., 2010).  
2.4.2 Macro-pathological lesions 
Thin-wall intestines distended with yellowish watery content, or soft content, and/or 
air can usually be observed in the entire small intestine, and sometimes in cecum and colon 
(Coussement et al., 1982). Lesion severity is usually inversely correlated to age at infection. 
As another member of the Alphacoronavirus genus, TGEV causes very similar or non-
differential clinical diseases and macro-pathological and histopathological lesions as PEDV 
(Debouck et al., 1981; Stevenson et al., 2013). However, these two viruses are antigenically 
distinct (Kim & Chae, 2003).  
2.4.3 Histopathological lesions 
Histopathologically, the virus has the tropism of primarily infecting cytoplasm of 
villous enterocytes of entire small intestine, but limited infection can also occur in cecum and 
colon surface enterocytes and crypt epithelia of any part of the intestine (Ducatelle et al., 
1981; Kim & Chae, 2003; Pospischil et al., 1981). Particularly, virus particles can only be 
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found in cytoplasm, and not in cell nuclei of infected enterocytes. Thus, histopathological 
lesions are only remarkable in small intestine (Pospischil et al., 1981). Attenuation and 
exfoliation of infected epithelial cells can be observed in small intestine villi from infected 
animals, but not in crypts (Coussement et al., 1982). Particularly, the villi become blunted, 
fragmented and contracted as the presentation of atrophy and vacuolation also occur. 
Aggregation of lymphocytes in the lamina propria was also associated with PEDV infection 
(Coussement et al., 1982). Without the coverage of epithelial cells, the whole villi will be 
subsequently damaged, presenting as shortened, atrophic villi. Virus may leave intestinal 
tract via lymphatics and macrophages, and virus can be detected with limited amount in 
serum, whole blood or non-gastrointestinal organs, but viral replication was not proved in 
these tissues (Debouck et al., 1981; Jung et al., 2015a; Madson et al., 2016; Pospischil et al., 
1981). 
2.4.4 Pathogenesis 
Since the virus predominantly infects matured small intestine villous enterocytes, in 
the situation of villi severe damage, the consequent fluid exudation results in watery diarrhea 
and dehydration (Saif et al., 2012). Since feed, milk and normal alimentary secretions cannot 
be absorbed in the condition of maldigestion and malabsorption, they were further fermented 
by bacteria and resulted in higher osmolality in intestine lumen, which leads to the osmotic 
diarrhea and piglet dehydration (Coussement et al., 1982; Gelberg, 2007). In addition, 
cytokines from immune responses can also contribute to watery diarrhea development. 
Soluble factors released by activated leukocytes can further increase intestinal secretion of 
chloride ions and water, increase intestinal permeability, and inhibit absorption (Gelberg, 
2007; Musch et al., 2002). However, this is controversial with the observation by Annamalai 
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et al. (2015), because they observed impaired innate immune function associated with more 
severe diarrhea in suckling pigs with PEDV infection (Annamalai et al., 2015). Possibly, the 
contribution of cytokines was minor in PEDV induced watery diarrhea and was overwritten 
by major contributing factors.  
The regenerative capacity of crypts will not be affected in PEDV infection; in 
contrast, crypt cell proliferation will be stimulated soon after the villi damage occur 
(Coussement et al., 1982; Debouck et al., 1981). Therefore, newly developed villi from crypt 
will replace the destroyed villi and remedy the function of villi, and increased small intestine 
crypt depth can be observed in PEDV infected pigs (Gelberg, 2007; Jung et al., 2015a). 
Villous height and crypt depth ratio (VH/CD) is a common parameter to quantify the 
histopathological lesion of PEDV, and decreased VH/CD is associated with the acute phase 
of PEDV infection.  
2.4.5 Age dependent virulence  
Low mortality would be observed in weaned or older pigs due to PEDV, but piglets 
will start to scour within 12 hours after exposure to the virus and mortality varies by virus 
clusters. The cluster II strains can result in as high as 100% neonatal piglet mortality, while 
the cluster I strains usually result in much lower neonatal mortality (Martelli et al., 2008; Sun 
et al., 2012). However, it was observed that classical PEDV (cluster I) caused more severe 
villous atrophy in weaned pigs, as compared to neonates (Pospischil et al., 1981). A U.S. 
prototype strain (cluster II) has been shown to be highly enteropathogenic and it causes more 
severe clinical disease and lesions in neonatal pigs compared to 3-4 weeks old weaned pigs 
(Jung et al., 2015a; Madson et al., 2016; Madson et al., 2014). The minimum infectious dose 
required to cause infection in neonatal pigs (0.056 TCID50) was also shown to be more than 
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1000 times lower than in weaned pigs (56 TCID50) under the same experimental condition, 
though only evaluated with the U.S. PEDV prototype strain (Thomas et al., 2015a).  
It takes longer for younger pigs to replace destroyed villi (Madson et al., 2014; Moon 
et al., 1973). Jung et al. (2015b) showed the stem cells in small intestinal crypts in weaned 
pigs proliferated exuberantly, regardless of PEDV infection, but not in 10-14-day-old pigs, 
which took 3-5 days turnover time to be remarkably stimulated after PEDV infection (Jung et 
al., 2015b). Consequently, younger pigs cannot effectively replace the villous damage to 
avoid fluid loss in the acute infection phase. In addition, the young pigs may be more 
vulnerable to dehydration as a result of the difference in body water content, distribution, and 
renal electrolyte regulation with age (Moon et al., 1973). Thus, these together may explain 
the higher dehydration and mortality incidence in neonatal pigs, even though some strains 
may cause more severe villous atrophy in weaned pigs. Furthermore, immature immune 
systems of suckling pigs, including impaired lytic activity and IFN-γ productivity by NK 
cells, was also found to coincide with increased PEDV infection severity (Annamalai et al., 
2015). However, the causative relationship cannot be concluded without confirming that the 
age-dependent pathogenesis pattern is consistent between cluster I and II PEDVs.  
2.4.6 Strain dependent virulence 
Overall, knowledge on pathogenesis differences among different PEDV strains was 
poor. It was observed in the field that the clinical impact of cases infected with classical 
group I strains and U.S. S-INDEL-variant-like strain PEDV was reduced, piglet mortality 
was lower, and the production returned to baseline faster, as compared with U.S. prototype 
strain (Goede et al., 2015; Martelli et al., 2008; Stevenson et al., 2013; Wang et al., 2014a; 
Yamamoto et al., 2015). In experimentally infected neonatal pigs, as compared to U. S. 
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prototype strain, it was observed that the U.S. S-INDEL-variant strain resulted in overall 
lower mortality, shortened duration of diarrhea, milder villous atrophy, and less amount of 
viruses in intestine (Lin et al., 2015). In addition, virulence variation was observed across 
litters and farms infected with U.S. S-INDEL-variant strain under experimental and/or field 
conditions (Chae et al., 2000; Lin et al., 2015; Stadler et al., 2015). The exact mechanisms 
causing such inconsistent virulence of U.S. S-INDEL-variant-like strain is not clear, but pig 
ages, potential maternal antibodies, different virus exposure dose, animal and environmental 
variation, and single nucleotide polymorphisms (SNPs) between viruses all have the 
possibility to contribute to the discrepancy. It is worth to thoroughly evaluate the 
pathogenesis of several representative strains of different PEDV clusters in pigs at different 
age models to correlate the pathogenesis characters with genetic characters.  
2.4.7 Transmission  
So far, swine is the only natural host species identified susceptible for PEDV 
infection. The virus replicates mainly in small intestine and a large amount of live virus is 
shed through feces. The virus was considered to transmit through the oral-fecal process. 
Therefore, pigs shedding virus in feces being introduced to a naïve farm is the direct vessel 
spreading PEDV and infecting other pigs in the same farm. Virus shedding in feces from an 
individual pig can last for at least 42 days in experimentally infected weaned pigs 
intermittently, but PEDV, that was able to infect naïve pigs at the age pigs, was shed 14-16 
days after infection (Crawford et al., 2015). On the farm, virus shedding can last longer than 
56 days post infection (Sun et al., 2014). Virus was also detected from milk of infected sows, 
which was also hypothesized as a route of PEDV vertical transmission from sows to suckling 
pigs (Sun et al., 2012), although abundant antibodies against PEDV may exist along with 
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virus in milk. The role of PEDV in milk in PEDV transmission is still an unresolved 
question. 
Additionally, anything contaminated with PEDV, which is likely to be orally 
contacted by pigs, may serve as an indirect transmission vessel that transmits the virus 
laterally to other farms. Specifically, feed is considered as an important medium to laterally 
spread the virus, especially for long distance transmission, despite effective biosecurity 
(Bowman et al., 2015a; Pasick et al., 2014). Feed and feed supplemental porcine originated 
spray-dried porcine plasma (SDPP) contaminated with PEDV RNA has been found in 
commercial manufactures and feed lot in pig barns, and could be infectious to pigs (Bowman 
et al., 2015a; Dee et al., 2014a; Pasick et al., 2014; Pillatzki et al., 2015). Contaminated 
SDPP was suspected to be responsible to transmit PEDV to Canada based on an 
epidemiological link and the capacity of susceptible samples to infect pigs (Pasick et al., 
2014). Porcine plasma is originally collected from slaughtered pigs regardless of the PEDV 
infection status, and PEDV RNA is detectable in serum samples, so it is very possible for the 
porcine plasma to be contaminated with PEDV. However, high temperatures (166°C as inlet 
temperature and 80°C as outlet temperature) are utilized in SDPP process. It has been shown 
that this process was able to efficiently inactivate all PEDV in porcine plasma and all PEDV 
spiked in bovine plasma (Gerber et al., 2014b; Pujols & Segales, 2014). Still, the virus may 
not be sufficiently inactivated under many other non-uniform parameter settings in the spray 
dryer amongst production cycles and/or methods, and there are still chances that 
contamination occurred thereafter the spray-dried process (EFSA AHAW Panel, 2014). The 
feed pelleting process is also hypothesized to contribute to virus inactivation, since the 
temperature is typically 70 to 100°C in pelleting system (Nitikanchana, 2014). In addition, 
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the PEDV antibodies in blood may have neutralizing effect on PEDV. However, the 
magnitude of both hypotheses needs further evaluation. Ultimately, porcine bi-product free 
of PEDV contamination will be more appreciated. 
Personnel, vehicles, equipment and other fomites without sufficient cleaning or 
downtime from an outbreak farm may be carriers of feces or feed with residual PEDV 
contamination, and thus increase the risk to indirectly transmit PEDV to naïve farms (Lowe 
et al., 2014; Pospischil et al., 2002). An epidemiology study indicated that more frequent 
feed truck visits increased the long distance PEDV transmission odds ratio, and that 
disinfectant contact time less than 20 minutes increased the odds ratios of both long distance 
and local PEDV transmission in Japan (Sasaki et al., 2016). It may be impractical to try to 
prevent PEDV spreading within a facility, since it only requires 0.056 TCID50 and 56 TCID50 
virus to cause initial infection in neonatal pigs and weaned pigs, respectively (Thomas et al., 
2015a), but reinforced biosecurity performance could dramatically help prevent introducing 
PEDV from other farms.  
Based on an epidemiology investigation by the Animal and Plant Health Service 
(APHIS), reusable Flexible Intermediate Bulk Containers (FIBC), widely used to transport 
pig feed among farms, were indicated as the most possible carrier that introduced PEDV to 
the U.S. and rapidly spread the virus countrywide (Scott et al., 2016). The authors also 
suspect FIBC may also be the source of feed contamination, where FIBCs are contaminated 
within PEDV outbreak farms and then contaminate the feed being transported to PEDV naïve 
farms. This hypothesis is worthwhile for further evaluation to confirm. Nevertheless, it is still 
uncertain what the source of infectious PEDV is in the contaminated feed.  
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PEDV can also be collected in air samples in or surrounding infected barns with the 
potential to transmit PEDV to neighbor farms, although a study showed pigs with only 
aerosol exposure to PEDV shedding pigs were not infected (Alonso et al., 2014; Hesse et al., 
2014). Low level of PEDV RNA was also detectable in semen from infected pigs, but the 
role of transmission remains unclear (Sun et al., 2014). 
As epidemiology studies revealed that spatial and spatio-temporal clustering patterns 
were observed in PEDV infected farms in the same region (Alvarez et al., 2016; Sasaki et al., 
2016), sharing some of the potential transmission vessels as discussed above without enough 
disinfection may contribute to such local transmission, such as personnel, equipment, 
vehicles, feed, space, or air. However, the effective magnitude of sharing these vectors needs 
to be further investigated. 
2.4.8 Viability 
As an enveloped virus, PEDV is fragile to most virucidal disinfectants, heat, and 
extreme pH (Pospischil et al., 2002; Song & Park, 2012), but when covered by or mixed with 
organic matter, the virus survival may be markedly extended in the environment.  
Cell culture-adapted virus isolate could tolerate pH ranged from 5.0 to 9.0 at 4°C, but 
was only stable between pH 6.5 to 7.5 at 37°C (Pospischil et al., 2002). PEDV stability also 
decreased with increasing temperature (Song & Park, 2012). PEDV adapted on cell culture 
could be inactivated when heated at 60°C for 0.5 hour, whereas it maintains moderate 
stability at 50°C (Song & Park, 2012). Our unpublished data with virus isolate in culture 
media, with original titer of 106 TCID50/ml, lost 1-log10 titer in 6 hours, and lost 3-log10 titer 
in 24 hours at room temperature incubation. Whereas, Nelson et al. (2014) showed that air-
dried virus isolate could survive at least 14 days at room temperature with only 1-log10 titer 
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lost, and was still able to be re-isolated on cell culture after 8 days incubation at 37°C 
(Nelson et al., 2014). 
In complete pig feed, virus survived up to 45 days during January winter ambient 
conditions in state of Minnesota (45°N, 95°W) and still caused infection in 6-day-old pigs, 
and virus viability varied greatly in different feed ingredients (Dee et al., 2015). In contrast to 
remaining viable in soybean meal for 180 days, PEDV lost viability within 7 days in a 
number of feed ingredients in the same winter condition, including porcine plasma (Dee et 
al., 2015). Promisingly, treatment with Sal CURB® in feed could effectively prevent PEDV 
transmission by contaminated feed, as demonstrated in vivo (Dee et al., 2014b).  
For trailer metal surfaces contaminated with PEDV-positive feces, PEDV maintained 
infectivity after 10 minutes with heat treatment at 63°C, while the virus possibly lost 
infectivity within 10 minutes at 71°C, or within 7 days at 20°C (Thomas et al., 2015b). 
However, preliminary data displayed that PEDV experimentally spiked into manure could 
survive for at least 14 days at 25°C, and contradictorily longer than 28 days at 4 or 20°C, 
meanwhile manure pit samples collected from a pig farm were found to be infectious 4 
months after PEDV positive pigs on the site (Tousignant, 2014). Preliminary data also 
showed PEDV could survive for 28 days in water or 14 days in slurry at room temperature, 
and survive for 28 days in slurry at 4°C (Goyal, 2014). Such various observations indicate 
that the complexity of field environment and virus reservoir may greatly affect the life of 
PEDV, and it is prudent to be cautious and assume the worst scenario. 
To disinfect the virus from the environment, studies have evaluated the efficacy of 
several commercial disinfectants and sanitation protocols in inactivating PEDV in feces, and 
consequently predict the efficacy in disinfecting trailers contaminated with PEDV-positive 
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feces. A report established that a phenolic disinfectant (1-stroke Environ®), a quaternary 
ammonia compound (Roccal-D® Plus), sodium hypochlorite (household bleach), an 
oxidizing agent (Virkon S®), and a quaternary ammonium/glutaraldehyde combination 
product (Synergize®) could render PEDV non-infectious in feces, but did not destroy all viral 
RNA (Bowman et al., 2015b). Another report revealed that incubation with Stalosan® F 
alone for 1 hour at 20°C was not sufficient to inactivate PEDV in feces, but 30 minute 
incubation with Accel® alone at 1:32 dilution was effective at inactivating PEDV in feces, 
and the sanitation protocol of pressure washing with detergent, followed by Synergize® 
disinfectant at 1:256 dilution for 10 minutes at 20°C was able to inactivate PEDV (Thomas et 
al., 2014). Furthermore, it is proven that 40 minutes of contact with 1:32 dilution of 
accelerated hydrogen peroxide® (AHP®) in a 10% propylene glycol (PG) solution, even at -
10°C, was also sufficient to inactivate PEDV in feces (Holtkamp et al., 2015). However, it is 
still suggested that thorough washing, disinfecting, and drying is the preferred method to 
disinfect pig trailers to reduce the risk of transmitting PEDV between groups of animals, 
rather than any approach alone (Thomas et al., 2014), and this sanitation strategy may also 
apply to other equipment or facility for the same purpose. It is noteworthy that none of the 
evaluated disinfectant above was able to produce completely negative real-time reverse 
transcription PCR (rRT-PCR) results, although the leftover virus was no longer infectious.   
 
2.5 PEDV Diagnosis 
To control PEDV, it is critical to detect outbreak in time to monitor PEDV circulation 
and change, as well as antibody levels. Based on the clinical signs and macroscopic lesions, 
PEDV infection can be suspected. However, laboratory testing needs to be performed to 
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confirm and differentiate PEDV infection from other enteric pathogens causing similar 
clinical signs and lesions.  
2.5.1 Virological detection assays (detection of virus particles, viral antigen, viral 
nucleic acid, and viable virus) 
2.5.1.1 Electron microscopy (EM) 
Electron microscopy allows direct visualization of virus particles. Electron 
microscopy was employed in the discovery of PEDV as a new virus different from TGEV 
(Pensaert & De Bouck, 1978). Observation of PEDV virion under EM is achievable from 
clinical samples with negative-stain method and ultrathin-section method, or from infected 
cells or tissues with ultrathin-section method (Ducatelle et al., 1981; Oka et al., 2014; 
Pospischil et al., 2002). Viral morphology can be identified under EM, but consequently, the 
diagnosis can only be narrowed down to viral family level. However, such EM results can 
provide valuable clues for further diagnostic test selection and development. The EM result 
can also serve as supporting diagnosis to other tests in initial PEDV outbreak, when other 
tests are not well evaluated (Stevenson et al., 2013). Ultrathin-section and negative-stain are 
also used for research to study ultrastructure of virus morphology, location of virus in 
infected cells, and the morphology of infected cells (Ducatelle et al., 1981; Pospischil et al., 
2002). Electron microscopy requires expensive equipment, reagents, and well-trained 
technician. EM is generally labor intensive. It may take the examiner hours to locate a virus 
particle of interest, and this can be largely extended if the virus concentration in the sample is 
low. However, EM has the advantage of the protocol being generally universal, non-specific 
to pathogen. This distinguishing feature is feasible for unknown pathogen diagnosis. 
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Therefore, EM can be an essential diagnostic test upon the PEDV initial outbreak in a region, 
where other tests are not available or not well evaluated. 
2.5.1.2 Virus isolation (VI)   
A classical tool to detect viable PEDV is to isolate and propagate the virus in cell 
culture from clinical samples (Hofmann & Wyler, 1988; Lee et al., 2015b; Oka et al., 2014; 
Temeeyasen et al., 2014). It is currently the only in vitro test that detects live PEDV in 
clinical samples. Differentially detecting live virus from dead virus particles is sometimes 
critical for assessing the risk of PEDV contaminated feed, equipment and environment. The 
appearance of cytopathic effect (CPE) is necessary for PEDV VI result confirmation, and 
also labeling virus on infected cells with visible conjugated antibodies is usually needed. By 
further plaque purification and propagation, a more homologous virus clone with higher virus 
concentration and expanded volume can be obtained. Besides serving as a diagnostic tool, the 
VI can also provide essential material for further applications, including inoculum material 
for reproducing the disease model, virological and serological assay development, and 
vaccine development. The relatively low sensitivity precludes the wide use of PEDV VI as a 
routine diagnostic tool. Thus, PEDV VI is mainly performed with the purpose to obtain a 
virus isolate with special characters. Nevertheless, collecting samples with potential high 
virus concentration and properly storing samples on dry ice all the time to keep the virus 
alive can be critical for increasing the VI success rate.  
African green monkey kidney (Vero) cell lines are most commonly used for PEDV 
VI with the addition of extraneous trypsin into culture media (Hofmann & Wyler, 1988). 
Characteristic PEDV CPE on Vero cells is the formation of syncytial bodies. Virus isolation 
is generally time-consuming, especially for PEDV VI on Vero cells. Virus may need several 
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blind passages to adapt to cell culture before efficient replication. Other immortalized cell 
lines including swine small intestinal epithelial cells (IEC and IPEC-J2), Marc-145 (MA104 
derived epithelial monkey kidney cells), MA104, MPK, and CPK, duck intestinal epithelial 
cells naturally expressing pAPN, and non-permissive cells transfected with pAPN cDNA can 
all support the growth of Vero cell-adapted PEDV isolate, but none of these cell lines have 
been evaluated for VI efficiency from clinical samples (Cong et al., 2015; Khatri, 2015; 
Lawrence et al., 2014; Li et al., 2007; Nam & Lee, 2010; Sato et al., 2011; Zhao et al., 
2014b). Therefore, discovering more susceptible cell lines for PEDV and modifying VI 
procedures to improve VI success rate is still desirable.   
2.5.1.3 Bioassay 
Since neonatal pigs are very susceptible to U.S. PEDV prototype strain infection 
(Thomas et al., 2015a), swine bioassay using neonatal pigs for detecting live PEDV can be a 
sensitive diagnostic tool (Dee et al., 2014a). In spite of the time for IACUC approval, 7 days 
should be enough for virus incubation in inoculated pigs, which is shorter than PEDV VI in 
cell culture in most cases. It may also maintain the virulence of PEDV as a method of 
propagating virus in the natural host, but the purity of PEDV cannot be guaranteed. Notably, 
it has not been evaluated whether neonatal pigs are the most susceptible population for all 
PEDV strains. The intensive labor, space, and equipment requirement makes bioassay hard to 
perform widely or with large-scale. In addition, it is not a humane way as a routine test.  
2.5.1.4 PCR  
To detect the presence of PEDV viral RNA, multiple RT-PCRs have been developed 
targeting different regions of viral genome (Li et al., 2012b; Miller et al., 2015; Yuan et al., 
2015; Zhao et al., 2014a). Screening RT-PCRs targeting conserved genes of PEDV can 
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detect different strains of PEDV, while multiplex RT-PCRs can also be developed to 
differentiate PEDV strains by targeting the variable regions of the genome, or differentiate 
PEDV from other viruses (Lin et al., 2015; Wang et al., 2014b; Zhao et al., 2013; Zhao et al., 
2014a). Real-time reverse transcription PCR (rRT-PCR) has probably been the most 
extensively used method for PEDV detection amongst all virological detection tests. The 
advantages of rRT-PCR also include the capabilities for semi-quantitation or quantitation, 
high throughput applications, and rapid turnaround time (Miller et al., 2015). The 
sensitivities and specificities of different PEDV rRT-PCRs may vary between each other, but 
generally PEDV rRT-PCRs have superior sensitivity (could be ~1 RNA copy/reaction) 
(Miller et al., 2015). When RNA concentration is low in the sample, the results can be 
scattered between repeated reactions with a variety of factors (Miller et al., 2015). In addition 
to advantages in performance, it is quick to develop a new rRT-PCR. As a result of the 
standardization of rRT-PCR reagents and conditions across different primers, developing a 
new rRT-PCR usually only requires the design and synthesis of primers and probes, which 
generally takes less than a week.  
While useful, currently available PCRs do not have the capability to determine the 
viability of virus, and reports showed some PCR-positive samples were not infectious in 
bioassay (Opriessnig et al., 2014; Pillatzki et al., 2015; Thomas et al., 2015b). Particularly, 
quite a few of disinfectants were shown to be able to efficiently inactivate PEDV in the 
environment, but still left PCR detectable PEDV RNA, hence caution is needed when 
interpreting weak positive PEDV PCR results from environmental samples (Bowman et al., 
2015b; Thomas et al., 2015b). Intercalating dye propidium monoazide (PMA) can penetrate 
through damaged virus and bacteria, intercalate into viral DNA/RNA, and block the binding 
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of DNA and PCR primers (Karim et al., 2015; Parshionikar et al., 2010). Pre-treating 
samples with PMA enabled PCR to differentiate live poliovirus (an RNA virus) from heat or 
hypochlorite inactivated virus, but not Norwalk virus (Karim et al., 2015; Parshionikar et al., 
2010). Such experience indicates the possible prospect for developing RT-PCRs to 
differentiate live PEDV from dead PEDV.  
It requires trained technicians, expensive equipment and DNase/RNase free 
environment to perform rRT-PCR. While with modified PCR reagents and simplified 
reaction conditions, qualitative RT-PCR can be run on portable devices. Portable PCRs 
provide the possibility to perform PCR rapidly on-site with comparable test accuracy to rRT-
PCR. For example, insulated isothermal PCR (iiPCR), and Palm PCR are two such devices 
that could provide rapid, pen-side testing and results (Lim et al., 2014; Zhang et al., 2016a). 
Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is an alternative 
method for PEDV RNA detection that only requires an isothermal conventional water bath 
(Ren & Li, 2011; Yu et al., 2015). Multiple pairs of primers need to be involved in RT-
LAMP to amplify target DNA in dumbbell-shaped stem loop to cauliflower-like bearing 
multiple loop structures (Ren & Li, 2011). Real-time RT-LAMP for PEDV has similar 
sensitivity and speed as PEDV rRT-PCR, and results can be read with a real-time 
turbidimeter or be visualized with fluorescence (Yu et al., 2015). The simple equipment 
requirement offers real-time RT-LAMP a promising potential for further development for on-
site application.  
2.5.1.5 Sequencing   
Determining nucleic acid sequences of PEDV helps monitor virus genetic variation 
and evolution. Two sequencing methods are predominantly used for PEDV research and 
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diagnostic purposes. Sanger sequencing is the traditional method that requires design of 
virus-specific primers. Since PEDV has a large genome, Sanger method may need 12 pairs of 
overlapping primers to amplify the cDNA fragments to determine the whole genome 
sequences (Chen et al., 2011), and roughly 40 pairs of primers for sequencing to achieve 2 
reads per site. To enhance sequence accuracy and success rate, the target gene is usually 
cloned into vectors to increase target gene quantity (Chen et al., 2008; Lee et al., 2010). As a 
result, Sanger method is usually performed to determine partial genome of PEDV to study 
virus genetic variation (Li et al., 2012a; Li et al., 2012b).  
In recent years, next generation sequencing (NGS) with different platforms have 
gained more popularity as an alternative sequencing tool (Hoang et al., 2013; Marthaler et 
al., 2013; Zhang et al., 2016b). Next generation sequencing is characterized with universal 
targeting capacity, low cost per base, short turnaround time, and high-throughput capacity 
(Zhang et al., 2016b). These features allow multiple, entire viral genome sequences to be 
rapidly determined with NGS in a single reaction with low cost (Zhang et al., 2016b). In 
addition, NGS does not require specific primers to sequence viruses, so this also provides the 
possibility to discover mutant PEDV sequences and unknown pathogens through NGS 
(Boniotti et al., 2016; Marthaler et al., 2014; Oka et al., 2014). However, due to mass non-
specific information output from NGS, the sequences of interest are immersed in large scale 
of host cell or environmental microbe sequences. Thus, much more advanced bioinformatics 
analysis is required to extract and assemble the target sequences, as compared to Sanger 
sequencing.  
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Furthermore, both sequencing methods have the same shortcoming. To determine 
whole genome sequence of a virus, the cDNA of 5’ and 3’ ends need to be amplified 
differently from the rest part of the genome in both methods (Chen et al., 2011).  
2.5.1.6 Antigen capture enzyme-linked immunosorbent assay (AC-ELISA) 
Assays based on the AC-ELISA principle using two PEDV antisera, as detector 
antibody and capture antibody, respectively, were developed to detect PEDV antigen 
(Carvajal et al., 1995a). Qualitative lateral flow immunochromatography (IC) assays based 
on the AC-ELISA principle are commercially available with the advantages of rapid 
detection, capability for long-term storage, and ease of operation (Chen et al., 2015b; Kim et 
al., 2015). Despite the lower sensitivity than rRT-PCR (Chen et al., 2015b; Kim et al., 2015), 
lateral flow IC assay is applicable for rapid detection of PEDV on site and for diagnostic 
laboratories without the capacity to perform PEDV rRT-PCR routinely. The development 
and the use of AC-ELISA as a tool to detect PEDV antigen is less preferred with the wide 
use of rRT-PCR in U.S. veterinary diagnostic laboratories.  
2.5.1.7 Immunohistochemistry (IHC) and In Situ hybridization (ISH)  
To detect virus in host cells in situ, staining viral protein with IHC or staining viral 
RNA with ISH is widely applied (Kim & Chae, 2000; Madson et al., 2014). By visualizing 
the virus location in host animal tissues, IHC and ISH not only associate lesions with virus 
infection site, but also are a tool to study viral tissue tropism. Since each IHC cross section 
only presents a layer of cells of the whole organ, analytical sensitivity of IHC can be lower 
than rRT-PCR when antigen concentration decreases (Burrough et al., 2015). However, IHC 
results may better predict the correlation between the detected antigen and the observed 
disease, as compared to PCR (Burrough et al., 2015). Comparing IHC and ISH, it should be 
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faster to generate ISH probes than generating antibodies for IHC. In addition, the possibility 
of antigenic cross-reactivity may be lower in ISH than in IHC, and viral protein can be 
denatured during formalin fixation and result in reduced IHC sensitivity (Kim & Chae, 
2000). 
2.5.2 Antibody detection 
2.5.2.1 ELISA  
Multiple ELISAs based on different whole viruses or individual proteins have been 
developed and extensively used to detect antibodies against PEDV (Carvajal et al., 1995a; 
Gerber et al., 2014a; Hou et al., 2007a; Kweon et al., 1999; Oh et al., 2005; Okda et al., 
2015; Ouyang et al., 2015; Thomas et al., 2015a). Generally, toxicity in the sample is not a 
concern for ELISA, thus ELISA can be applied to multiple samples types, including serum, 
colostrum/milk, oral fluid, and feces. An optical density (OD) value from the ELISA plate 
can be measured automatically with a plate reader, and the unknown sample OD is usually 
adjusted with the ODs of blank well controls and positive controls (Carvajal et al., 1995a; 
Thomas et al., 2015a). While OD values can be compared to quantitate results (Kweon et al., 
1999; Thomas et al., 2015a), the relative antibody titer levels can also be determined by 
serial dilution of samples. ELISA can also specifically detect different immunoglobulin (Ig) 
isotypes (Hou et al., 2007a; Ouyang et al., 2015).  It is worth noting that antibody level 
detected by ELISA may not associate with the viral inactivating capability, since the single 
Ig type includes multi-clones of antibodies binding to different domains of detector antigen. 
Some of the labeled Ig clones may not be responsible for the neutralization function, and 
other Ig types associated with neutralization may not be labeled. 
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2.5.2.2 Virus neutralization (VN) assay  
The advantage of VN, also known as fluorescent focus neutralization assay (FFN), is 
to evaluate the antibody functional ability to neutralize and inactivate live virus in vitro 
(Okda et al., 2015). Since live cells are involved, the non-sterilized samples need UV and 
heat inactivation before use to reduce potential cytotoxicity and bacterial contamination 
(Ouyang et al., 2015). Currently, serum and colostrum/milk are primary sample types for VN 
assay (Okda et al., 2015; Song et al., 2007), but fecal samples, oral swab and plasma can also 
be tested by VN (Ouyang et al., 2015). Neutralizing antibody levels can also be relatively 
quantitated by serial dilution of samples (Song et al., 2007; Thomas et al., 2015a). However, 
determining antibody titer, it still requires subjective manual reading which is time 
consuming, labor intensive and easily biased by human variation (Oh et al., 2005). False 
positive results can be noticeably observed at low VN titer (1:2 and 1:4) due to non-specific 
reaction (Oh et al., 2005). Samples, for instance serum and colostrum/milk, can neutralize 
trypsin in PEDV growth media, and subsequently inhibit virus growth and display false 
positive results. Thus, it is required to completely wash the sample off from cells after 
incubating samples and virus with cells, as trypsin is necessary for PEDV growth. Since the 
replication of virus and cells are involved in VN, the turnover time for VN needs multiple 
days, which is longer than most of the other serological tests including ELISA, indirect 
fluorescent antibody (IFA), and fluorescent microsphere immunoassay (FMIA).  
2.5.2.3 Indirect fluorescent antibody (IFA) assay  
Similar to the principle of ELISA, PEDV antibodies in samples can bind to virus 
coated in an IFA plate, and the PEDV antibodies can be visualized with fluorescent labeled 
anti-swine Ig antibody. (Okda et al., 2015; Thomas et al., 2015a). Differently, the virus in 
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IFA assay is usually coated in plate by fixation of PEDV infected cells (Okda et al., 2015). 
Antibody level can be relatively quantitated by serial diluting samples (Thomas et al., 
2015a). Fluorescent results also need to be read manually, so IFA is also time consuming, 
labor intensive and remains subjective in interpretation (Okda et al., 2015). IFA is also able 
to label different Ig isotypes separately, and again the IFA antibody titer may not correlate to 
the functional virus inhibiting efficiency. Non-specific staining by fluorescence labeled 
secondary antibodies sometimes complicates the result determination. 
2.5.2.4 Fluorescent microsphere immunoassay (FMIA)  
The bead-based fluidic and particle array, FMIA, has been increasingly adapted for 
serologic diagnosis in recent years (Langenhorst et al., 2012; Lawson et al., 2010). One 
advantage of FMIA is to simultaneously detect antibodies against multiple pathogens in a 
single reaction (Lawson et al., 2010; Okda et al., 2015). In addition, quantitative results, 
presented as median fluorescent intensity (MFI), are interpreted automatically by a reader. 
Overall, these advantages of FMIA offer the high throughput capability to simultaneously 
screen antibodies against a multiplex of infections, for surveillance purposes and for studying 
kinetics of different types of antibody (Okda et al., 2015).  
2.5.3 Summary of PEDV diagnosis  
More sensitive diagnostic tests can provide higher confidence to interpret the 
contamination/infection status of a sample, but detection limit and sensitivities should be 
considered conjunctively. When virus concentration is close to the limit of detection and 
unevenly located in the sample, the sensitivity of an assay can decrease significantly. Thus, 
the virus may not be detected, even by an overall highly sensitive diagnostic test, especially 
when small a volume of sample is tested. However, samples with low virus concentration 
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indicate a high collective risk at the pig farm level and may eventually result in infected pigs, 
which leaves the dilemma for managing contamination of pig feed  (Davies, 2015). 
Increasing sample size or repeat testing of the same sample will increase the possibility to 
detect the target, when low virus concentration is targeted in the population. 
Different PEDV serological tests have their own advantages and disadvantages, so a 
whole repertoire of tests is beneficial (Okda et al., 2015). Comparison showed high level of 
testing agreement among PEDV IFA, FMIA and ELISA assays (Okda et al., 2015). 
Gimenez-Lirola et al. (2014) showed whole virus based ELISA detected IgG antibody longer 
than IFA assay after infection (Giménez-Lirola et al., 2014). Detecting PEDV antibodies not 
only indicates the antibody distribution and the immunity level of an animal, but also 
indicates an infection history of a non-immunized herd, since antibodies last longer than 
PEDV virus shedding in pigs. Therefore, antibody assays can also be used to retrospectively 
study PEDV epidemiology. However, PEDV is evolving continuously, and there are already 
multiple strains existing in the world. The efficiency of any antibody assay with a single 
antigen as an indicator to detect antibody induced by different strains is not reported yet, 
which remains indispensable to be evaluated. Such efficiency can reveal whether any PEDV 
serological assay can be used to identify infection strains, determine how many PEDV 
serotypes there are, and deduce the in vivo cross protection efficacy amongst strains.    
 
2.6 Disease Control Strategies 
2.6.1 Feedback 
During the initial PEDv outbreak in a region, there may not be licensed vaccine 
available to control PEDV spread and importing foreign vaccines should be a very cautious 
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decision, due to several potential downsides (Chattha et al., 2015). In the lack of effective 
vaccines against PEDV, intentionally infecting naïve pigs with pooled diarrheic feces and/or 
homogenized intestines from acutely infected suckling pigs is commonly practiced at a whole 
herd level (Jung & Saif, 2015; Olanratmanee et al., 2010; Stevenson et al., 2013). 
Simultaneous feedback containing wild-type live virus to all sows can build herd-wide 
immunity and subsequently eliminates virus shedding from all sows at similar time in the 
herd and reduces neonate mortality (Chattha et al., 2015; Olanratmanee et al., 2010). With a 
large amount of live virus infecting through natural infection, feedback measure has the 
capability to stimulate a strong immune response including humoral, gut mucosal and 
maternal immunity in pregnant sows (Gerber & Opriessnig, 2015; Okda et al., 2015). 
Consequently, neonatal pigs will be protected by maternal antibodies from sows through 
colostrum and milk (Song et al., 2015). The protection efficacy of immunizing weaned pigs 
and suckling pigs was also demonstrated previously. Orally immunizing weaned pigs with 
wild-type live virus can protect pigs against subsequent homologous challenge by completely 
preventing infection at 11 weeks of age (Crawford et al., 2015), and immunization with wild-
type virus in suckling pigs prevented clinical diseases against challenge at 4 weeks of age 
(Lin et al., 2015). In addition, feedback virus is homologous to the circulating virus in the 
specific farm, so mismatch of immunization and challenge antigens will be minimal. In the 
case of piglets showing illness and shedding high level of PEDV, the infected piglets can still 
transmit the disease to other piglets in spite of sow lactogenic immunity. Thus, monitoring 
and removing piglets with PEDV clinical signs is also critical for PEDV control in a herd 
with feedback procedure (Chattha et al., 2015). However, the differences between feedback 
measure and modified live vaccine need to be kept in mind: 1) the potential risk to transmit 
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other pathogens through feedback; 2) the risk of spreading PEDV to other farms; 3) 
potentially asymmetric virus concentration in feedback material, consequently resulting in 
inconsistent efficiency to induce sow immunity, especially in a convalescent farm where the 
virus circulating level may be much lower than acute outbreak; and 4) high virulence of the 
virus in feedback materials may lead to severe clinical diseases in sows and gain virulence, 
especially with the presence of other factors that can vary the disease severity (Chattha et al., 
2015; Olanratmanee et al., 2010; Song et al., 2015). Taken together, safe and effective 
vaccines are still on demand.  
2.6.2 Vaccination 
Inactivated (killed) vaccines and modified live vaccines (MLV) based on cluster I 
strains are routinely applied in Asian countries including China, South Korea, and Japan 
(Kadoi et al., 2002; Kweon et al., 1999; Lee, 2015; Song et al., 2015; Sun et al., 2015a). 
Commercial vaccines used in Korea can reduce neonatal pig mortalities, but not morbidity 
including diarrhea or virus shedding (Lee, 2015). In the U.S., only conditionally licensed 
inactivated vaccines and vectored vaccines based on U.S. prototype PEDV strain are 
available on the market. Since PEDV caused much less clinical disease in Europe before 
2014, a vaccine is not available in European countries.  
Prolonged immune pressure from vaccine or infection may increase the virus 
variation and a large variety of PEDV strains have evolved world-wide (Sun et al., 2015a). 
Strain mismatch between vaccine and circulating virus may be contributed to the limited 
efficacy of PEDV MLV in the field (Lee, 2015). Although the cross-protection efficacy has 
not been evaluated yet to confirm this suspect, the urgency of developing a new vaccine that 
is more genetically close to current field strain is advocated (Lee, 2015; Song et al., 2015; 
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Sun et al., 2015a). New PEDV vaccines based on U.S. prototype-like strains are under 
development in Asia (Lee, 2015; Lee & Lee, 2014). CV777 should still protect cluster II 
virus, since they share the conserved neutralizing epitope, but protection efficacy can also be 
affected by the format of vaccine (Hao et al., 2014; Sun et al., 2015a). In vitro study 
evaluated that S proteins and IgG against S proteins from a cluster I and a cluster II PEDV, 
respectively, were able to cross-react and cross-neutralize with each other with reduced 
heterologous titers (Wang et al., 2015). It was also revealed in vivo that immunity induced by 
U.S. S-INDEL-variant strain containing genogroup I S gene partially protected pigs against 
challenge with a U.S. prototype strain containing genogroup II S gene (Goede et al., 2015; 
Lin et al., 2015). Whether a genogroup II based vaccine can provide more advanced 
protection to genogroup II virus challenge than current genogroup I based vaccine needs to 
be further compared.  
Since PEDV is associated with high mortalities in neonatal piglets, reducing suckling 
pig mortality due to PEDV in the first few days after delivery is the priority of PEDV 
vaccination. Vaccinating pregnant sows or gilts to protect neonatal piglets with passive 
maternal antibodies in colostrum and milk is commonly practiced. However, monitoring 
sanitization and factors affecting lactation performance is also important, so that sows can 
provide enough milk to litters (Lee, 2015).  
2.6.2.1 Modified live vaccines  
Cell-adapted PEDV acquires attenuation through high serial passages on Vero cells 
(Kweon et al., 1999; Sato et al., 2011). Genetically, S proteins of the Korean and Japanese 
attenuated vaccine strains mutated at similar sites and more closely resemble each other than 
their parent virus (Sato et al., 2011). Therefore, it seems that the S gene mutations in Vero 
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cells of these two strains were under one-directional selective pressure (Sato et al., 2011). 
Nevertheless, the determining mutation(s) for PEDV virulence attenuation in vivo is still not 
clearly identified yet.  
The opinion on the efficacy of Asian MLV is contradictory (Lee, 2015; Li et al., 
2012a; Song et al., 2015). The efficacy of orally immunizing pigs at different ages with wild-
type live virus has been discussed above in the “feedback” section. This may imply the 
potential efficacy of MLV as a promising vaccine. It was shown that a China commercialized 
trivalent TGVE, PEDV (CV777 strain) and porcine rotavirus (G5 type) MLV reduced the 
incidence of diarrhea from 8%-12% to 3%-5% in trials (Sun et al., 2015a). However, the 
MLV attenuated strain may partially lose tropism for the natural host as indicated by 
shedding less virus and presenting as less immunogenicity, compared to virulent virus 
inoculation (de Arriba et al., 2002; Song et al., 2005). De arriba et al. (2002) showed that the 
CV777 strain MLV vaccination was not as protective as wild-type live virus immunization in 
preventing infection in weaned pigs (de Arriba et al., 2002). Therefore, successful protection 
is more likely to result with more efficient replication of MLV in pigs. Another factor that 
affects MLV efficacy is the administration route. Orally immunizing pregnant sows with 
attenuated PEDV resulted in significantly higher levels of serum and colostrum IgA and 
lower neonatal piglet mortalities than intramuscularly (IM) immunizing sows (Song et al., 
2007). Nonetheless, the differences of serum IgG levels and serum VN titers were not 
statistically significant between two routes of administration in sows, and reduced neonate 
mortality was also observed in IM vaccination, as compared with the non-vaccinated group 
(Kweon et al., 1999; Song et al., 2007). Piglets from orally vaccinated sows also had higher 
serum IgA and VN titers than those from IM vaccinated sows (Song et al., 2007). Therefore, 
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the different IgA content in colostrum that resulted from oral and IM immunization may have 
determined the mortality differences (Song et al., 2007). Secretory IgA showed more 
resistance to intestinal proteolytic degradation than IgG and serum IgA, and was more potent 
in the gut system than IgG (Offit & Clark, 1985). In addition to the importance of IgA, the 
concept of a common mucosal immune system also implies the potential advantages of oral 
immunization (Mestecky, 1987). Protection efficacy of oral MLV also depends on vaccine 
virus concentration (de Arriba et al., 2002). Despite reduced mortalities, virus shedding may 
not be completely prevented by MLV vaccination (de Arriba et al., 2002; Song et al., 2007). 
Cumulatively, regardless of virus and pig variation, the protection efficacy of PEDV MLV 
against homologous challenge can be varied by the MLV virus immunogenicity in pigs, 
administration routes, and MLV virus concentration per dose.   
Multiple dose vaccination, with the combination use of MLV and inactivated 
vaccines, is recommended in sows or gilts in Korea in the following order: live-killed-killed 
or live-live-killed-killed, respectively (Lee, 2015). A second dose of parental 
inactivated/subunit TGEV vaccine via IM route was also shown to boost IgA in milk and 
colostrum in orally TGEV primed sows (Chattha et al., 2015). Nonetheless, it was shown that 
the 2nd dose of oral vaccination with attenuated PEDV virus can boost colostrum IgA level, 
but not for IM vaccination (Song et al., 2007).  
A disadvantage of MLV is the long developing period. It generally takes longer to 
commercialize an MLV than a non-viable vaccine (killed vaccines, subunit vaccines, and 
vectored vaccine), since safety and stability of the vaccine virus need to be determined as 
well as efficacy. In addition, killed vaccine can obtain conditional license even faster with 
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assured purity, safety, and a reasonable expectation of efficacy before the completion of all 
required efficacy testing (Chattha et al., 2015). 
2.6.2.2 Killed vaccines 
Live virus can be inactivated, for example with binary ethylenimine (BEI), to serve as 
killed vaccine (Collin et al., 2015; Song et al., 2015). Killed vaccines with classical strains, 
for instance SM98-1 and CV777, have been vastly applied in Asian countries along with 
MLVs (Lee, 2015; Sun et al., 2015a). A conditional licensed killed vaccine based on U.S. 
prototype strain has also been commercially available in the U.S. since 2014. However, the 
efficacy of killed vaccines was not revealed comprehensively. The short duration of 
protection and the need of multiple booster immunizations with high concentration are the 
limitations of the use of killed vaccines (Sun et al., 2015a). 
In the situation with a wide range of PEDV variance and limited cross-protection 
efficacy amongst strains, autogenous killed vaccine can be a safe option to provide 
homologous protection to the target pig farms. However, due to the difficulty of isolating 
PEDV in cell culture, generating autogenous killed PEDV vaccine can be a challenge. Collin 
et al. (2015) revealed a U.S. prototype based autogenous killed PEDV vaccine showed dose 
dependent immunogenicity (Collin et al., 2015).   
2.6.2.3 Genetically engineered vaccines (GEV) 
All GEVs are under experimental development currently and are not commercially 
available, except Alphavirus replicon particle (RP) based PEDV vaccine with conditional 
licensure in the U.S. The common advantage of GEVs is the capacity of differentiating 
infected from vaccinated animals (DIVA). 
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Since S protein contains multiple neutralizing epitopes, S1 or the entire S gene is the 
primary target when only partial genome of the virus is used as a vaccine candidate, for 
instance, subunit vaccines, RNA/DNA vaccine, infectious vectored vaccines, and 
recombination vaccines. With IM administration, both boosting with an experimental S1 
subunit vaccine following MLV prime and 2 doses of S1 subunit vaccination resulted in low 
VN titers in sera and in colostrum, in contrast to the high VN titers that resulted from a killed 
vaccine booster following MLV prime in sows (Oh et al., 2014). Surprisingly, all three 
vaccination measures resulted in mild intestinal lesions in neonates, as compared to 
moderate-to-severe villus atrophy in non-vaccinated groups (Oh et al., 2014). In addition, 
vaccination involving at least 1 dose of S1 subunit reduced overall diarrhea degree more 
efficiently than MLV followed by killed vaccine (Oh et al., 2014).  
Bacteria displaying PEDV protein on the surface may enhance the recognition of 
PEDV protein by the immune system and mediate adjuvant effect with bacterial surface 
components (Hou et al., 2007b). With generally accepted safety and the capacity to survive 
and colonize in intestinal tract, Lactobacillus casei (L. casei) is an ultimate vector candidate, 
which may display PEDV protein continuously in gut and increase the exposure dose to pigs. 
PEDV N protein was successfully expressed on surface of L. casei with the poly-γ-glutamate 
synthetase A protein (pgsA) of Bacillus subtilis as an anchoring matrix, and even heat-killed 
recombinant L. casei significantly increased serum IgG and colostrum IgA in orally infected 
sows and piglet IgG against N protein (Hou et al., 2007b). In another study, recombinant L. 
casei, either surface expressing or secreting PEDV COE, and adjuvant Escherichia coli heat-
labile enterotoxin B (LTB) were able to stimulate the secretion of IgA and IgG in 
orogastrically immunized mice (Ge et al., 2012). Liu et al. (2012) further demonstrated that 
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mixture of L. casei respectively expressing S1 and N will induce more IgA against S1 and 
higher titers of VN antibodies than L. casei expressing S1 only in mice (Liu et al., 2012). 
Alphavirus RP as a vaccine vector is intended to infect pigs and express PEDV protein in 
vivo in a single viral replication cycle. Because of mature production technology, RP vector 
has the advantage of rapidly developing novel vaccines and autogenous vaccines (Chen et 
al., 2012b). In addition, RP vector is infectious but replication deficient, so it can express 
foreign protein at a high level without involving any live pathogen in vivo (Chen et al., 
2012b). Yet, protection efficacy of these vectored recombinant PEDV vaccines remains 
uncertain in pig models.   
Experimental DNA vaccine expressing PEDV S1 has been developed in eukaryotic 
expression vector (Meng et al., 2013). By IM immunizing mice, the DNA plasmid was able 
to mediate promising neutralizing antibodies and to effectively activate cell mediated 
immune (CMI) responses (Meng et al., 2013), although the role of CMI in controlling the 
impact of PEDV is uncertain. In addition, DNA vaccines have the potential to avoid existing 
immunities against PEDV (Chen et al., 2012b). On the other side, low transportation 
efficiency into target cells and low expressing efficiency of target protein in vivo usually 
hinders practical usage of DNA plasmid as a vaccine candidate (Chen et al., 2012b). 
2.6.3 Supplemental prophylactic and therapeutic measures 
Artificial passive immunization (prior to PEDV challenge) and therapeutic treatment 
(after PEDV challenge) have been attempted with different recipes. Neonatal mortalities 
against PEDV challenge were reduced in therapeutic treatment with continuous 
administering neonatal piglets with oral IgY from egg yolk of PEDV immunized chickens 
(anti-PEDV IgY) (Kweon et al., 2000). In addition, anti-PEDV-S1 IgY was generated 
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similarly and was further evaluated. Specifically, 2 doses of anti-PEDV-S1 IgY or anti-
PEDV IgY were orally administrated to neonatal pigs after PEDV challenge, respectively. 
Significant reduction in viral shedding was observed in both IgY treated groups, as compared 
to placebo treated group (Lee et al., 2015a). Meanwhile, anti-PEDV-S1 IgY was found to 
decrease both macro-pathological and histo-pathological lesion severity more efficaciously 
than anti-PEDV IgY (Lee et al., 2015a). A meta-analysis was performed to assess the IgY 
treatment effect on overall diarrhea caused by different pathogens. The analysis revealed that 
passive immunization by oral administration of IgY significantly reduced diarrhea relative 
risk (RR) in pigs, as compared to placebo treatment, although 95% confidence interval of RR 
included 1 (Diraviyam et al., 2014). Therapeutic treatment with hyperimmune cow colostrum 
(HCC) was also shown to prevent PEDV infection and reduce piglet mortality, and the 
protection efficacy was HCC dose dependent (Shibata et al., 2001). Poonsuk et al. 
demonstrated the partially ameliorated effect of passive intraperitoneally administrated anti-
PEDV IgG antibodies by the higher neonate survival rate against PEDV challenge (Poonsuk 
et al., 2016). Overall, the concept of preventing or reducing the negative impact of PEDV 
infection with the passive immunization and therapeutic treatment methods has been proven. 
However, generating these non-porcine originated materials usually requires 
hyperimmunizing animals with large amount of antigens, which may be the obstacle for the 
wide application of these treatments. Therefore, developing technology to economically 
produce such materials can be the focus of future studies. 
Novel vaccine adjuvant development has also been endeavored. Injection of soluble 
pAPN is able to enhance the PEDV antibody production after challenge in Guinea pigs and 
rabbit, but not in sows (Oh et al., 2004). The less effect observed in sows may be due to the 
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insufficient amount of pAPN administered to the sows, since sows may hold abundant pAPN 
naturally (Oh et al., 2004). Escherichia coli heat-labile enterotoxin B (LTB) has also been 
adopted as a molecular adjuvant, and it showed enhancing effect at inducing mucosal IgA, 
humoral IgG, CMI, and VN antibodies in recombined L. casei co-expressing LTB and PEDV 
COE (Ge et al., 2012). In addition, the GEV vectors themselves have adjuvant properties 
(Chattha et al., 2015). 
2.6.4 Biosecurity 
Last but not least, as none of the current vaccines has consistent and ideal efficacy, 
and feedback protocol seems too aggressive, implementing strict biosecurity to keep the pig 
farms free of PEDV is considered as another key to control PEDV outbreak (Lee, 2015). 
Blocking PEDV entry to a farm against lateral transmission and eliminating existing virus 
from the environment against vertical transmission are the two major components of pig farm 
biosecurity. Since it only requires very little amount of PEDV virus to cause infection in 
naïve piglets, it may not be easy to completely eradicate all the existing risks from a naïve 
farm without extreme effort. However, as reviewed above, abundant investigations have 
studied viral transmission and virus viability under different conditions, such as treatment 
with different disinfectants and different disinfection protocols. This current knowledge will 
guide improvement of farm biosecurity. To accomplish this, it is not recommended to share 
any resource, including space. Alternatively, thorough disinfection and sufficient downtime 
of all personnel and equipment prior to accessing the farm is required. For arriving pigs, feed, 
and other material that cannot be disinfected, the possibility of PEDV contamination needs to 
be excluded by tracking source history and using diagnostic tools. This is also the major way 
to stop PEDV transmission across borders.  
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2.7 Conclusions and Objectives of This Dissertation 
In conclusion, to efficiently control PEDV, a repertoire of diagnostic assays needs to 
be offered routinely for rapidly detecting PEDV infection and monitoring PEDV 
epidemiology, as well as for subsequent rapid response. In addition, deeper understanding of 
PEDV features and developing means to stop the virus transmission is still vital, including 
virus disinfection, biosecurity, and vaccination. 
Tremendous knowledge on PEDV has been learned in recent years. However, when 
PEDV emerged in the U.S. 3 years ago (in 2013), many questions related to PEDV diagnosis, 
pathogenesis, transmission, disinfection, immunity, prevention, and control were unknown. 
Diagnosticians at the Iowa State University Veterinary Diagnostic Laboratory were the first 
to detect PEDV in U.S. swine and were the first to identify two genetically different PEDV 
strains circulating in the U.S. (U.S. PEDV prototype strain and U.S. PEDV S-INDEL-variant 
strain). However, before the work described in this dissertation was implemented, there 
lacked knowledge on various aspects: how to efficiently isolate PEDV from clinical samples 
and grow the virus in cell cultures? Can the U.S. prototype strain-based serological assays 
detect antibodies against both U.S. PEDV strains? What are the pathogenicity differences 
between the two U.S. PEDV strains in pigs at different ages? Is there cross-protection 
between two U.S. PEDV strains? The objectives of this dissertation are: 1) to isolate and 
characterize two U.S. PEDV strains in cell cultures; 2) to determine the serological cross-
reactivity between U.S. PEDV strains; 3) to compare pathogenesis differences amongst U.S. 
PEDV strains and amongst pigs at various ages; 4) to evaluate cross-protection efficacy 
between U.S. PEDV strains in vivo.  
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Abstract 
Porcine epidemic diarrhea virus (PEDV) was detected in May 2013 for the first time 
in U.S. swine and has since caused significant economic loss. Obtaining a U.S. PEDV isolate 
that can grow efficiently in cell culture is critical for investigating pathogenesis and 
developing diagnostic assays and for vaccine development. An additional objective was to 
determine which gene(s) of PEDV is most suitable for studying the genetic relatedness of the 
virus. Here we describe two PEDV isolates (ISU13-19338E and ISU13-22038) successfully 
obtained from the small intestines of piglets from sow farms in Indiana and Iowa, 
respectively. The two isolates have been serially propagated in cell culture for over 30 
passages and were characterized for the first 10 passages. Virus production in cell culture 
was confirmed by PEDV-specific real-time reverse-transcription PCR (RT-PCR), 
immunofluorescence assays, and electron microscopy. The infectious titers of the viruses 
during the first 10 passages ranged from 6 × 102 to 2 × 105 50% tissue culture infective doses 
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(TCID50)/ml. In addition, the full-length genome sequences of six viruses (ISU13-19338E 
homogenate, P3, and P9; ISU13-22038 homogenate, P3, and P9) were determined. 
Genetically, the two PEDV isolates were relatively stable during the first 10 passages in cell 
culture. Sequences were also compared to those of 4 additional U.S. PEDV strains and 23 
non-U.S. strains. All U.S. PEDV strains were genetically closely related to each other 
(>99.7% nucleotide identity) and were most genetically similar to Chinese strains reported in 
2011 to 2012. Phylogenetic analyses using different genes of PEDV suggested that the full-
length spike gene or the S1 portion is appropriate for sequencing to study the genetic 
relatedness of these viruses. 
 
Introduction 
Porcine epidemic diarrhea (PED) was first observed in feeder pigs and fattening 
swine in England in 1971 (1). The causative agent, porcine epidemic diarrhea virus (PEDV), 
was identified in 1978 (2, 3). PEDV is an enveloped, single-stranded, positive-sense RNA 
virus belonging to the order Nidovirale, the family Coronaviridae, subfamily Coronavirinae, 
genus Alphacoronavirus (4). PEDV has a genome of approximately 28 kb and includes 5’ 
and 3’ untranslated regions (UTR) and 7 known open reading frames (ORFs) (5). ORF1a and 
ORF1b occupy the 5’ two-thirds of the genome and encode two replicase polyproteins (pp1a 
and pp1ab). Similar to other coronaviruses, expression of the pp1ab protein requires a -1 
ribosomal frameshift during translation of the genomic RNA (6). The 3’-proximal one-third 
of the genome encodes four structural proteins, including spike (S), envelope (E), membrane 
(M), and nucleocapsid (N) proteins, and one hypothetical accessory protein encoded by 
ORF3 (5). 
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During the 1970s and 1990s, PEDV caused widespread epidemics in multiple swine-
producing countries in Europe (2, 3, 7, 8). Since then, PED outbreaks have been rare in 
Europe, though occasional epidemics have been reported (9). In Asia, PED first occurred in 
Japan in 1982 (10), South Korea in 1993 (11), China (year unsure) (12, 13), and Thailand in 
2009 (14). PED remains a major concern in Asian countries, particularly China. Since 
October 2010, a severe PED epizootic has been affecting pigs of all ages that is characterized 
by high mortality rates among suckling piglets in many provinces of China, resulting in 
tremendous economic losses (15–21). 
PEDV was first detected in U.S. swine in May 2013 (22). Based on the USDA 
APHIS VS NVSL National Animal Health Laboratory Network (NAHLN) report, as of 28 
September 2013, a total of 679 PEDV-positive swine cases (1,750 positive swine samples) 
from over 17 states have been diagnosed in the following age groups: 123 suckling, 94 
nursery, 246 grower/finisher, 122 sow/ boar, and 94 unknown ages (www.aasv.org). PED in 
U.S. swine is characterized by watery diarrhea, dehydration, variable vomiting, and high 
mortality in affected swine, particularly neonatal piglets (22). The clinical disease and lesions 
of PED are indistinguishable from those caused by transmissible gastroenteritis virus 
(TGEV), another Alphacoronavirus. As an acute, highly contagious, and devastating enteric 
disease, PED has caused significant economic loss to the U.S. swine industry, though the 
corresponding monetary values remain unknown. 
Although a number of veterinary diagnostic laboratories quickly developed and 
launched PEDV-specific reverse-transcription PCR (RT-PCR) assays for accurate and rapid 
diagnosis of PEDV infection, more PEDV research is needed with regard to studying 
pathogenesis, evaluating the environmental stability of and effect of disinfectants on the 
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virus, developing and validating virological and serological diagnostic assays, and 
developing a live attenuated or inactivated vaccine for prevention and/or control of the 
disease. Obtaining a U.S. PEDV isolate that can grow efficiently in cell culture is critical for 
performing the aforementioned work. Attempts to grow PEDV in cell culture have proven 
difficult. Even if PEDV can be isolated from clinical samples, the virus may gradually lose 
infectivity upon further passages in cell culture. Here we report optimization of the 
procedures to isolate two U.S. PED viruses. At this time, the two isolates have been 
successfully serially propagated in cell cultures for over 30 passages, but only the first 10 
passages of viruses have been characterized and reported in this study. In addition to 
characterizing the growth and titer of the virus during the serial passages in cell culture, we 
have also determined the entire genome sequences of viruses at selected passages to study 
their genetic stability. The sequences of the two U.S. PEDV isolates at different passages 
were compared to those of 4 additional U.S. PEDV strains whose sequences had been 
determined from clinical samples and of 23 PEDV strains collected outside the United States 
with entire genome sequences available to date. Phylogenetic analysis using different genes 
of PEDV was also performed to determine the gene(s) suitable for studying the genetic 
relatedness and molecular epidemiology. 
 
Materials and Methods 
Clinical samples 
Thirty-three feces and 17 intestinal homogenates that tested positive by a PEDV N 
gene-based real-time RT-PCR at the Iowa State University Veterinary Diagnostic Laboratory 
(ISU VDL) were selected for virus isolation (VI) attempts. Small-intestine tissues were used 
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to generate a 10% (wt/vol) homogenate in Earle’s balanced salt solution (Sigma-Aldrich, St. 
Louis, MO). The suspension was centrifuged at 4,200 × g for 10 min at 4°C. The supernatant 
was filtered through a 0.22-m-pore-size filter and used as an inoculum for virus isolation. 
One-tenth gram of feces was suspended in 1 ml phosphate-buffered saline (PBS), vortexed 
for 5 min, and then centrifuged at 4,200 × g for 5 min. The supernatant was filtered through a 
0.22-m-pore-size filter and used as an inoculum for virus isolation. 
PEDV N gene-based real-time RT-PCR 
Viral RNA extraction was performed with 50 l of small-intestine homogenates or 
virus isolates or 100 l of processed feces using a MagMAX viral RNA isolation kit (Life 
Technologies, Carlsbad, CA) and a Kingfisher 96 instrument (Thermo Scientific, Waltham, 
MA) following the instructions of the manufacturers. Viral RNA was eluted into 90 l of 
elution buffer. Real-time RT-PCR was performed on nucleic acid extracts using a Path-ID 
Multiplex One- Step RT-PCR kit (Life Technologies, Carlsbad, CA). The primers and probe 
targeting conserved regions of the PEDV nucleocapsid protein gene were as described by 
Kim et al. (23) with modifications to match a U.S. PEDV nucleotide sequence deposited in 
GenBank (accession no. KF272920). The real-time RT-PCRs were conducted on an ABI 
7500 Fast instrument (Life Technologies, Carlsbad, CA) and the results analyzed by the 
system software. 
Virus isolation, propagation, and titration  
Virus isolation of PEDV was attempted on Vero cells (ATCC CCL-81) as previously 
described (24) with modifications. Vero cells were cultured and maintained in minimum 
essential medium (MEM) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 
0.05 mg/ml gentamicin, 100 unit/ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml 
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amphotericin. Confluent Vero cells in 6-well plates were washed twice with the 
postinoculation medium and inoculated with 300 l of sample and 100 l of postinoculation 
medium. The postinoculation medium was MEM supplemented with tryptose phosphate 
broth (0.3%), yeast extract (0.02%), and trypsin 250 (5 g/ml). After a 2-h incubation at 
37°C with 5% CO2, 3.6 ml postinoculation medium was added to each well. A similar 
inoculation was performed on Vero cells in 96-well plates (100 l inoculum per well) for 
immunofluorescence staining. Inoculated cells (passage 0 [P0]) were incubated at 37°C with 
5% CO2. When a 70% cytopathic effect (CPE) developed, the plates were subjected to 
freeze-thaw once. The mixtures were centrifuged at 3,000 × g for 10 min at 4°C. The 
supernatants were harvested for further propagation or saved at -80°C. If no CPE was 
observed at 7 days postinoculation, the plates were frozen and thawed once and the 
supernatants were inoculated on new Vero cells for a second passage. Inoculated cells at each 
passage were also tested by an immunofluorescence assay (IFA) as described below. If CPE 
and IFA staining were negative after 4 passages, the virus isolation result was considered 
negative. 
Virus titration was performed in 96-well plates with 10-fold serial dilutions 
performed in triplicate per dilution. After 5 days of inoculation, the plates were subjected to 
IFA staining and the virus titers determined according to the Reed and Muench method (25) 
and expressed as the 50% tissue culture infective dose (TCID50)/ml. 
Immunofluorescence assay  
Inoculated cells in 96-well plates were fixed with 80% acetone, air dried, and 
incubated with 200 × diluted mouse monoclonal antibody 6C8 (BioNote; Hwaseong-si, 
Gyeonggi-do, South Korea) specifically against PEDV (22) for 40 min followed by a 100 × 
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dilution of fluorescein-labeled goat anti-mouse IgG (KPL, Gaithersburg, MD). Cell staining 
was examined under a fluorescence microscope. 
EM 
 Samples were prepared for negative-stain and thin-section examination by electron 
microscopy (EM) following previously described procedures (26) with modifications. The 
ISU13-22038 small-intestine homogenate was centrifuged at 4,200 × g for 10 min, and the 
supernatants were subjected to ultracentrifugation at 30,000 × g for 30 min to pellet the virus 
particles, which were then negatively stained with 2% phosphotungstic acid (PTA; pH 7.0) 
and examined with a FEI Tecnai G2 BioTWIN electron microscope (FEI Co., Hillsboro, OR). 
Vero cells infected with the ISU13-22038 P3 virus isolate were trypsinized at 24 h 
postinfection and centrifuged at 800 × g for 5 min. The cell pellets were resuspended in 0.01 
M PBS (pH 7.2 to 7.4) and centrifuged again at 800 × g for 5 min. The cell pellets were fixed 
with 2.5% glutaraldehyde– 0.1 M sodium cacodylate. The cell pellets were postfixed in 1% 
osmium tetroxide for 90 min. The samples were dehydrated in an ascending ethanol series 
followed by propylene oxide and embedded in Eponate 12 resin (Ted Pella Inc., Redding, 
CA). Ultrathin sections were stained with uranyl acetate and lead citrate and examined with 
the FEI Tecnai G2 BioTWIN electron microscope. 
NGS  
The sequences of the entire genome of PEDV in the original small-intestine 
homogenates as well as those of the P3 and P9 isolates were determined by next-generation 
sequencing (NGS) technology using an Illumina MiSeq platform. Total RNA from the 
homogenates and P3 and P9 PEDV isolates was extracted using a total RNA isolation kit 
(Norgen Biotek Corp., Niagara-on-the-Lake, Ontario, Canada). One hundred microliters of 
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each sample was used to prepare the lysate, and the isolated RNA was eluted in 50 l RNase-
free water. The extracted RNA was quantified by the use of a Qubit 2.0 spectrophotometer 
(Life Technologies, Carlsbad, CA) to estimate concentrations and then stored at -80°C until 
use. The cDNA libraries were constructed from 100 ng of total RNA using a TruSeq 
Stranded total RNA sample preparation kit (Illumina, San Diego, CA) following the 
guidelines of the manufacturers. Multiplex libraries were prepared using barcoded primers 
and a median insert size of 340 bp. Libraries were analyzed for size distribution using a 
Bioanalyzer and quantified by quantitative RT-PCR using a Kapa library quantification kit 
(Kapa Biosystems, Boston, MA), and relative volumes were pooled accordingly. The pooled 
libraries were sequenced on an Illumina MiSeq platform with 150-bp end reads following 
standard Illumina protocols. An average of 0.8 Gb of sequence was produced per sample. 
Sequences obtained by NGS technique were mapped to PEDV reference strain 
USA/Colorado/2013 (Genbank accession no. KF272920) or AH2012 (Genbank accession no. 
KC210145) using BWA software. Bases and single-nucleotide variants (SNVs) were called 
using the SAMtools “mpileup” command. Sites were filtered to avoid unreliable calls using 
the following criteria: (i) a minimum depth of 5 reads at each position, (ii) a minimum 
average base quality of 10, (iii) a minimum SNV quality of 25, and (iv) at least 85% of reads 
at the correct position to support the call as homozygous. The consensus sequences were 
generated by the VCFtools software package. 
Sanger sequencing  
The spike (S) gene sequences and partial ORF1b gene sequences of PEDV in the 
original homogenates and in P3 and P9 of both isolates were also determined by the 
traditional Sanger method to confirm the NGS results. The S gene was amplified in two 
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fragments using a Qiagen One-Step RT-PCR kit (Qiagen, Valencia, CA). The first fragment 
was amplified using primers PEDV-S1F (5’-GTGGCTTTTCTAATCATTTGGTC-3’) and 
PEDV-S1R (5’-CTGGGTGAGTAATTGTTTACAACG-3’) under thermal cycler conditions 
of 50°C for 30 min, 95°C for 15 min, 40 cycles of 94°C for 30 s, 50°C for 30 s, and 72°C for 
3.5 min, and 72°C for 10 min. The second fragment was amplified using primers PEDV-S2F 
(5’-GGCCAAGTCAAGATTGCACC-3’) and PEDV-S2R (5’-
AGCTCCAACTCTTGGACAGC-3’) under thermal cycler conditions of 50°C for 30 min, 
95°C for 15 min, 40 cycles of 94°C for 30 s, 53°C for 30 s, and 72°C for 2.5 min, and 72°C 
for 10 min. The partial ORF1b gene was amplified and sequenced using primers PEDV-
19923F (5’-ACATGCGTGTGCTACATCTTGG-3’) and PEDV-20600R (5’-
TGGCGTCATTATTACGCACTAGC-3’) under thermal cycler conditions of 50°C for 30 
min, 95°C for 15 min, 40 cycles of 94°C for 30 s, 54°C for 30 s, and 72°C for 1 min, and 
72°C for 10 min. Sequence data were assembled and analyzed using the DNAStar Lasergene 
11 Core Suite (DNAstar, Madison, WI). 
Phylogenetic analysis  
Phylogenetic analysis was performed using the nucleotide sequences of the six PEDV 
viruses from this study as well as four other U.S. PEDV strains (USA/Colorado/2013-
KF272920 [27], IA2013-KF452322 [22], IN2013-KF452323 [22], and USA2013-019349- 
KF267450 [unpublished]) and 23 non-U.S. PEDV strains with entire genome sequences 
available in GenBank. Phylogenetic trees were constructed using the entire genome, the spike 
gene, the S1 portion (S gene nucleotides 1 to 2205, corresponding to amino acids 1 to 735) 
(28), the S2 portion (S gene nucleotides 2206 to 4152, corresponding to amino acids 736 to 
1383) (28), a hypothetical protein gene (ORF3), the envelope (E) gene, the membrane (M) 
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gene, and the nucleocapsid (N) gene sequences. The trees were constructed using the 
distance-based neighbor-joining method of MEGA5.2 software. Bootstrap analysis was 
carried out on 1,000 replicate data sets. 
Nucleotide sequence accession numbers  
The full-length genomic nucleotide sequences of the ISU13-19338E-IN homogenate, 
ISU13-19338E-IN P3, ISU13-19338E-IN P9, the ISU13-22038-IA homogenate, ISU13-
22038-IA P3, and ISU13-22038-IA P9 were deposited in GenBank under accession numbers 
KF650370, KF650371, KF650372, KF650373, KF650374, and KF650375, respectively. 
 
Results 
Virus isolation and characterization 
Virus isolation was attempted on 33 PEDV-PCR-positive feces samples and 17 
PEDV-PCR-positive intestine homogenates on Vero cells. Two PEDV isolates designated 
ISU13-19338E and ISU13-22038 were successfully obtained from the small intestines of 
piglets from sow farms in Indiana (collected on 16 May 2013) and Iowa (collected on 6 June 
2013), respectively. Attempts at virus isolation from the remaining samples were 
unsuccessful. Cytotoxicity was observed in cells inoculated with several intestine samples 
and many of the fecal samples. 
A distinct cytopathic effect (CPE), characterized by cell fusion, syncytium formation, 
and eventual cell detachment, was observed for ISU13-19338E from passage 1 (P1) and for 
ISU13-22038 from P0. In order to determine if the isolated viruses can be efficiently 
propagated and maintained in cell cultures, the two virus isolates were further serially passed 
in Vero cells for a total of 10 passages (P0 to P9). Prominent CPE was usually observed 
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within 24 h postinoculation during the propagation process. Examples of CPE and IFA 
images are shown in Fig. 1. Compared to the negative-control Vero cells (Fig. 1C), the Vero 
cells infected with the ISU13-19338E P9 (Fig. 1A) and the ISU13-22038 P9 (Fig. 1B) 
isolates showed cell enlargement, obvious cell fusion, and syncytium formation. Virus 
growth was confirmed by IFA using 6C8, a PEDV-specific monoclonal antibody. The PEDV 
protein stained by the monoclonal antibody was distributed in the cytoplasm but not in the 
nucleus (Fig. 1D and E). During the first 10 serial passages, the infectious titers of both 
isolates ranged from 6 × 102 to 2 × 105 TCID50/ml (Table 1). The level of viral genome or 
transcript in each passage for both isolates was also assessed by a PEDV N gene-based real-
time RT-PCR, and the cycle threshold (CT) values are shown in Table 1. 
The PEDV particles in the small-intestine homogenates and in infected Vero cells 
were also examined by EM techniques. As shown in Fig. 2A, multiple virus particles with 
distinctive crown-shaped projections were visible in the 13-22038 small-intestine 
homogenates as examined by negative-staining EM. On thin sections of the Vero cells 
infected with the 13-22038 P3 isolate, masses of virus particles adhering to the cytoplasm 
membrane were observed at 24 h postinfection (Fig. 2B and C). 
Genetic stability of PEDV isolates during serial passages in cell cultures  
In order to determine if the two PEDV isolates are genetically stable during the first 
10 serial passages in cell culture, the entire genomes of all six viruses (ISU13019338E 
homogenate, P3, and P9; ISU13022038 homogenate, P3, and P9) were sequenced using the 
NGS technology. Using the Colorado/2013 PEDV (GenBank accession no. KF272920) as 
the initial reference, the NGS reads of all six viruses were successfully assembled to obtain 
the entire genome sequences. All six PEDV viruses (ISU13019338E homogenate, P3, and 
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P9; ISU13022038 homogenate, P3, and P9) have a genome 28,038 nucleotides in length. The 
genomic organization of all six PEDV viruses is similar to what was previously described (5, 
27) and includes the 5’ UTR, ORF1a and ORF1b, S, ORF3, E, M, N, and 3’ UTR (Table 2). 
By alignment with other coronaviruses, the slippery sequence 12610TTTAAAC12616 followed 
by sequences that form a putative pseudoknot structure was identified in PEDV genomes. 
Translation of the replicase pp1ab is assumed to occur by a -1 RNA-mediated ribosomal 
frameshift at the end of the slippery sequence; thus, the nucleotides encoding the pp1ab are 
predicted to be 293 to 12616 and 12616 to 20637 in the PEDV genomes (Table 2). The full-
length S genes (about 4.1 kb) of all 6 PEDV viruses were also sequenced using the Sanger 
sequencing method, and the sequences were completely identical to those determined by the 
NGS for each virus (data not shown). 
The entire genome sequences of PEDV from the homogenate and from the P3 and P9 
cell cultures of the two isolated strains were compared, and the results are summarized in 
Table 2. Compared to the 13-19338E homogenate, 13-19338E P3 had acquired three 
nucleotide changes at positions 1303, 3519, and 21756, and 13-19338E P9 had acquired one 
additional nucleotide change at position 21403, at the whole-genome level. Three amino acid 
changes resulting from the nucleotide changes were located in the pp1ab (1 amino acid [aa]) 
and the spike protein (2 aa). Compared to the 13-22038 homogenate, 13-22038 P3 had 
acquired only one nucleotide change at position 21355, and 13-122038 P9 had acquired three 
additional nucleotide changes at positions 10689, 21265, and 25616, at the whole-genome 
level. Four amino acid changes resulting from the nucleotide changes were located in pp1ab 
(1 aa), the spike protein (2 aa), and the envelope protein (1 aa). For both virus isolates, the 
mutations acquired at P3 were sustained through P9 (Table 2). 
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Sequence comparisons with other PEDV strains  
The entire genome sequences of the six PEDV viruses examined in this study were 
compared to those of four other U.S. PEDV strains (sequenced from fecal samples) and 23 
non-U.S. PEDV strains with entire genome sequences available in GenBank. All of the 10 
U.S. PEDV strains were genetically closely related to each other (99.7% to 99.9% nucleotide 
identity) and differed from each other by 1 to 55 nucleotides at the whole-genome level 
(Table 3). The nucleotide identities and numbers of nucleotide differences between the U.S. 
PEDV strains and 23 non-U.S. PEDV strains ranged from 96.3% (differences of 1,022 to 
1,041 nucleotides compared to the SM98-GU937797 strain) to 99.5% (differences of 118 to 
146 nucleotides compared to the AH2012-KC210145 strain) (Table 3). 
Alignment of the 10 U.S. PEDV strains identified a single nucleotide insertion (C or 
A) between nucleotides 20204 and 20205 in three strains, IA2013_KF452322 (22), 
IN2013_KF452323 (22), and USA-13-019349_KF267450 (27), compared to the six PEDV 
sequences determined in this study as well as to the USA/Colorado/2013_KF272920 strain 
sequence (Fig. 3). When the other 23 non-U.S. PEDV strains were included for comparison, 
it was found that only the AH2012_KC210145 strain had such an insertion and the other 22 
strains did not (Fig. 3). Without such an insertion, the pp1ab protein of U.S. PEDV is 
predicted to be 6,782 aa in length. With such a frame-shifting insertion, the pp1ab protein of 
U.S. PEDV is predicted to stop earlier and be 6,649 aa in length. Since the entire genome 
sequences of all 10 U.S. PEDV viruses were determined by next-generation sequencing 
technology, the ORF1b portions (nucleotides 19923 to 20600) covering this insertion site 
were also sequenced using the traditional Sanger sequencing method for six PEDV (ISU13-
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19338E homogenate, P3, and P9 and ISU13-22038 homogenate, P3, and P9) for 
confirmation. None of the six PEDV sequences had such an insertion at that position. 
Phylogenetic analysis of PEDV  
A total of 33 PEDV viruses (6 determined in this study, 4 other U.S. PEDV strains, 
and 23 non- U.S. PEDV strains) were used for phylogenetic analysis based on different 
genes. Phylogenetic analysis based on the entire genome sequences demonstrated that 33 
PEDV viruses can be clustered into group I and group II; each of the groups can be further 
divided into subgroups Ia, Ib, IIa, and IIb. The U.S. PEDV strains all clustered within 
subgroup IIa together with the AH2012_KC210145 strain that was detected in China in 2012 
(Fig. 4 [“Entire genome”]). The phylogenetic trees based on the S gene, S1 portion, and S2 
portion collectively demonstrated the same grouping structure as the tree based on the entire 
genome except as follows: (i) on the basis of the S, S1, and S2 trees, the U.S. PEDV strains 
were most closely related to strain CH-ZMDZY-11_KC instead of strain 
AH2012_KC210145 and (ii) strains DR-13-virulent_JQ023161 and CH-FJND-3-
2011_JQ282909 clustered differently in the trees of S, S1, and S2 compared to the entire 
genome tree. The S1 and S2 trees were very similar to the S tree. The ORF3 tree also formed 
clusters I and II, but the structures were different from those of the other trees. The E tree 
included clusters I and II, but there were no clear subgroups in cluster II. The clusters formed 
in the M and N trees were similar to those in the trees based on the entire genome, S, S1, and 
S2; however, almost all virus strains in subgroup IIa of the M and N trees were equally 
genetically related to each other, which was not the case with the entire genome, S, S1, and 
S2 trees. 
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Discussion 
After PEDV was identified in the United States for the first time (22), endeavors to 
isolate a PEDV that can efficiently grow and propagate in cell culture were initiated. We 
attempted PED virus isolation (VI) from 33 feces samples and 17 intestine homogenates, and 
only 2 isolates were obtained (success rate, 4%). None of the VI attempts from feces were 
successful. Although the sample quality could have been a contributing factor to the low 
success rate, the isolation procedures also need to be further improved to increase the success 
rate of PEDV VI, particularly from fecal samples. The two isolates were serially propagated 
in cell culture and characterized. By examining the CPE development, immunofluorescence 
staining, EM, infectious virus titers, and entire genome sequences, we clearly demonstrated 
that the two PEDV isolates are phenotypically (titers, growth characteristics) and genetically 
stable during at least the first 10 serial passages in cell culture. Availability of the U.S. PEDV 
isolates provides an important tool for PEDV pathogenesis investigation, virological and 
serological assay development, and vaccine development. In fact, our PEDV isolates have 
been used in developing a PEDV-specific IFA that is currently offered (September 2013) at 
ISU VDL to measure PEDV antibodies in serum. In this study, we characterized the two 
isolates for the first 10 passages, but we have serially passaged the two isolates in cell culture 
for over 30 passages thus far. In general, live attenuated virus vaccines tend to elicit 
protective immunity more efficiently than inactivated virus vaccines, subunit vaccines, or 
DNA vaccines. We are continuing serial passages of these viruses in efforts to develop a live 
attenuated PEDV vaccine that could potentially be used to vaccinate nursery pigs and 
pregnant sows to mitigate the negative impact caused by PEDV infection. Viruses at selected 
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passages will be inoculated into pigs to evaluate their virulence/attenuation phenotypes so 
that the genetic changes potentially associated with virus attenuation can be identified. 
Next-generation sequencing technology provides a powerful tool to determine entire 
genome sequences with shorter turnaround time and lower costs. We are aware of 10 U.S. 
PEDV strains (ISU13-19338E homogenate, P3, and P9, ISU22038 homogenate, P3, and P9, 
Colorado2013_KF272920, IA2013_KF452322, IN2013_KF452323, and USA-13-
019349_KF267450) whose whole-genome sequences have been determined, and all of these 
were completed using the NGS technology. Among 33 PEDV strains evaluated in this study, 
only IA2013_KF452322, IN2013_KF452323, USA-13-019349_KF267450, and 
AH2012_KC210145 had one nucleotide insertion between positions 20204 and 20205 
whereas the remaining 29 strains did not have such an insertion (Fig. 3). When strain 
Colorado2013_KF272920, which does not have such an insertion, was used as the reference 
sequence to map and assemble the ISU13-19338E and ISU13-22038 sequences, the resultant 
sequences did not have such an insertion. When the AH2012_KC210145, which has such an 
insertion, was used as the reference to map and assemble the sequences, surprisingly, the 
resultant sequences included such an insertion. In order to resolve the discrepancy and 
confirm the true status of the strains, the ISU13-19338E and ISU13-22038 viruses were 
sequenced for a portion covering the insertion site using the Sanger sequencing method. It 
was confirmed that such an insertion was not present in the ISU13-19338E and ISU13-22038 
viruses. NGS technology has been increasingly used in research and diagnostic laboratories 
in recent years. However, bioinformatics analysis of NGS data is still a challenge for most 
laboratories. De novo assembly and analysis are time-consuming. For known viruses, a 
reference sequence is often used to map the NGS sequence data. It would be prudent to 
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analyze the NGS data using two or more reference sequences and confirm any discrepancies 
by the Sanger method. 
Based on sequence comparison and phylogenetic analysis, it appears that the U.S. 
PEDV strains are genetically closely related to some PEDV strains that were circulating in 
China in 2011 to 2012. However, it remains unknown how PEDV was introduced into the 
United States (22). The 10 U.S. PEDV viruses examined in this study are genetically closely 
related to each other, with 99.7% to 99.9% nucleotide identities at the whole-genome level. 
With the elapse of time and spread of PEDV to more farms in more states, a molecular 
epidemiology study is now needed to investigate the genetic evolution of PEDV in U.S. 
swine spatially and temporally. We are currently in the process of performing such a study. 
Swine practitioners, diagnosticians, and researchers frequently ask which gene(s) of 
PEDV is appropriate for sequencing to study the genetic relatedness of viruses. We found 
that the phylogenetic trees based on the full-length S gene, the S1 portion, the S2 portion, the 
M gene, or the N gene of 33 PEDV strains have cluster structures similar to those seen in the 
tree based on the entire genome sequences. But the M and N genes are relatively conserved, 
and various PEDV strains may cluster together without reflecting the true genetic differences 
exhibited at the whole-genome level (e.g., subgroup IIa of the M and N trees in Fig. 4). In 
contrast, the full-length S gene, the S1 portion, or the S2 portion appears to be able to reflect 
the genetic diversity observed at the whole-genome level. As with other coronavirus S 
proteins, the PEDV spike protein makes up the surface projections of the virion and functions 
as the virus attachment protein interacting with the cell receptor (29). In addition, 
neutralization epitopes have been found in the PEDV spike protein (30–32). The full-length S 
gene is adequate for sequencing and molecular analysis of PEDV. However, the full-length S 
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gene is approximately 4.1 kb and it may be difficult to sequence as a routine diagnostic 
service. The S1 portion is approximately 2.2 kb in length, and the S2 portion is 
approximately 1.9 kb in length. Considering that the receptor binding sites and majority of 
the neutralization epitopes are located in the S1 portion, it would be more appropriate to 
utilize this region of the genome for sequencing and molecular analysis to determine the 
genetic relatedness of different PEDV viruses. 
In summary, two PEDV isolates associated with the PED outbreak in U.S. swine have 
been obtained and characterized. To our knowledge, this is the first report describing the 
isolation and characterization of U.S. PEDV. The U.S. PEDV strains were genetically closely 
related to each other and to some strains reported in China during 2011 to 2012. The full-
length S gene or the S1 portion is appropriate for sequencing to study the genetic related- 
ness and molecular epidemiology of PEDV. 
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Table 1 Summary of two U.S. PEDV isolates during the first 10 passages in cell culture 
  
Resulta 
 
Origin of Intestine 
Isolate and parameter sample homogenate P0 P1 P2 P3 P4 P5 P6 P7 P8 P9 
ISU13-19338 Indiana            
Cytopathic effect  N.A.                     
Real-time PCR CT  17.0 16.0 15.2 15.4 16.3 14.0 15.8 16.9 15.1 11.2 11.7 
Infectious titer (log10 TCID50/ml)  N.D. N.D. N.D. 3.5 4.5 4.3 5.3 3.5 4.5 5.3 4.3 
ISU13-22038 Iowa            
Cytopathic effect  N.A.                     
Real-time PCR CT  16.0 17.2 13.8 12.2 14.8 18.0 13.9 10.0 14.3 14.6 13.8 
Infectious titer (log10 TCID50/ml)  N.D. 2.8 4.8 3.5 4.3 4.3 3.5 4.8 4.5 4.8 4.8 
a N.A., not applicable; N.D., not done. 
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Table 2 Nucleotide and amino acid changes of PEDV isolates 13-19338E and 13-20338 during serial passages in cell culture 
 
Virus 
PEDV 13-19338E 
Genome region or ORF Nucleotide ina  :                                   Amino acid inb  :   
 
(nucleotide position[s])a Encoded protein Position Homogenate P3 P9 Position Homogenate P3 P9 
5’ UTR (1–292) None  -
c -  - -      
ORF1a (293–12646) pp1a         
ORF1ab (293–12616, 12616–20637) pp1ab 1303 T C C     
  3519 C T T 1076 Ala Val Va
l S (20634–24794) Spike 21403 A A G 257 Asn Asn Ser 
  21756 C T T 375 Leu Phe Ph
e ORF3 (24794–25468) Hypothetical protein 3 -  -  -  -  - - - - 
E (25449–25679 Envelope - 
 
- 
 
-   
-  
-
 
-
 
- 
   -  - -  -  -  -  -  
M (25687–26367) Membrane -
 
- 
 
 
-   
  
-
 
-
 
- 
-  - -  -  -  -  -  
N (26379–27704) Nucleocapsid -  -  -  -  -  -  -  -  
3’ UTR (27705–28038) None -  -  -  -      
PEDV 13-22038 5’ UTR (1–292) 
ORF1a (293–12646) 
None 
pp1a 
-  -  -      
 ORF1ab (293–12616, 12616–20637) pp1ab 10689 C C T 3466 Thr Thr Ile 
 S (20634–24794) Spike 21265 C C T 211 Thr Thr Ile 
   21355 T C C 241 Val Ala Al
a  ORF3 (24794–25468) Hypothetical protein 3   -  -  -  - -  -  -  
 E (25449–25679 Envelope 25616 G G T 56 Leu Leu Ph
e  M (25687–26367) Membrane -  -  -  -  -  -  -  -  
 N (26379–27704) Nucleocapsid -  -  -  -  -  -  -  -  
 3’ UTR (27705–28038) None -  -  -  -      
a Nucleotides are numbered according to the PEDV 13-19338E sequences (GenBank accession no. KF650370). 
b Only nonsynonymous mutations are shown, and silent mutations are not shown. Amino acids of replicase proteins are numbered 
according to their locations in the replicase polyprotein pp1ab. Amino acids of structural proteins are numbered according to their 
locations in the respective structural proteins. 
c -, no nucleotide or amino acid change occurred. 
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13-19338E-
IN-Homo
13-19338E-
IN-P3
13-19338E-
IN-P9
13-22038-
IA-Homo
13-22038-
IA-P3
13-22038-
IA-P9
Colorado
2013_KF
272920
IA2013_
KF452322
IN2013_
KF452323
USA-13-
019349-
KF267450
*
AH2012-
KC210145
BJ-2011-1-
JN825712
GD-B-
JX088695
CH-
ZMDZY-11-
KC196276
JS-
HZ2012_
KC210147
SM98-
GU937797
CV777-
AF353511
13-19338E-IN-Homo 3 (99.9) 4 (99.9) 10 (99.9) 11 (99.9) 14 (99.9) 42 (99.8) 22 (99.9) 1 (99.9) 50 (99.8) 120 (99.5) 208 (99.2) 204 (99.2) 264 (99) 184 (99.3) 1035 (96.3) 906 (96.7)
13-19338E-IN-P3 1 (99.9) 13 (99.9) 14 (99.9) 17 (99.9) 45 (99.8) 25 (99.9) 4 (99.9) 53 (99.8) 123 (99.5) 211 (99.2) 207 (99.2) 267 (99) 187 (99.3) 1036 (96.3) 907 (96.7)
13-19338E-IN-P9 14 (99.9) 15 (99.9) 18 (99.9) 46 (99.8) 26 (99.9) 5 (99.9) 54 (99.7) 124 (99.5) 212 (99.2) 208 (99.2) 268 (99) 188 (99.3) 1039 (96.2) 910 (96.7)
13-22038-IA-Homo 1 (99.9) 4 (99.9) 40 (99.8) 20 (99.9) 9 (99.9) 48 (99.8) 118 (99.5) 206 (99.2) 202 (99.2) 262 (99) 182 (99.3) 1031 (96.3) 902 (96.7)
13-22038-IA-P3 3 (99.9) 42 (99.8) 21 (99.9) 12 (99.9) 49 (99.8) 119 (99.5) 207 (99.2) 203 (99.2) 263 (99) 183 (99.3) 1032 (96.3) 903 (96.7)
13-22038-IA-P9 44 (99.8) 24 (99.9) 15 (99.9) 52 (99.8) 122 (99.5) 210 (99.2) 206 (99.2) 266 (99) 186 (99.3) 1035 (96.3) 906 (96.7)
Colorado2013_KF272920 53 (99.8) 43 (99.8) 15 (99.9) 138 (99.5) 196 (99.3) 192 (99.3) 276 (99) 172 (99.3) 1034 (96.3) 905 (96.7)
IA2013_KF452322 22 (99.9) 55 (99.7) 128 (99.5) 218 (99.2) 214 (99.2) 274 (99) 194 (99.3) 1022 (96.3) 893 (96.8)
IN2013_KF452323 49 (99.8) 120 (99.5) 209 (99.2) 205 (99.2) 265 (99) 185 (99.3) 1036 (96.3) 907 (96.7)
USA-13-019349_KF267450 146 (99.4) 205 (99.2) 201 (99.2) 285 (98.9) 181 (99.3) 1041 (96.2) 912 (96.7)
AH2012_KC210145 176 (99.3) 163 (99.4) 264 (99) 146 (99.4) 1025 (96.3) 893 (96.8)
BJ-2011-1_JN825712 91 (99.6) 258 (99) 74 (99.7) 989 (96.4) 859 (96.9)
GD-B_JX088695 255 (99) 32 (99.8) 1024 (96.3) 894 (96.8)
CH-ZMDZY-11_KC196276 239 (99.1) 1036 (96.3) 906 (96.7)
JS-HZ2012_KC210147 1006 (96.4) 876 (96.8)
SM98_GU937797 148 (99.4)
CV777_AF353511
Table 3 Nucleotide differences and nucleotide identities of 33 PEDV strains with entire genome sequences availablea 
a Due to space limits, only comparison results of 17 PEDV strains are shown here. All of the 10 U.S. PEDV strains are included. 
Among the 23 PEDV strains collected outside the United States, the 7 strains with lowest and highest nucleotide identities to U.S. 
PEDV strains are shown. The other 16 strains having nucleotide identities of 96.4% to 98.9% compared to the U.S. PEDV strains are 
not shown. Nucleotide differences and nucleotide identities between the viruses were determined at the whole-genome level. 
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Fig 1 Cytopathic effects and IFAs of PEDV isolates in infected Vero cells. Vero cells were 
infected with PEDV 13-19338E P9 and PEDV 13-22038 P9 isolates. At 24 h postinfection, 
cytopathic effects were recorded (A, B, and C; ×160 magnification) and cells were examined 
by IFA using PEDV-specific monoclonal antibody (D, E, and F; ×100 magnification).  
90 
 
 
 
FIG 2 EM images on original homogenate and PEDV-infected Vero cells. (A) Negatively 
stained PEDV particles in the ISU13-22038 intestine homogenates. Some virus particles are 
shown by arrows. Crown-shaped spikes are visible. Bar =100 nm. Magnification, ×150,000. 
(B) Thin section of Vero cells infected with ISU13-22038 P3 PEDV at 24 h postinfection. 
Bar =500 nm. Magnification, ×11,000. (C) Enlarged image of the partial cytoplasm 
membrane showing accumulation of released virus particles. Bar =100 nm. Magnification, 
×68,000. 
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FIG 3 Alignment of partial ORF1b nucleotide sequences of 33 PEDV strains with entire 
genome sequences available. A single-nucleotide insertion between positions 20,204 and 
20,205 of some PEDV strains is shown. The amino acid codon immediately before the 
insertion is shown as underlined. 
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FIG 4 Phylogenetic analysis of the full-length genome, S gene, S1 portion, S2 portion, 
ORF3, E, M, and N gene nucleotide sequences of 6 U.S. PEDV from this study and 27 
previously published PEDV sequences (GenBank numbers are shown in the figure). The 
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trees were constructed using the distance-based neighbor-joining method of the software 
MEGA5.2. Bootstrap analysis was carried out on 1,000 replicate data sets, and values are 
indicated adjacent to the branching points. The viruses identified in this study are indicated 
by diamonds. Bar, 0.002 nucleotide substitutions per site. 
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FIG 4 continued 
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Abstract 
Background: At least two genetically different porcine epidemic diarrhea virus 
(PEDV) strains have been identified in the United States (U.S. PEDV prototype and S-
INDEL-variant strains). The current serological assays offered at veterinary diagnostic 
laboratories for detection of PEDV-specific antibody are based on the U.S. PEDV prototype 
strain. The objectives of this study were: 1) isolate the U.S. PEDV S-INDEL-variant strain in 
cell culture; 2) generate antisera against the U.S. PEDV prototype and S-INDEL-variant 
strains by experimentally infecting weaned pigs; 3) determine if the various PEDV 
serological assays could detect antibodies against the U.S. PEDV S-INDEL-variant strain 
and vice versa. 
Results: A U.S. PEDV S-INDEL-variant strain was isolated in cell culture in this 
study. Three groups of PEDV-negative, 3-week-old pigs (five pigs per group) were 
inoculated orally with a U.S. PEDV prototype isolate (previously isolated in our lab), an S-
INDEL-variant isolate or virus-negative culture medium. Serum samples collected at 0, 7, 14, 
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21 and 28 days post inoculation were evaluated by the following PEDV serological assays: 1) 
indirect fluorescent antibody (IFA) assays using the prototype and S-INDEL-variant strains 
as indicator viruses; 2) virus neutralization (VN) tests against the prototype and S-INDEL-
variant viruses; 3) PEDV prototype strain whole virus based ELISA; 4) PEDV prototype 
strain S1-based ELISA; and 5) PEDV S-INDEL-variant strain S1-based ELISA. The positive 
antisera against the prototype strain reacted to and neutralized both prototype and S-INDEL-
variant viruses, and the positive antisera against the S-INDEL-variant strain also reacted to 
and neutralized both prototype and S-INDEL-variant viruses, as examined by IFA antibody 
assays and VN tests. Antibodies against the two PEDV strains could be detected by all three 
ELISAs although detection rates varied to some degree. 
Conclusions: These data indicate that the antibodies against U.S. PEDV prototype 
and S-INDEL-variant strains cross-reacted and cross-neutralized both strains in vitro. The 
current serological assays based on U.S. PEDV prototype strain can detect antibodies against 
both U.S. PEDV strains. 
 
Background 
Porcine epidemic diarrhea (PED), caused by porcine epidemic diarrhea virus (PEDV), 
was first recorded in England in the early 1970s and has since spread to other European and 
Asian countries [1]. In North America, PEDV was detected for the first time in the United 
States (U.S.) in April 2013 [2] and subsequently PEDV was reported in Canada [3] and 
Mexico [4]. PEDV is an enveloped, single-stranded, positive-sense RNA virus belonging to 
the order Nidovirales, the family Coronaviridae, subfamily Coronavirinae, genus 
Alphacoronavirus [5]. The PEDV genome is approximately 28 kb in length and includes 
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ORF1a and ORF1b encoding the replicase polyproteins and other opening reading frames 
(ORFs) encoding four structural proteins [spike (S), envelope (E), membrane (M), and 
nucleocapsid (N)] and one nonstructural protein NS3B (encoded by ORF3) [1]. 
In the U.S., a highly virulent PEDV strain (U.S. PEDV prototype strain) was 
identified during the initial PED outbreaks [2, 6, 7]. Lately, a PEDV variant strain having 
insertions and deletions (INDEL) in the spike gene compared to the U.S. prototype strain was 
identified in U.S. swine with mild clinical signs based on field observations [8]. This U.S. 
PEDV variant strain, also known as S INDEL strain [4], formed a distinct phylogenetic 
cluster compared to U.S. PEDV prototype strains [4, 8, 9]. One PEDV isolate (PC177) 
having a 197-aa deletion in the N- terminal S protein was discovered during PEDV isolation 
in cell culture; however, this PEDV isolate still phylogenetically clustered with the U.S. 
PEDV prototype strains and was not considered as one of the S-INDEL-variant strains [10]. 
Marthaler et al. [11] reported a ‘third’ strain of PEDV (Minnesota188) in U.S. swine that had 
6 nucleotide deletions (2 amino acid deletions) in the spike gene (different from the U.S. S-
INDEL-variant strains). However, the PEDV Minnesota188 was genetically very closely 
related to the U.S. PEDV prototype strains and it is arguable whether it should be called a 
‘third’ strain of PEDV in the U.S. The PEDV PC177 and Minnesota188 are probably the 
mutants of the U.S. PEDV prototype strains. Therefore, there are at least two genetically 
different PEDV strains currently circulating in U.S. swine: U.S. PEDV prototype strain and 
S-INDEL-variant strain. The U.S. PEDV prototype strains have been successfully isolated 
and propagated in cell culture by several groups [7, 10, 12, 13]. A number of serological 
assays, including an indirect fluorescent antibody (IFA) assay, a virus neutralization (VN) 
test, a whole virus-based enzyme-linked immunosorbent assay (ELISA), a recombinant S1 
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protein-based ELISA, and recombinant nucleocapsid protein-based ELISAs, have been 
developed for the detection of PEDV-specific antibodies [14–18]. All of these serological 
assays are based on the U.S. PEDV prototype strains. 
In this study, we isolated a U.S. PEDV S-INDEL-variant strain in cell culture. Pigs 
were experimentally inoculated with a U.S. PEDV prototype strain and the newly isolated 
U.S. PEDV S-INDEL-variant strain, respectively, to generate strain-specific antisera. 
Subsequently, the generated swine antisera were subjected to an in vitro evaluation for 
serological cross-reactivity and cross-neutralization between the two strains. Specifically, 1) 
PEDV IFA antibody assays (using the prototype and S-INDEL-variant strains as indicator 
viruses, respectively) and ELISAs (PEDV prototype strain whole virus-based ELISA, PEDV 
prototype strain S1-based ELISA, and PEDV S-INDEL-variant strain S1-based ELISA) were 
conducted to evaluate the antibody cross-reactivity of the two U.S. strains; and 2) VN tests 
using the prototype and S-INDEL-variant strains as indicator viruses were conducted to 
evaluate the in vitro cross-neutralization of two U.S. strains. 
 
Methods 
Isolation of U.S. PEDV S-INDEL-variant strain in cell culture 
Sixty-eight clinical samples (27 fecal swabs, 24 feces, 13 small intestines and 4 oral 
fluids), which were tested positive by a PEDV N gene-based real-time RT-PCR [17, 19] at 
the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) and confirmed 
positive for the U.S. PEDV S-INDEL-variant strain but negative for the U.S. prototype strain 
by a PEDV S gene-based differential real-time RT-PCR (Chen et al., unpublished), were 
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selected to attempt virus isolation in Vero cells (ATCC CCL-81) following previously 
described procedures [7]. 
Among the aforementioned 68 clinical samples positive for the U.S. PEDV S-
INDEL-variant strain, one small intestine homogenate (with PEDV N gene-based real-time 
RT-PCR cycle threshold (Ct) value of 16.1) [17, 19] from a pig located in Illinois was 
inoculated orogastrically into three PEDV-naïve weaned pigs at 3 weeks of age (10 ml per 
pig). The homogenate used for inoculation was confirmed negative for transmissible 
gastrointestinal virus (TGEV), porcine rotavirus groups A, B, C and porcine deltacoronavirus 
(PDCoV) by virus-specific RT-PCRs at the ISU VDL. Rectal swabs and feces were collected 
from each inoculated pig twice a day and tested by the PEDV real-time RT-PCR on the same 
day. Once the RT-PCR Ct values of the rectal swabs were <15, the pig was euthanized and 
necropsied within 24 h. Small intestine tissues and cecum contents were collected for 
attempting virus isolation in cell culture as previously described [7]. This animal study was 
performed according to the procedures approved by the Iowa State University Institutional 
Animal Care and Use Committee (IACUC, approval number 3-14-7766-S).  
The whole genome sequence of the U.S. PEDV S-INDEL-variant strain cell culture 
isolate USA/IL20697/2014 obtained in this study was determined by next-generation 
sequencing (NGS) technology using an Illumina MiSeq platform as described previously [7]. 
The PEDV S1 portion sequences of the isolate USA/ IL20697/2014 and the clinical sample 
from which the virus isolate was derived were determined by Sanger sequencing following 
the previously described procedures [7]. 
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Generation of antisera against the U.S. prototype and S-INDEL-variant PEDVs 
Fifteen 3-week-old pigs, negative for PEDV as confirmed by a real-time RT-PCR on 
rectal swabs and by IFA antibody assay on sera, were first segregated by weight and then 
assigned randomly into 3 groups with 5 pigs per group and with similar average weight per 
group, one group per room. Five pigs within each group were housed together in one room 
on a solid floor. After acclimation for 3 days, three groups of pigs were orogastrically 
inoculated with a U.S. PEDV prototype cell culture isolate USA/IN19338/2013 (Pro group) 
[7], a U.S. PEDV S-INDEL-variant cell culture isolate USA/IL20697/2014 (Var group), and 
virus- negative culture medium (Neg group), respectively, with virus titers of 104 
TCID50/ml, 10 ml per pig. Rectal swabs were collected from all pigs daily between 0 and 7 
DPI, and then at 10, 14, 21 and 28 DPI, and tested by a PEDV N gene-based quantitative 
real-time RT-PCR [20] to confirm infection. Serum samples were collected from all pigs at 0, 
7, 14, 21 and 28 days post inoculation (DPI) for cross-reactivity and cross-neutralization 
evaluations. This animal study was performed according to the procedures approved by the 
Iowa State University IACUC committee (approval number 6-14-7809-S). 
Twenty-five serum samples collected at 0, 7, 14, 21, and 28 DPI from the Pro group 
(Pro antisera), 25 serum samples collected from the Var group (Var antisera), and 25 serum 
samples collected from the Neg group (Neg antisera), were tested by various serological 
assays in this study. In addition, one pig antiserum against the European PEDV CV777 
strain, one pig antiserum against the TGEV Purdue strain, one pig antiserum against the 
porcine heamagglutinating encephalomyelitis virus (PHEV), one pig antiserum against the 
porcine respiratory coronavirus (PRCV), and one pig antiserum against PDCoV were 
included in this study for evaluations. Antisera against PEDV CV777, TGEV Purdue, and 
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PHEV strains were purchased from National Veterinary Service Laboratory, Ames, IA. 
Antisera against PRCV and PDCoV were positive control sera obtained from the ISU VDL. 
Indirect fluorescent antibody (IFA) assay 
Eighty serum samples were tested by the PEDV proto- type strain-based IFA (Pro 
IFA) and S-INDEL-variant strain-based IFA (Var IFA) following the previously described 
procedures [20]. The PEDV prototype isolate USA/IN19338/2013 was used as the indicator 
virus in the Pro IFA assay and the S-INDEL-variant isolate USA/ IL20697/2014 was used as 
the indicator virus in the Var IFA assay. A positive signal at a serum dilution of 1:40 or 
higher was considered to be IFA antibody positive. 
PEDV ELISAs for antibody detection 
The U.S. PEDV prototype strain whole virus-based indirect ELISA (ProWV ELISA) 
was developed and validated at the ISU VDL for detection of PEDV-specific IgG antibody 
[15, 16]. All serum samples were tested by this ProWV ELISA following the procedures that 
had been previously described in detail [20]. The sample-to-positive (S/P) ratio of >0.8 was 
considered antibody positive, an S/P ratio between 0.6 and 0.8 was considered suspect, and 
an S/P ratio <0.6 was considered negative. 
A previously published U.S. PEDV prototype strain S1-based indirect ELISA (ProS1 
ELISA) was used to test all the serum samples in this study for the IgG antibody following 
the previously described procedures [14]. The S/P ratio of >0.2 was considered antibody 
positive, 0.14–0.2 was considered suspect, and an S/P ratio <0.14 was considered negative. 
A U.S. PEDV S-INDEL-variant strain S1-based indirect ELISA (VarS1 ELISA) was 
developed in this study to detect the IgG antibody. The region encoding the S1 portion (aa 1–
735) of the U.S. PEDV S-INDEL-variant strain was codon optimized and synthesized with 
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the addition of a 5′ Kozac sequence, a 5′ eukaryotic signal sequence, and a 3′ 6 × -His tag by 
GeneArt® Gene Synthesis (Thermo Fisher Scientific, Waltham, MA, USA). The resultant 
2,358 base pair DNA fragment was cloned into a Zoetis proprietary eukaryotic expression 
vector (pZOE15). The authenticity and orientation of the insert in the recombinant plasmid 
was confirmed by sequencing. The recombinant plasmid was transiently transfected into 
human embryonic kidney (HEK) 293 cells using a Zoetis proprietary PEI transfection 
method. At 7 days post-transfection, culture supernatants were harvested and filter sterilized. 
The recombinant protein was purified via Ni-NTA Purification System (Thermo Fisher 
Scientific). The optimum antigen concentration and the optimum serum dilutions for the 
VarS1 ELISA were determined using a checkerboard titration. Poly-styrene 96-well 
microtitration plates (Nunc®, Thermo Fisher Scientific) were coated (100 μl per well) with 
PEDV variant S1 protein and incubated overnight at 4 °C. After 5 washes with phosphate 
buffered saline (PBS), the plates were blocked (300 μl/well) with PBS containing 1 % bovine 
serum albumin (Jackson ImmunoResearch Inc., West Grove, PA, USA) for 2 h at 25 °C. 
Plates were dried at 37 °C for 4 h and stored at 4 °C in a sealed bag with desiccant packs 
until use. Serum samples were diluted 1:50 and added to the coated plates (100 μl/well). 
Plates were incubated at 25 °C for 1 h and then washed 5 times with PBS. Subsequently 100 
μl of peroxidase-conjugated goat anti-porcine IgG (H + L) (Jackson ImmunoResearch Inc., 
West Grove, PA, USA) at 1:25,000 dilution was added and plates were incubated at 25 °C 
for 1 h. After a washing step, 100 μl tetramethylbenzidine-hydrogen peroxide substrate 
(TMB, Dako North America Inc., Carpinteria, CA, USA) was added. Plates were incubated 
at room temperature for 5 min and the reaction was stopped by adding 50 μl stop solution (1 
M sulfuric acid). Reactions were measured as optical density (OD) at 450 nm using an 
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ELISA plate reader operated with commercial software (Biotek® Instruments Inc., Winooski, 
VT, USA). The serum antibody response was presented as sample-to-positive (S/P) ratios 
calculated as: S/P ratio = (sample OD – negative control mean OD)/(positive control mean 
OD – negative control mean OD). The PEDV VarS1 ELISA was validated using 29 field 
serum samples collected from a farm with documented exposure to the U.S. PEDV S-
INDEL-variant strain (serum samples were collected from 29 weaned pigs one month after 
they were found positive for S-INDEL-variant strain by PCR) and 20 PEDV-negative field 
serum samples. The S/P ratio of >0.3 was considered antibody positive, 0.2–0.3 was suspect, 
and <0.2 was negative. 
Virus neutralization (VN) test 
Serum samples were tested by a U.S. PEDV prototype strain-based VN (Pro VN) and 
a U.S. PEDV S-INDEL-variant strain-based VN (Var VN) following the previously 
described procedures [20]. The PEDV prototype isolate USA/IN19338/2013 was used as the 
indicator virus in the Pro VN assay and the S-INDEL-variant isolate USA/IL20697/2014 was 
used as the indicator virus in the Var VN assay. The reciprocal of the highest serum dilution 
resulting in >90% reduction of staining as compared to the negative serum control was 
defined as the VN titer of the serum sample. A VN titer of ≥8 was considered positive. 
Statistical analysis 
The Log2 (IFA titer/10) of the Pro antisera and the Var antisera tested by Pro IFA and 
Var IFA were analyzed in a generalized linear mixed model (GLIMMIX). Days post 
inoculation and antigen were used as independent variables, and pig ID and the interaction of 
pig ID and antigen were set as random effects. The Log2 (VN titer) of the Pro antisera and 
the Var antisera tested by Pro VN and Var VN were analyzed in a similar way. For ELISA 
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analysis, ELISA antigen, pig ID and DPI were used as independent variables. All statistical 
analyses were performed with Statistical Analysis System (SAS) version 9.3 (SAS institute, 
Cary, NC, USA), with p value <0.05 considered significantly different. 
 
Results 
Isolation of the U.S. PEDV S-INDEL-variant strain in cell culture 
Virus isolation was first attempted on 68 clinical samples received at the ISU VDL 
that tested positive for the U.S. PEDV S-INDEL-variant strain but virus isolation at- tempts 
in cell culture were unsuccessful. Subsequently a PEDV S-INDEL-variant strain-positive 
intestine homogenate was used to inoculate three 3-week-old pigs. The rectal swab of one pig 
had a PEDV RT-PCR Ct < 15 at 2 DPI and the pig was euthanized and necropsied at 3 DPI. 
The rectal swabs of the other two pigs had PEDV RT-PCR Ct < 15 at 3 DPI and both pigs 
were euthanized and necropsied at 4 DPI. The small intestine tissues and cecum contents 
collected at necropsy were used to attempt virus isolation in Vero cells. The U.S. PEDV S-
INDEL-variant strain was successfully isolated from small intestine homogenates and cecum 
contents collected from all 3 pigs. Typical PEDV cytopathic effects including syncytial body 
formation and cell detachment were observed and the virus growth was confirmed by 
immunofluorescence staining using PEDV-specific monoclonal antibody. 
One U.S. PEDV S-INDEL-variant isolate designated as USA/IL20697/2014 was 
selected for further propagation and characterization. This isolate was serially passed in Vero 
cells and the infectious titers ranged from 103–105 TCID50/ml for the first ten passages. The 
whole genome sequences of the isolate USA/IL20697/2014 at passage 5 (P5) had 99.3–99.9 
% nucleotide identity to other U.S. PEDV S-INDEL-variant sequences available in GenBank. 
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The S1 sequences of the USA/IL20697/2014 cell culture isolate P5 had 99.8 % nucleotide 
identity (only 4 nucleotide differences) to the original intestine homogenate from which the 
virus isolate was derived. The USA/ IL20697/2014 isolate was tested at the ISU VDL and 
confirmed negative for TGEV, PRCV, PDCoV, porcine rotavirus A, B, C, influenza A virus, 
porcine reproductive and respiratory syndrome virus, and porcine circovirus 2 by virus-
specific PCRs. 
Generation of antisera against the U.S. prototype and S-INDEL-variant PEDVs 
The U.S. PEDV prototype isolate USA/IN19338/2013 and S-INDEL-variant isolate 
USA/IL20697/2014 successfully established infections in all inoculated pigs as evidenced by 
PCR testing of the rectal swabs. In prototype group, 4/5, 5/5, 5/5, 5/5, 5/5, 5/5, and 3/5 pigs 
shed the virus in rectal swabs at 2, 4, 7, 10, 14, 21, and 28 DPI, respectively, as tested by 
PEDV real-time RT-PCR. In S-INDEL-variant group, 3/5, 5/5, 5/5, 5/5, 4/5, 3/5 and 1/5 pigs 
shed the virus in rectal swabs at 2, 4, 7, 10, 14, 21 and 28 DPI, respectively. The rectal swabs 
of the negative control pigs remained PEDV PCR negative throughout the study period. In 
total, 25 antisera were collected from the prototype strain-inoculated pigs (Pro antisera), 25 
antisera collected from the variant strain-inoculated pigs (Var antisera), and 25 antisera 
collected from negative control group (Neg antisera), at 0, 7, 14, 21, and 28 DPI. 
Evaluation of cross-reactivity of antibodies against the U.S. PEDV prototype strain and 
S-INDEL-variant strain by PEDV IFA antibody assays 
As shown in Fig. 1, the Pro antisera tested antibody negative (0/5) at 0 and 7 DPI and 
100 % positive (5/5) at 14, 21, and 28 DPI by the prototype strain-based IFA antibody assay 
(Pro IFA). The variant strain-based IFA (Var IFA) gave similar results on the Pro antisera 
except that one serum collected at 14 DPI was negative by the Var IFA assay. When the 
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antibody titers were compared, the positive Pro antisera overall reacted better to the Pro IFA 
assay than to the Var IFA assay, with 1.4 log2 higher titer on average (Fig. 1). 
The Var antisera tested negative (0/5) at 0 and 7 DPI and 100 % positive (5/5) at 14, 
21, and 28 DPI by both the Pro IFA and Var IFA antibody assays. When the antibody titers 
were compared, the positive Var antisera reacted similarly to both Pro IFA and Var IFA 
assays, with less than 0.1 log2 titer differences on average (Fig. 1). 
The antisera collected from the negative control group (Neg antisera) were antibody 
negative by both PEDV Pro IFA and Var IFA assays throughout the study. The pig antiserum 
against the European PEDV CV777 strain had similar antibody titers by the Pro IFA assay 
(titer 320) and by the Var IFA assay (titer 160). The anti- sera against TGEV Purdue, PHEV, 
PDCoV, and PRCV viruses were all negative by both PEDV Pro IFA and Var IFA assays. 
Evaluation of cross-reactivity of antibodies against the U.S. PEDV prototype strain and 
S-INDEL-variant strain by various PEDV ELISAs 
As shown in Fig. 2, the Pro antisera collected at 0 and 7 DPI were all antibody 
negative by ProWV ELISA, ProS1 ELISA, and VarS1 ELISA. For the Pro antisera collected 
at 14 DPI, 2 sera were positive and 3 were in the suspect range by the ProWV ELISA; 3 
positives and 1 suspect by the ProS1 ELISA; 2 positives and 1 suspect by the VarS1 ELISA. 
The Pro antisera collected at 21 and 28 DPI were all positive by three ELISAs. When 
comparing the total number of positive Pro antisera at 14, 21 and 28 DPI by each ELISA, 
there were no significant differences among three ELISAs to detect antibody against the U.S. 
PEDV prototype strain. 
The Var antisera collected at 0 and 7 DPI were anti- body negative by all three 
ELISAs, with the exception of one serum at 7 DPI that was in the suspect range by the ProS1 
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ELISA (Fig. 2). The Var antisera collected at 14, 21 and 28 DPI had variable numbers of 
positive, suspect and negative results by three ELISAs (Fig. 2). Overall for the Var antisera, 
the ProWV ELISA detected 14 sera as antibody positive, 1 as suspect, and 10 as negative; the 
ProS1 ELISA detected 8 sera as positive, 5 as suspect, and 12 as negative; the VarS1 ELISA 
detected 12 sera as positive, 3 as suspect, and 10 as negative. When comparing the total 
number of positive Var antisera at 14, 21 and 28 DPI by each ELISA, the ProWV ELISA 
was significantly better than the ProS1 ELISA to detect antibody against the U.S. PEDV S-
INDEL-variant strain (p = 0.0079). However, there were no significant differences between 
the ProWV ELISA and VarS1 ELISA (p = 0.3643), or between the ProS1 ELISA and VarS1 
ELISA (p = 0.0723), to detect antibody against the U.S. PEDV S-INDEL-variant strain. 
The antisera collected from the negative control group (Neg antisera) were antibody 
negative by all three PEDV ELISAs throughout the study period 0–28 DPI. The pig 
antiserum against the European PEDV CV777 strain was antibody positive by all three 
PEDV ELISAs. The anti-sera against TGEV Purdue, PHEV, PDCoV, and PRCV viruses 
were all negative by three PEDV ELISAs. 
Evaluation of cross-neutralization of antibodies against the U.S. PEDV prototype strain 
and S-INDEL-variant strain by virus neutralization tests 
As shown in Fig. 3, VN antibodies were detected as early as 7 DPI in sera of most of 
the pigs inoculated with either a prototype strain or an S-INDEL-variant strain, regardless of 
testing by Pro VN or Var VN assays. Serum samples collected at 14, 21 and 28 DPI from all 
pigs inoculated with PEDV prototype strain or S-INDEL-variant strain were VN antibody 
positive by both Pro VN and Var VN assays. 
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The positive Pro antisera had similar VN antibody titers by the Pro VN and Var VN 
assays and there was no significant difference between the two assays. The positive Var 
antisera had similar VN antibody titers by the Pro VN and Var VN assays and overall there 
was no significant difference between the two assays (p = 0.42) although the average VN 
antibody titers of Var antisera at 21 and 28 DPI were slightly higher by the Var VN assay 
than by the Pro VN assay (Fig. 3). 
The VN antibody titers of the positive Pro antisera tested by the homologous Pro VN 
assay were, on average, 0.8 log2 higher than the VN antibody titers of the positive Var 
antisera tested by the homologous Var VN assay (Fig. 3). 
The antisera collected from the negative control group (Neg antisera) were antibody 
negative by both Pro VN and Var VN assays throughout the study period 0–28 DPI. The pig 
antiserum against the European PEDV CV777 strain was antibody positive by the Pro VN 
assay (titer 64) and by the Var VN assay (titer 16). The antisera against TGEV Purdue, 
PHEV, PDCoV, and PRCV viruses were all negative by both PEDV Pro VN and Var VN 
assays. 
 
Discussion 
Our lab has previously isolated the U.S. PEDV proto-type strains in Vero cells [7]. In 
order to obtain a cell culture isolate of U.S. PEDV S-INDEL-variant strains to generate 
strain-specific antisera for evaluation, virus isolation was first attempted in Vero cells using 
68 PEDV S-INDEL-variant strain-positive clinical samples submitted to the ISU VDL. 
However, attempts to isolate S-INDEL-variant virus in cell culture from these samples were 
unsuccessful. This could be due to multiple factors such as low concentration of virus in 
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samples, cytotoxicity of some samples, and variable storage conditions of the clinical 
samples after collection. Next, among the 68 clinical samples, one intestine homogenate 
containing the S-INDEL-variant PEDV was inoculated into pigs to generate more fresh 
materials with abundant virus load for virus isolation attempts in cell culture. Using this 
approach, U.S. S-INDEL-variant PEDV was successfully isolated in Vero cells. It is 
speculated that high concentration of virus in the samples and immediate virus isolation 
attempts on the fresh samples are the key to success of virus isolation in cell culture. For 
other viruses under occasions that there is difficulty to isolate those viruses in cell cultures 
directly from the clinical samples of naturally infected animals, the approach described in 
this study can be considered, namely amplifying the virus in host animals to obtain fresh 
samples with high concentration of virus for virus isolation attempts in cell cultures.  
Some field serum samples collected from swine farms were submitted to the ISU 
VDL for PEDV antibody detection. However, due to the lack of clear exposure history of 
these cases as well as the possibility of infection with multiple pathogens or with more than 
one PEDV strain, these field serum samples were not ideal for evaluating serological cross-
reactivity of different PEDV strains. Therefore, in the present study, antisera against the U.S. 
PEDV prototype and S-INDEL-variant strains were generated in weaned pigs under strict 
experimental conditions, for evaluation of cross-reactivity by various serological assays. 
The positive antisera against the prototype strain reacted with both prototype and S-
INDEL-variant viruses, and the positive antisera against the S-INDEL-variant strain also 
reacted with both prototype and S-INDEL-variant viruses, as examined by IFA antibody 
assays. When taking the antibody titers into consideration, antibodies against the prototype 
strain reacted better to the Pro IFA assay than to the Var IFA assay whereas antibodies 
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against the S-INDEL-variant strain reacted similarly to the Var IFA and Pro IFA assays. 
Thus, the current U.S. PEDV prototype strain-based IFA antibody assay offered at veterinary 
diagnostic laboratories can be used to detect antibodies against both U.S. PEDV strains. 
The ProWV ELISA and ProS1 ELISA have been previously developed and validated 
to detect PEDV-specific antibodies [14–16]. A PEDV VarS1 ELISA was developed in this 
study. However, this VarS1 ELISA was only validated using a limited number of field 
antisera against the U.S. PEDV S-INDEL-variant strain before testing the experimentally 
generated antisera in this study. Further validation of this VarS1 ELISA using large number 
of serum samples would be needed to determine the performance of this assay. All three 
PEDV ELISAs reacted with the Pro antisera and Var antisera. The three ELISAs detected 
Pro antisera similarly. However, it appeared that the ProS1 ELISA used in this study was not 
as efficient as the ProWV ELISA and the VarS1 ELISA to detect the antibodies against the 
U.S. PEDV S-INDEL-variant strain under the conditions of this study. 
The antibodies against the U.S. prototype strain and the antibodies against the U.S. S-
INDEL-variant strain neutralized both virus strains to similar titers. The U.S. PEDV 
prototype strain-based VN tests currently run in the laboratories can be used to detect 
antibodies against both U.S. PEDV strains. 
Both the prototype and S-INDEL-variant PEDV-inoculated pigs developed detectable 
IFA and ELISA antibodies in sera starting from 14 DPI in this study. In contrast, both groups 
of pigs developed low levels of serum neutralizing antibodies starting from 7 DPI. The IFA 
and ELISA assays in this study detected IgG antibodies; the VN tests could potentially detect 
any antibody isotype with neutralizing activity. It is unclear whether this contributes to the 
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observed early detection of low-level VN antibody. In a previous study, it has also been 
reported that PEDV VN antibody could be detected as early as 7 DPI [20]. 
The distinct genetic differences between the U.S. prototype and S-INDEL-variant 
PEDVs are located in the S1 region (nucleotides 1–2214 corresponding to aa 1–738, 
according to positions in the prototype strain USA/IN19338/2013, GenBank accession 
number KF650371), especially the N-terminal region of the S gene (nucleotides 1–1170 
corresponding to aa 1–390) whereas the remaining portions of the genomes are relatively 
conserved between the two U.S. strains [4, 8, 10]. The PEDV prototype strain S1 protein 
used for the ProS1 ELISA and the PEDV S-INDEL- variant strain S1 protein used for the 
VarS1 ELISA had 92 % amino acid identity. The reported PEDV neutralizing epitopes are 
located in the S protein amino acid residues 499–638, 744–759, 756–771, and 1368–1374 [1, 
21]. The protein sequences in these locations harboring the neutralizing epitopes are 
conserved between the U.S. prototype and S-INDEL-variant PEDVs. This can explain why 
the antibodies against the two PEDV strains were able to cross-neutralize two virus strains. 
The ProS1 and VarS1 ELISAs were developed using the recombinant PEDV S1 proteins (aa 
1–738). Although the U.S. prototype and S-INDEL-variant PEDVs have considerable 
differences in aa 1–390, the two strains still have some common epitopes in this region. In 
addition, the recombinant S1 proteins of two PEDV strains have relatively conserved 
sequences from aa 390–738 including the neutralizing epitopes in this region. These may be 
the reasons why the ProS1 and VarS1 ELISAs can detect antibodies against both U.S. PEDV 
strains despite possible differences on the sensitivity between assays. The IFA antibody assay 
and ProWV ELISA are supposed to detect antibodies against multiple antigenic proteins of 
PEDV and thus they are expected to detect antibodies against both U.S. prototype and S-
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INDEL-variant PEDVs. Other laboratories have developed nucleocapsid protein-based 
ELISAs [18] that were not evaluated in this study. Considering that the nucleocapsid protein 
is rather conserved among PEDVs, it is expected that the nucleocapsid protein-based ELISAs 
should detect antibodies against both U.S. PEDV strains. We also included one pig antiserum 
against the classical European PEDV CV777 strain for evaluation and the PEDV CV777 
antibody was detected by all serological assays evaluated in this study. However, antisera 
against TGEV Purdue, PHEV, PDCoV and PRCV had no cross-reactivity with PEDV 
serological assays evaluated in this study. 
In a previous study by Lin et al. [22], hyperimmune pig antisera against U.S. PEDV 
prototype strain, U.S. PEDV S-INDEL-variant strain, TGEV Purdue strain, and TGEV Miller 
strain were generated and tested by cell culture immunofluorescence (CCIF) assay (similar to 
our IFA antibody assay) and fluorescent focus reduction virus neutralization (FFRVN) assay 
(similar to our VN test). They found that antisera against the U.S. PEDV proto- type strain, 
S-INDEL-variant strain, and European CV777 strain all had cross-reactivity by CCIF and 
FFRVN assays. Our findings are consistent with their results. In addition to similar 
serological assays used by Lin et al., we also evaluated PEDV serological reactivity via three 
PEDV ELISAs. Also, we tested sequential serum samples (0–28 DPI) from pigs 
experimentally infected with two U.S. PEDV strains, providing useful information about the 
kinetics of PEDV antibody production in weaned pigs. An interesting finding in the Lin et al. 
study was that hyperimmune antisera against TGEV Miller strain rather than TGEV Purdue 
strain cross-reacted with all PEDV strains by CCIF assay but not by FFRVN assay. They 
further demonstrated that one epitope on the N-terminal region of PEDV/TGEV N protein 
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may contribute to this cross-reactivity. We did not include an antiserum against TGEV Miller 
strain in our study and could not evaluate its cross-reactivity in our PEDV assays. 
 
Conclusions 
The data in the present study indicate that the antibodies against U.S. PEDV 
prototype and S-INDEL-variant strains cross-reacted and cross-neutralized both strains in 
vitro. The current serological assays based on U.S. PEDV prototype strain can detect 
antibodies against both U.S. PEDV strains. However, the cross-protection efficacy of these 
two PEDV strains needs to be determined by in vivo pig studies. Goede et al. [23] showed 
that sows exposed to S-INDEL-variant PEDV infection 7 months ago could provide partial 
protection to newborn piglets challenged with a U.S. PEDV prototype strain. But more in 
vivo studies in this respect are needed to reveal whether a U.S. PEDV prototype strain or the 
S-INDEL-variant strain or both should be used to develop a vaccine for providing protection 
against both PEDV strains circulating in U.S. swine.  
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Fig. 1 IFA antibody testing of antisera against the U.S. PEDV prototype and S-INDEL-
variant strains. The average IFA antibody titers are shown at the top and the number of IFA 
antibody positive samples is shown at the bottom. Pro antisera: antisera collected from the 
U.S. PEDV prototype strain-inoculated pigs; Var antisera: antisera collected from the U.S. 
PEDV S-INDEL-variant strain-inoculated pigs; Neg antisera: antisera collected from 
negative control pigs; Pro IFA: the U.S. PEDV prototype strain-based IFA; Var IFA: the U.S. 
PEDV S-INDEL-variant strain-based IFA 
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Fig. 2 Testing of antisera against the U.S. PEDV prototype and S-INDEL-variant strains by 
ProWV ELISA (a), ProS1 ELISA (b) and VarS1 ELISA (c). For each assay, the solid black 
line indicates the S/P ratio above which the sample was positive; the dot black line indicates 
the S/P ratio below which the sample was negative; samples with S/P ratios between the solid 
and dot black line were suspect. ProWV ELISA: the U.S. PEDV prototype strain whole 
virus-based ELISA; ProS1 ELISA: the U.S. PEDV prototype strain S1-based ELISA; VarS1 
ELISA: the U.S. PEDV S-INDEL-variant strain S1-based ELISA 
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Fig. 3 Virus neutralization antibody testing of antisera against the U.S. PEDV prototype and 
S-INDEL-variant strains. The average VN antibody titers are shown at the top and the 
number of VN antibody positive samples is shown at the bottom. Pro VN: the U.S. PEDV 
prototype strain-based VN; Var VN: the U.S. PEDV S-INDEL-variant strain-based VN 
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Abstract 
At least two genetically different porcine epidemic diarrhea virus (PEDV) strains 
have been identified in the United States: U.S. PEDV prototype and S-INDEL-variant 
strains. The objective of this study was to compare the pathogenicity differences of the U.S. 
PEDV prototype and S-INDEL-variant strains in conventional neonatal piglets under 
experimental infections. Fifty PEDV-negative 5-day-old pigs were divided into 5 groups of 
10 pigs each and were inoculated orogastrically with three U.S. PEDV prototype isolates 
(IN19338/2013, NC35140/2013, and NC49469/2013), an S-INDEL-variant isolate 
(IL20697/2014), and virus-negative culture medium, respectively, with virus titers of 104 
TCID50/ml, 10 ml per pig. All three PEDV prototype isolates tested in this study, regardless 
of their phylogenetic clades, had similar pathogenicity and caused severe enteric disease in 5-
day-old pigs as evidenced by clinical signs, fecal virus shedding, and gross and 
histopathological lesions. Compared to pigs inoculated with the three U.S. PEDV prototype 
isolates, pigs inoculated with the S-INDEL-variant isolate had significantly diminished 
clinical signs, virus shedding in feces, gross lesions in small intestines, ceca and colons, 
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histopathological lesions in small intestines and immunohistochemistry staining in ileum. 
However, the U.S. PEDV prototype and the S -INDEL-variant strains induced similar 
viremia levels in inoculated pigs. Whole genome sequences of the PEDV prototype and S-
INDEL-variant strains were determined but the molecular basis of virulence differences 
between these PEDV strains remains to be elucidated using reverse genetics approach. 
 
Introduction 
Porcine epidemic diarrhea virus (PEDV) is an enveloped, positive-sense, single-
stranded RNA virus belonging to the family Coronaviridae, genus Alphacoronavirus (Saif, 
2011). PEDV is the causative agent of porcine epidemic diarrhea (PED) that was first 
recorded in England in the early 1970s (Oldham, 1972). Thereafter, PEDV has caused 
epidemic and endemic infections in Europe and particularly in Asia (Saif et al., 2012; Song 
& Park, 2012). Since October 2010, severe PED epizootic outbreaks have been reported in 
China that affected pigs of all ages but with a more severe form in neonates (Li et al., 
2012; Sun et al., 2012). In April 2013, PEDV emerged in United States (U.S.) swine 
(Stevenson et al., 2013) and spread rapidly across the country, resulting in the estimated 
death of over 7 million pigs in the first year and substantial economic losses (Cima, 2014). 
The initial PED outbreaks in U.S. swine were characterized by watery diarrhea, 
dehydration, variable vomiting, high mortality in neonatal piglets, and high morbidity but 
low mortality in weaned pigs (Stevenson et al., 2013). Sequence analyses revealed that the 
original U.S. PEDVs (U.S. PEDV prototype strain) are most genetically similar to some 
PEDVs circulating in China in 2011-2012 (Chen et al., 2014; Huang et al., 2013; Stevenson 
et al., 2013). In January 2014, some PED outbreaks with mild clinical signs based on field 
observations were noticed in U.S. swine and sequence analyses identified a PEDV 
122 
 
variant strain (Wang et al., 2014). Compared to the U.S. PEDV prototype strain, the U.S. 
PEDV variant strain has insertions and deletions (INDEL) in the spike gene and was also 
called S INDEL strain (Vlasova et al., 2014). In this study, we describe PEDVs 
circulating in the U.S. as the U.S. PEDV prototype strain and U.S. PEDV S-INDEL-
variant strain. After the PED outbreak in the U.S., detection of U.S. prototype-like PEDV 
has been reported in Canada, Mexico, Taiwan, South Korea, Japan and Ukraine (Dastjerdi 
et al., 2015; Lee & Lee, 2014; Lin et al., 2014; Ojkic et al., 2015; Van Diep et al., 2015; 
Vlasova et al., 2014); detection of U.S. S-INDEL-variant-like PEDV has been reported in 
South Korea, Germany, Belgium, France, Portugal, Japan, Italy and Austria (Boniotti et al., 
2016; Grasland et al., 2015; Hanke et al., 2015; Lee et al., 2014; Mesquita et al., 2015; 
Stadler et al., 2015; Steinrigl et al., 2015; Theuns et al., 2015; Yamamoto et al., 2015). 
The pathogenicity of the U.S. PEDV prototype strain has been evaluated in 
gnotobiotic (Jung et al., 2014), cesarean-derived-colostrum-deprived (CDCD) (Liu et al., 
2015; Madson et al., 2016), and conventional pigs (Jung et al., 2015a; Madson et al., 2014; 
Thomas et al., 2015); these studies experimentally confirmed that the U.S. PEDV prototype 
isolates are highly virulent. Evaluation of the pathogenicity of the U.S. S-INDEL-variant 
strain in experimentally infected pigs had not been reported until recently (Lin et al., 
2015a) when we were in the process of revising this manuscript. In Lin et al. (2015a), 
pathogenesis of a U.S. S-INDEL-variant PEDV was investigated in 3-4 day-old suckling 
piglets housed together with sows. The objective of the current study was to evaluate the 
pathogenesis of the U.S. PEDV S-INDEL-variant strain and also compare to the 
pathogenesis of 3 U.S. PEDV prototype isolates in 5-day-old conventional piglets. 
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Results 
Isolation and sequence comparison of U.S. PEDVs 
Three U.S. PEDV prototype isolates USA/NC35140/2013, USA/IA49379/2013 and 
USA/NC49469/2013 were isolated in Vero cells. Typical PEDV cytopathic effects 
including syncytial body formation and cell detachment were observed and virus growth was 
confirmed by immunofluorescence staining. All isolates grew efficiently in Vero cells and 
the infectious titers ranged from 103-106 TCID50/ml for the first ten passages. The whole 
genome sequences of the three U.S. PEDV prototype isolates NC35140, IA49379, and 
NC49469 were determined and compared to those of the previously described U.S. PEDV 
prototype isolate USA/IN19338/2013 and U.S. PEDV S-INDEL-variant isolate 
USA/IL20697/2014 with results summarized in Table 1. Schematic diagrams of PEDV 
genome organization and putative functions of viral proteins are described in Supplemental 
Fig S1. The prototype isolates IN19338, NC35140, IA49379 and NC49469 all had a 
genome of 28,038 nucleotides in length and had 99.75-99.91% nucleotide (nt) identity 
(26-69 nt differences) to each other at the whole genome level. The spike genes of these 
prototype isolates all had 4,161 nucleotides in length and had 99.54-99.88% nt identity (5-
19 nt differences) to each other. The S-INDEL-variant isolate IL20697 had a genome of 
28,029 nucleotides in length and had 99.08-99.22% nt identity (220-259 nt differences) at 
the whole genome level to the four prototype isolates evaluated in this study. Among 
them, about 64-96 nt differences were located in ORF1a/1b region especially the nsp12 
and nsp16 regions; however, a majority of these nt changes on nsp12 and nsp16 were 
synonymous (silent) changes at the amino acid level (Table 1). Striking differences between 
the U.S. PEDV prototype and S-INDEL-variant isolates were located in the spike gene 
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(96.25-96.37% nt identity; 151-156 nt differences) especially the S1 portion (93.14-
93.32% nt identity; 148-152 nt differences); the nucleotide changes at the S1 portion 
resulted in changes of the deduced amino acids (Table 1). Compared to the prototype 
isolates, the S gene of the variant isolate IL20697 had three characteristic deletions (a 
1-nt deletion of G at position 167, an 11-nt deletion of AGGGTGTCAAT at positions 176-
186, and a 3-nt deletion of ATA at positions 416-418) and one insertion (a 6-nt 
insertion of CAGGAT between positions 474 and 475). 
Phylogenetic analyses of the PEDV isolates described in this study and 45 PEDV 
reference sequences are provided in Fig 1. In the whole genome sequence-based 
neighbor-joining tree Fig 1(a), the U.S. PEDV prototype-like strains clustered together, 
which can be further divided into clade 1 and clade 2; however, the U.S. PEDV S-INDEL-
variant-like strains clustered separately. In the whole genome sequence-based maximum-
likelihood tree (Fig. 1b), the US PEDV prototype-like strains also clustered into clade 1 and 
clade 2; however, the S-INDEL-variant-like strains formed a separate sublineage within 
clade 2. In contrast, the phylogenetic clusters in the S1 sequence-based neighbour-joining 
tree (Fig. 1c) and the maximum-likelihood tree (Fig. 1d) were similar. In both (Fig. 1c, d), 
the US PEDV prototype-like strains clustered together and could be further divided into 
clade 1 and clade 2, similar to the whole genome sequence-based neighbor-joining tree (Fig. 
1a); the US PEDV S-INDEL-variant-like strains formed a separate branch that was more 
closely related to some classical PEDV isolates such as Europe/CV777, South Korea/SM98 
and China/SD-M, which had the same pattern of insertions and deletions in the S gene as the 
US PEDV S-INDEL-variant-like strains. 
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The prototype isolates IN19338 and IA49379 belonged to clade 1 and the isolate 
NC35140 belonged to clade 2 in both the whole genome-based trees (Fig. 1a, b) and the S1-
based trees (Fig. 1c, d). However, the prototype isolate NC49469 belonged to clade 1 in the 
whole genome-based trees (Fig. 1a, b) but to clade 2 in the S1-based trees (Fig. 1c, d). Three 
prototype isolates (IN19338 in clade 1, NC35140 in clade 2, and NC49469 in clade 1 or 
clade 2 depending on whole genome- or S1-based phylogenetic analyses) and one S-INDEL-
variant isolate, IL20697, were selected to compare their pathogenesis in pigs (Table 2). 
Clinical assessment 
All pigs in groups 1 (G1, IN19338), 2 (G2, NC35140) and 3 (G3, NC49469) 
developed soft to watery diarrhoea starting from 1 day post-infection (p.i.) and continuing 
through 6 or 7 days p.i. In contrast, in group 4 (G4, IL20697), only one pig had mild 
diarrhoea with soft faeces at 1 day p.i. The mean diarrhoea scores are summarized in Fig. 
2(a). Overall, pigs in G1 (P=0.001) and G3 (P<0.0001) had significantly higher mean 
diarrhoea scores than pigs in G2 when 0–7 days p.i. diarrhoea scores were analysed as 
described in Methods. Pigs in G1–G3, inoculated with the prototype PEDV isolates, overall 
had significantly higher mean diarrhoea scores than G4 (P<0.0001), inoculated with the 
PEDV variant isolate, and G5 (negative control, P<0.0001). The mean diarrhoea scores were 
not significantly different between G4 and G5 (P=1). 
No vomiting was observed from any pig throughout the study. In G1–G3, inoculated 
with the prototype isolates: (1) almost all pigs lost their appetite during the study period and 
tube feeding had to be administered; (2) severe dehydration, rough hair, and flat or thin 
flanks were observed in all pigs with most severe body conditions at about 4 days p.i.; (3) 
various degrees of lethargy, including head down and recumbence, were observed from 1 day 
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p.i. to the end of the study. In contrast, in G4 inoculated with the variant isolate: (1) all pigs 
had normal appetite; (2) no dehydration or lethargy was observed; (3) 90% of pigs had mild 
flat flanks at 1 or 2 days p.i. but recovered to normal after 4 days p.i. All G5 pigs were active, 
without diarrhoea, dehydration, lethargy or anorexia during the study period. 
From -1 to 3 days p.i., PEDV-inoculated pigs (G1–G4) had significantly lower mean 
daily weight gain (MDG, P≤0.0001) than pigs in G5 (negative control), but there were no 
significant differences in MDG (P values ranged from 0.089 to 1) among G1–G4 (Fig. 2b). 
From -1 to 7 days p.i., G1–G3 (prototype isolates) had significantly lower MDG (P values 
ranged from 0.0 to 0.037) than G4 (variant isolate), although none of G1, G2, G3 or G4 had 
significant difference in MDG (P values ranged from 0.078 to 0.847) compared with G5 
(negative control) (Fig. 2b). 
Virus shedding and distribution 
PEDV RNA was detected in rectal swab samples from all pigs in G1–G3 (prototype 
isolates) at 1 day p.i. until the end of the study. In G4 (variant isolate), PEDV RNA was 
detected in rectal swabs from 5/10, 8/10, 10/10, 5/5, 5/5, 3/5 and 2/5 pigs at 1, 2, 3, 4, 5, 6 
and 7 days p.i., respectively. The mean numbers of genomic copies ml21 of virus shed in 
rectal swabs are summarized in Fig. 2(c). Pigs in G1 and G2 had similar levels (P=0.601) of 
faecal virus shedding from 1 to 7 days p.i., with the quantity ranging from 107.2 to 109.0 
genomic copies ml-1, corresponding to Ct values of 16–22. Pigs in G3 had the highest level of 
faecal virus shedding at 1–2 days p.i. (approx. 109 genomic copies ml-1, with Ct of 16) and 
the faecal virus shedding gradually declined to approximately 105.4 genomic copies ml-1 at 7 
days p.i., corresponding to a Ct value of 28. In contrast, pigs in G4 had about 10
2.3 genomic 
copies ml-1 (Ct 31.8) faecal virus shedding at 1 day p.i.; the faecal virus shedding gradually 
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increased, peaked at 5 days p.i. (105.4 genomic copies ml-1 with Ct of 28.8) and then declined 
to approximately 101.3 genomic copies   ml-1 (Ct 36.3) at 7 days p.i. Statistical analyses 
indicated that G1–G3 (prototype isolates) had significantly larger amounts of viral RNA 
shedding in rectal swabs (P<0.0001) than did G4 (variant isolate). 
PEDV RNA was detected in serum samples from all pigs in G1–G4 necropsied at 3 
days p.i., with mean Ct values of 33.2 (G1), 30.5 (G2), 31.9 (G3) and 28.4 (G4). There were 
no significant differences between mean PEDV genomic copies in sera of G1–G4 at 3 days 
p.i. (P values ranged from 0.077 to 0.646, Fig. 2d). At 7 days p.i., PEDV RNA was detected 
in serum samples from three or four out of five pigs in G1–G4, with mean Ct values (only for 
PCR- positive pigs) of 33.5 (G1), 34.2 (G2), 37.4 (G3) and 35.8 (G4). The mean number of 
genomic copies of PEDV in sera of G4 (variant isolate) showed no significant difference (P 
values ranged from 0.050 to 0.717) from those in G1–G3 (prototype isolates) at 7 days p.i. 
(Fig. 2d). 
Virus distributions in tissues are summarized in Table S1. At 3 days p.i., regardless of 
G1, G2, G3 or G4, mean PEDV RNA concentrations in ileums, caeca, colons and mesenteric 
lymph nodes were higher than the concentrations in other tissues within the same inoculation 
group. When viral RNA concentrations in each tissue type were compared across the four 
inoculation groups at 3 days p.i., viral RNA concentrations in caecum and colon of G4 
(variant isolate) were overall significantly lower than in caecum and colon of G1–G3 
(prototype isolates). However, viral RNA concentrations in other tissues of G4 were similar 
to those in the corresponding tissues of G1–G3; the same types of tissues in G1–G3 had 
similar levels of viral RNA. Data at 7 days p.i. overall supported similar conclusions to 3 
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days p.i., except that the numbers of viral genomic copies in caecum and colon were much 
lower than those in ileum and mesenteric lymph node in G4. 
All rectal swabs, sera and tissue samples from G5 (negative control) were negative by 
PEDV real-time reverse transcription PCR (RT-PCR) throughout the study period. 
Gross pathology 
At 3 days p.i., thin and transparent walls, sometimes dilated by gas and/or yellowish 
fluid, were observed in small intestine, caecum and colon tissues in most pigs inoculated with 
the PEDV prototype isolates (G1–G3). In addition, almost all pigs in G1–G3 had watery 
contents in small intestines, caeca and colons. In contrast, only mildly thin walls could be 
observed in small intestines of 3/5 pigs inoculated with the PEDV variant isolate (G4); no 
apparent gross lesions were observed in caeca or colons of pigs in G4. Also, in G4, only 1/5 
pigs had watery contents in the small intestine, caecum and colon; two other pigs had semi-
watery contents in the caecum. Statistically, all G1–G3 (prototype isolates) had significantly 
higher small intestine, caecum and colon content scores (P values ranged from <0.0001 to 
0.0127) than G4 (variant isolate) and G5 (negative control) (Fig. 3a). A significant difference 
was not observed among G1–G3 (P values ranged from 0.3722 to 1) for small intestine, 
caecum and colon content scores (Fig. 3a). For G4, only caecum content scores were 
significantly higher than for G5 (P=0.003), not small intestine or colon content scores (P 
values ranged from 0.5259 to 1; Fig. 3a). All prototype isolate-inoculated groups (G1–G3) 
had significantly higher tissue lesion scores on small intestine, caecum and colon (P values 
ranged from 0.0012 to 0.049) than the variant isolate-inoculated group (G4) and the negative 
control group (G5) (Fig. 3b). No significant differences were observed in small intestine, 
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caecum and colon lesion scores among G1–G3 (P values ranged from 0.1585 to 1) or 
between G4 and G5 (P values ranged from 0.4766 to 1; Fig. 3b). 
At 7 days p.i., most pigs in G1–G3 still had thin-walled and/or gas-distended small 
intestines, but only about 50% of pigs in G1–G3 had thin-walled and/or gas-distended caeca 
and colons. All pigs in G1 and G2, and 4/5 pigs in G3 had watery small intestine contents. 
About 60–100% of pigs in G1–G3 had semi-watery or watery contents in caeca and colons. 
In G4, only 1/5 pigs had thin-walled small intestines and none of the pigs had gross lesions in 
caeca and colons. In G4, 5/5, 1/5 and 0/5 pigs had semi-watery or watery contents in small 
intestines, caeca and colons, respectively. In G5, 1/5 pigs had thin-walled small intestine, 
caecum and colon; 3/5 pigs had semi-watery or watery contents in small intestines, caeca and 
colons. Significant differences in tissue content scores and tissue lesion scores were observed 
between some groups (Fig. 3). 
Rectal swabs collected at 3 and 7 days p.i. were confirmed negative for porcine 
deltacoronavirus (PDCoV), transmissible gastroenteritis virus (TGEV), and porcine 
rotaviruses (groups A, B and C) and negative for haemolytic Escherichia coli and Salmonella 
spp. 
Histopathology 
No remarkable microscopic lesions were observed in stomach, caecum, colon, tonsil, 
mesenteric lymph node, heart, lung, liver, spleen and kidney sections of all piglets (G1–G5) 
at either 3 or 7 days p.i. 
Severe lesions consistent with viral enteritis (e.g. villous enterocyte swelling, villous 
atrophy, collapsed lamina propria) were observed in small intestinal sections (duodenum, 
jejunum and ileum) of all pigs in G1–G3 (prototype isolates) necropsied at 3 and 7 days p.i. 
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Mild microscopic lesions consistent with viral enteritis were observed in small intestinal 
sections of pigs in G4 (variant isolate) necropsied at 3 days p.i.; however, microscopic 
lesions were not remarkable in small intestinal sections of pigs in G4 necropsied at 7 days p.i. 
Microscopic lesions were not apparent in small intestinal sections of pigs in G5 (negative 
control) at either 3 or 7 days p.i. Representative images of haematoxylin and eosin (H&E)-
stained ileum sections of pigs necropsied at 3 days p.i. from G1–G5 are shown in Fig. 4(a–e). 
Villus height, crypt depth and villus height/crypt depth ratio were measured and 
compared on small intestinal sections of the five inoculation groups. At 3 days p.i., pigs in 
G1–G3 (prototype isolates) had significantly decreased mean villus heights, increased mean 
crypt depths, and lower mean villus/crypt ratios in duodenum, proximal jejunum, middle 
jejunum, distal jejunum and ileum compared with pigs in G4 (variant isolate) and G5 
(negative control), with some exceptions (Fig. 5); exceptions include villus height and 
villus/crypt ratio in duodenum of G2 and G4 as well as crypt depth in middle jejunum of G1 
and G4. The mean villus heights, crypt depths and villus/crypt ratios of small intestine 
sections at 3 days p.i. were, overall, similar across the three groups G1–G3 inoculated with 
the prototype isolates (Fig. 5). The mean crypt depths of all small intestinal sections at 3 days 
p.i. were not significantly different between G4 (variant isolate) and G5 (negative control); 
however, pigs in G4 had significantly decreased mean villus heights and lower mean 
villus/crypt ratios in duodenum, middle and distal jejunum, and ileum at 3 days p.i. compared 
with pigs in G5 (Fig. 5). 
At 7 days p.i., the mean villus heights and villus/crypt ratios of small intestinal 
sections were, overall, similar across the three groups G1–G3 (Fig. 6a, c). Pigs in G1–G3, 
overall, had significantly decreased mean villus heights and lower mean villus/crypt ratios in 
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small intestinal sections com- pared with pigs in G4 and G5 at 7 days p.i. (Fig. 6a, c). 
Interestingly, the mean villus heights at 7 days p.i. either were not significantly different 
between G4 (variant isolate) and G5 (negative control) or were significantly higher in G4 
than G5 (Fig. 6a). The mean villus/crypt ratios at 7 days p.i. were not significantly different 
in proximal, middle and distal jejunum, and ileum between G4 and G5, although the mean 
villus/crypt ratios in duodenum were significantly different between G4 and G5 (Fig. 6c). 
Comparison of mean crypt depths at 7 days p.i. is presented in Fig. 6(b). The mean crypt 
depths were similar in all small intestinal sections between the prototype isolate-inoculated 
groups G2 and G3; both G2 and G3 had significantly greater crypt depths than the negative 
control group G5. Another prototype-isolate-inoculated group, G1, had mean crypt depth 
values that were between the negative control group G5 and the prototype-isolate- inoculated 
groups G2 and G3. The variant-isolate-inoculated group G4 had significantly increased mean 
crypt depths in duodenum, and proximal and distal jejunums compared with the negative 
control group G5, while G4 had mean crypt depths similar to those of G1, G2 and G3 in most 
of the small intestinal sections. 
Immunohistochemistry (IHC) 
At 3 days p.i., PEDV-specific IHC staining was performed on serial sections of 
ileum, caecum and colon of all five inoculation groups. None of the five pigs in G5 (negative 
control) was IHC positive in the ileum, caecum or colon. All five pigs in each of G1–G4 
were IHC positive in the ileum, with mean IHC scores of 3.9 (G1), 3.7 (G2), 3.8 (G3) and 2.5 
(G4). The mean IHC scores for ileum were similar across G1–G3 and were significantly 
higher than for G4 (Fig. 5d). Regarding IHC staining of caeca, 5/5 (G1), 4/5 (G2), 5/5 (G3) 
and 3/5 (G4) pigs were positive, with no significant differences in mean IHC scores among 
132 
 
G1–G4 (Fig. 5d). For colons, 5/5 (G1), 4/5 (G2), 4/5 (G3) and 2/5 (G4) pigs were IHC 
positive, but the mean IHC scores were not significantly different among G1–G4 (Fig. 5d). 
Representative PEDV IHC staining images are shown in Fig. 4(f–t). 
At 7 days p.i., PEDV IHC staining was only performed on serial sections of ileum. 
Mild/scant IHC staining was observed in G1 and G2 but no staining was observed in G3, G4 
and G5 (Fig. 6d). 
 
Discussion 
Sequence analyses demonstrated that at least two genetically different PEDV strains 
have been circulating in the USA (Vlasova et al., 2014; Wang et al., 2014), and they are 
referred to as US PEDV prototype strain and US PEDV S-INDEL-variant strain. The US 
prototype PEDVs can be phylogenetically further divided into clade 1 and clade 2. In the 
whole genome sequence-based phylogenetic analyses, the US S-INDEL-variant-like PEDVs 
clustered separately from clade 1 and clade 2 in the neighbour-joining tree, but they formed a 
separate sub-lineage within clade 2 in the maximum-likelihood tree (Fig. 1a, b). This 
suggests that phylogenetic analysis tools and tree construction methods could result in some 
differences in the outcomes of the analyses; thus, conclusions should be drawn cautiously by 
clearly indicating the tools and methods used for phylogenetic analyses. Among US 
prototype PEDVs, some always belong to clade 1 or clade 2 regardless of whether whole 
genome-based trees or S1-based trees are used; however, some (e.g. NC49469 and 
Minnesota62) belong to clade 1 in whole genome-based trees but belong to clade 2 in S1-
based trees (Fig. 1). This is probably because the S1 sequences of NC49469 and 
Minnesota62 PEDVs are more closely related to clade 2 whereas the remaining genome 
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sequences are more closely related to clade 1 PEDVs. Our group has isolated various PEDVs 
in cell culture that fall into each category described above, enabling us to compare the 
pathogenesis of various US prototype and S-INDEL-variant PEDVs. 
Previous studies have demonstrated that neonatal piglets are more susceptible than 
weaned pigs to PEDV infection, and PEDV infection induces greater disease severity in 
neonates than in weaned pigs (Jung et al., 2015a; Thomas et al., 2015). Therefore, a sensitive 
5-day-old neonatal piglet model was selected for pathogenesis comparisons in this study. 
Among three US PEDV prototype isolates (IN19338, NC35140 and NC49469), the mean 
diarrhoea scores induced by the NC35140 isolate were lower than those induced by the 
IN19338 and NC49469 isolates; however, three prototype isolates had similar virus 
shedding, gross lesions, histopathological lesions and IHC staining. Overall, we conclude 
that the three US PEDV prototype isolates evaluated in this study have similar pathogenicity 
in neonatal piglets regardless of their phylogenetic clades. In contrast, data in the current 
study clearly demonstrate that the US PEDV S-INDEL-variant isolate IL20697 had 
significantly diminished clinical signs, virus shedding in faeces, gross lesions in small 
intestines, caeca and colons, histopathological lesions in small intestines, and IHC scores in 
ileum, compared with three US PEDV prototype isolates, IN19338, NC35140 and NC49469. 
Recent experimental studies by other groups also demonstrated that S-INDEL PEDVs overall 
had lower pathogenicity than the US prototype strains in 3–4-day-old or 1-week-old pigs 
(Lin et al., 2015a; Yamamoto et al., 2015). However, Lin et al. (2015a) observed that three 
litters of piglets inoculated with a US S-INDEL Iowa106 strain had zero mortality but one 
litter of piglets inoculated with the same virus strain had 75% mortality. They hypothesized 
that the sows’ health condition can have a direct impact on colostrum/milk production and 
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thus affect the infection outcome of their piglets (Lin et al., 2015a). The virulence of S-
INDEL PEDVs observed in the field has variations among farms and countries. In the USA, 
the S-INDEL variant strain OH851 infection only caused minimal to no clinical signs in 
suckling piglets on the farm (Wang et al., 2014). In Germany, two sow farms were infected 
with an S-INDEL PEDV that has 99.4% nucleotide identity to the US S-INDEL-variant 
OH851 at the whole genome level; however, severity of clinical signs and mortality in 
suckling piglets varied significantly between the two farms (Stadler et al., 2015). Factors 
contributing to the contradictory findings have not been clearly identified, but source of 
viruses (WT or cell-culture-adapted viruses), inoculation/infection doses, 
animal/environmental conditions, and nucleotide/amino acid variations among S-INDEL 
PEDVs could contribute to the observed discrepancies among various experimental studies 
and field outbreaks. In addition, PEDV pathogenicity can be age-dependent. Further 
investigations of pathogenicity of S-INDEL PEDV variants in weaned pigs, finisher pigs, 
gilts and sows are warranted. 
Previous studies showed that viraemia can occur in the acute stage of infection with 
US PEDV prototype isolates (Jung et al., 2014; Madson et al., 2016). In the present study, 
we also detected PEDV RNA in serum samples. In addition, the PEDV variant isolate and 
three prototype isolates had similar viraemia levels under the conditions of this study. PEDV 
is an enteropathogenic coronavirus that infects the villous enterocytes, resulting in villous 
atrophy and malabsorptive diarrhoea. Some quantities of PEDV could be taken into the blood 
stream through mechanisms not fully understood. But PEDV is not believed to actively 
replicate in blood, and viraemia levels may not necessarily correlate to 
virulence/pathogenicity. In the current study, high levels of PEDV RNA were detected in 
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small intestine, caecum, colon and mesenteric lymph nodes, while low levels of PEDV RNA 
were detected in non-enteric tissues (tonsil, heart, lung, liver, spleen, kidney and muscle) 
from pigs inoculated with either prototype or S-INDEL-variant PEDV. Previous studies 
indicated that PEDV viral antigen (US prototype isolates) could be detected in small 
intestine, mesenteric lymph node, and some colon and spleen tissues (Jung et al., 2014, 
2015b; Madson et al., 2016), but other non-enteric tissues such as lung, heart, kidney and 
liver were all negative for PEDV antigen (Madson et al., 2016). Therefore, detection of 
PEDV RNA does not necessarily mean that PEDV replicates in all of these non-enteric 
tissues. Considering that the blood was not drained before collecting each organ, the 
possibility that virus in these tissues was from blood cannot be excluded. 
In the current study, PEDV IHC staining was only performed on ileum, caecum and 
colon of inoculated pigs. Among four groups inoculated with PEDVs (three proto- type 
isolates and one variant isolate), PEDV IHC staining was observed in 100% of ileums, 60–
100% of caeca and 40–100% of colons at 3 days p.i. The mean IHC scores in ileums were 
significantly lower in the variant isolate-inoculated pigs than in the prototype isolates-
inoculated pigs, consistent with observations on gross pathology and histopathological 
lesions of small intestines. Although the mean IHC scores in caeca and colons were 
numerically lower in pigs inoculated with the variant isolate than in pigs inoculated with the 
three prototype isolates, the differences were not significant. However, PEDV variant isolate-
inoculated pigs had fewer gross changes in caecum and colon than the prototype isolate-
inoculated pigs. Thus, the correlations of caecal and colonic changes with PEDV 
virulence/pathogenicity may need to be further elucidated. 
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All four groups G1–G4 inoculated with PEDVs (three prototype isolates and one 
variant isolate) had significantly shortened villus heights compared with the negative control 
group G5 at 3 days p.i., and G1–G3 (prototype isolates) had significantly shortened villus 
heights compared with G4 (variant isolate). This indicates that both US prototype and variant 
PEDV isolates can infect and destroy villus epithelium of small intestines, but the US PEDV 
variant isolate caused less severe villous atrophy than prototype isolates. Intestinal crypt 
epithelial cells serve to replace the destroyed villous enterocytes. At 3 days p.i., the mean 
crypt depths of G4 (variant isolate) were not significantly different from G5 (negative 
control), but the mean crypt depths of G1–G3 (prototype isolates) were significantly greater 
than G4 and G5. This may suggest that mild villous atrophy caused by the US PEDV variant 
isolate had not triggered significant proliferation and elongation of intestinal crypt at 3 days 
p.i.; however, intestinal crypts had started to elongate to some degree to repair severe villous 
atrophy in prototype isolate-inoculated groups G1–G3. At 7 days p.i., prototype isolate-
inoculated groups had greater mean crypt depth than the negative control group, suggesting 
that crypt elongation continued to replace the damaged villus enterocytes but the villus 
epithelium had not recovered back to normal. The mean crypt depths of some G4 (variant 
isolate) sections of small intestine were significantly greater than G5 (negative control) at 7 
days p.i., suggesting that elongation of crypts occurred later in G4 than in the prototype 
isolate-inoculated groups G1–G3. The proliferated crypts eventually recovered the destroyed 
villus enterocytes apparent at 3 days p.i. in G4. IHC staining also supported these 
observations. 
Some studies showed that the antibodies against US PEDV prototype and S-INDEL-
variant strains can cross-react and cross-neutralize both strains in vitro (Chen et al., 
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unpublished; Lin et al., 2015b). An in vivo study (Goede et al., 2015) showed that sows 
exposed to S-INDEL-variant PEDV infection 7 months previously could provide partial 
protection to newborn piglets challenged with a US PEDV prototype strain. Another in vivo 
study (Lin et al., 2015a) demonstrated that 3–4-day-old piglets exposed to S-INDEL-variant 
PEDV were partially protected against subsequent challenge with a US prototype PEDV. We 
also have unpublished data that demonstrates that both US PEDV prototype and S- INDEL-
variant strains can provide homologous and heterologous protection against two virus strains 
in a weaned pig model. In the current study, it was demonstrated that US PEDV S-INDEL-
variant strain is less virulent than US PEDV prototype strains in neonatal pigs. These data 
collectively suggest that US PEDV S-INDEL-variant strain could potentially be a modified 
live virus vaccine candidate against PED, although additional evaluation work is needed. 
The striking sequence differences between US prototype and S-INDEL-variant 
PEDVs are located in the spike gene, especially the S1 portion. The sequence differences in 
the spike gene may be responsible for the virulence differences between US prototype and S-
INDEL-variant PEDVs, but this remains to be confirmed using a reverse genetics approach. 
 
Methods 
Virus isolates and cells.  
Isolation and characterization of the US PEDV prototype isolate USA/IN19338/2013 
and S-INDEL-variant isolate USA/IL20697/2014 have been described elsewhere (Chen et 
al., 2014; Chen et al., unpublished). Three additional US PEDV prototype isolates, 
USA/NC35140/2013, USA/IA49379/2013 and USA/NC49469/2013, were obtained for this 
study, all from archived piglet faeces submitted to the Iowa State University Veterinary 
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Diagnostic Laboratory (ISU VDL) for routine diagnosis following previously described virus 
isolation procedures (Chen et al., 2014). All PEDV isolation, propagation and titration were 
performed in Vero cells (ATCC CCL-81) as previously described (Chen et al., 2014). All 
PEDV isolates used in this study were confirmed negative for PDCoV, TGEV, porcine 
rotaviruses (groups A, B and C), porcine reproductive and respiratory syndrome virus and 
porcine circovirus. 
Virus sequencing, comparative sequence analysis and phylogenetic analysis. 
The whole genome sequences of the PEDV isolates described in this study were 
determined by next generation sequencing technology using the Illumina MiSeq platform, 
and assembled with SeqMan Pro version 11.2.1 (DNASTAR) as described previously (Chen 
et al., 2014). The sequence data of these PEDV isolates were deposited in GenBank with the 
following accession numbers: USA/IN19338/2013 [KF650371], USA/NC35140/2013 
[KM975735], USA/IA49379/2013 [KM975736], USA/NC49469/2013 [KM975737] and 
USA/IL20697/2014 [KT860508]. 
The whole genome sequences and individual gene sequences (nucleotide and amino 
acid sequences) of all PEDV isolates used in this study were aligned using Clustal_X version 
2.0 (Larkin et al., 2007) and BioEdit version 7.0.4.1 (Hall, 1999) to compare the genetic 
similarity. Phylogenetic analysis was conducted using the entire genome and the S1 portion 
(S gene nt 1–2205 according to the sequence KF650371) nucleotide sequences of the PEDV 
isolates described in this study as well as representative global PEDVs (in total, 50 
sequences). Phylogenetic trees were constructed using the distance-based neighbour-joining 
method and maximum-likelihood method of MEGA6 (Tamura et al., 2013). Bootstrap 
analysis was carried out on a 1000 replicate dataset.  
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Experimental design.  
The animal study protocol was approved by the Iowa State University Institutional 
Animal Care and Use Com- mittee (approval number 6-14-7821 S; approved on 10 July 
2014). Fifty 5-day-old piglets were purchased from a conventional breeding farm and 
delivered to the Iowa State University Laboratory Animal Resources facilities. All pigs were 
intramuscularly injected with a dose of Excede (Zoetis) upon arrival and confirmed negative 
for PEDV, PDCoV, TGEV and porcine rotaviruses (groups A, B and C) by virus- specific 
PCRs on rectal swabs, and negative for PEDV antibody by a virus-specific indirect 
fluorescent antibody assay on serum samples at the ISU VDL. Pigs were blocked by weight 
and then randomly divided into five groups of ten pigs each, one group per room on a solid 
floor. Pigs were fed a mixture of Esbilac (PetAg, Hampshire, Illinois, USA) liquid milk 
replacer and yogurt and had free access to water. After 1 day acclimation (after which piglets 
were 6 days old), pigs in groups G1–G5 were orogastrically inoculated with three US PEDV 
prototype isolates, USA/IN19338/2013 (G1), USA/NC35140/2013 (G2) and 
USA/NC49469/2013 (G3), one US S-INDEL-variant isolate, USA/ IL20697/2014 (G4), or 
virus-negative culture medium (G5), respectively (10 ml per pig; all viruses were at the 
seventh passage in cell culture with a titre of 104 TCID50 ml
-1) (Table 2). 
Piglets were evaluated daily for presence of vomiting and clinical signs of diarrhoea, 
lethargy and body condition. Diarrhoea severity was scored with the following criteria: 0, 
normal; 1, soft (cowpie); 2, liquid with some solid content; 3, watery with no solid content. 
Lethargy levels were categorized as: normal, mild lethargy (slow to move, head down), 
moderate lethargy (stands but wants to lie down) or severe lethargy (recumbent, moribund). 
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Body condition was categorized as: normal, mild loss (flat flank), moderate (flank tucked in) 
or severe (backbone/ribs prominent). 
Body weights were recorded prior to inoculation (at -1 day p.i.) and then at 3 and 7 
days p.i. The MDG was calculated for pigs from -1 to 3 days p.i. and -1 to 7 days p.i. Serum 
samples were collected at 0, 3 and 7 days p.i. Rectal swabs were collected daily from each 
pig from 0 days p.i. to necropsy and were submerged into 1 ml PBS immediately after 
collection. Five pigs from each group were randomly selected for necropsy at 3 days p.i., and 
the remaining pigs were necropsied at 7 days p.i. Fresh and formalin-fixed samples collected 
at necropsy included tonsil, heart, lung, liver, spleen, kidney, skeletal muscle from rear leg, 
stomach, mesenteric lymph node, duodenum, proximal jejunum, middle jejunum, distal 
jejunum, ileum, caecum and colon. Collection of different intestinal segments was performed 
as previously described (Madson et al., 2014). 
At necropsy, the small intestine, caecum and colon were examined for gross lesions 
by veterinary pathologists blind to the treatment groups. Tissue lesions were categorized as 
normal, thin-walled and/or gas-distended. The presence of thin-walled intestines or gas-
distended organs was numerated as 1 point; the presence of both thin-walled and gas-
distended was numerated as 2 points. Contents of small intestine, caecum and colon were 
examined and scored with the criteria: 0, normal; 1, liquid with some solids (semi-watery); 2, 
watery. 
To rule out the possibility of concurrent infections with other pathogens, rectal swabs 
collected at 3 and 7 days p.i. before necropsy were tested for PDCoV, TGEV and porcine 
rotaviruses (groups A, B and C) by virus-specific PCRs and for haemolytic E. coli and 
Salmonella spp. by routine bacterial cultures at ISU VDL. 
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Virus shedding as examined by a quantitative PEDV N-gene-based real-time RT-PCR.  
Viral RNA was extracted from rectal swabs, serum and 10% tissue homogenates as 
previously described (Chen et al., 2014). Five microlitres of each RNA template was used in 
a PCR setup in a 25 ml total reaction using the Path-ID Multiplex One-Step RT-PCR kit 
(Thermo Fisher Scientific). The primers, probes and in vitro-transcribed RNA used to 
generate standard curves of a quantitative PEDV N-gene-based real-time RT-PCR have been 
previously described (Lowe et al., 2014; Madson et al., 2014; Thomas et al., 2015). Based on 
standard curves, the virus concentration (expressed as genomic copies ml-1) in tested samples 
was calculated. The mean Ct values were calculated based on PCR-positive samples, and the 
mean virus concentrations were calculated based on all pigs within the group (both PCR-
positive and PCR-negative pigs). 
Histopathology.  
Tonsil, heart, lung, liver, spleen, kidney, mesenteric lymph node, stomach, 
duodenum, proximal jejunum, middle jejunum, distal jejunum, ileum, caecum and colon 
tissues were fixed in 10% formalin, embedded, sectioned and stained with H&E, and 
examined by a veterinary pathologist blinded to individual animal identifications and 
treatment groups. Villus lengths and crypt depths were measured from three representative 
villi and crypts of duodenum, proximal jejunum, middle jejunum, distal jejunum and ileum, 
using a computerized image system following previously described procedures (Madson et 
al., 2014). Villus-height-to-crypt-depth (villus/crypt) ratio of each tissue was calculated as 
the quotient of the mean villus length divided by the mean crypt depth. 
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IHC.  
Serial sections of ileum, caecum and colon at 3 days p.i. necropsy were evaluated for 
PEDV antigen by IHC using a PEDV-specific mAb (BioNote) as previously described 
(Madson et al., 2014). At 7 days p.i. necropsy, IHC staining was only performed on serial 
sections of ileum. The IHC antigen detection was semi-quantitatively scored as previously 
described (Chen et al., 2015) with the following criteria: 0, no staining; 1, approximately 1–
10% enterocytes with positive staining; 2, approximately 10–25% enterocytes with positive 
staining; 3, approximately 25–50% enterocytes with positive staining; 4, approximately 50–
100% enterocytes with positive staining. 
Statistical analyses.  
A generalized linear mixed (GLIMMIX) model was used for all statistical 
comparisons with Statistical Analysis System (SAS) version 9.3 (SAS Institute). A P value 
<0.05 was defined as statistically significant. P values of overall faecal viral shedding level 
[log10(genomic copies    ml
-1)] were assessed among treatments from 0–7 days p.i., with days 
p.i. and treatment as interacting variables, and similarly for analysis of diarrhoea scores. 
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Table 1. Nucleotide and amino acid differences between the US PEDV prototype and S-INDEL-variant isolates 
Genome region or ORF (nt 
position)*  Protein region [length (aa)] 
Differences among Prototype isolates†   
Differences between the Prototype 
isolates and S-INDEL-variant‡ 
∆nt, N (%)§ ∆aa, N (%)§   ∆nt, N (%)§ ∆aa, N (%)§ 
Whole genome (1-28038)   26-69 (0.09-0.25)     220-259 (0.78-0.92)   
5' UTR (1-292) N/A 0-2 (0-0.68) N/A   0-2 (0-0.68) N/A 
Nonstructural proteins             
ORF1ab (293-20637) 1ab polyprotein (6781) 16-50 (0.08-0.25) 9-16 (0.13-0.23)   64-96 (0.31-0.47) 7-19 (0.10-0.28) 
  nsp1: Met1-Gly110 (110) 0 (0) 0 (0)   0 (0) 0 (0) 
  nsp2: Asn111-Gly895 (785) 5-13 (0.21-0.55) 3-5 (0.38-0.64)   4-17 (0.17-0.72) 1-6 (0.13-0.76) 
  nsp3: Gly896-Gly2516 1621) 5-22 (0.10-0.45) 3-9 (0.18-0.56)   6-24 (0.12-0.49) 1-10 (0.06-0.62) 
  nsp4: Ala2517-Gln2997 (481) 0-1 (0-0.07) 0 (0)   1-2 (0.07-0.14) 0 (0) 
  nsp5: Ala2998-Gln3299 (302) 0-2 (0-0.22) 0 (0)   0-1 (0-0.11) 0 (0) 
  nsp6: Ser3300-Gln3579 (280) 0-2 (0-0.24) 0 (0)   0-1 (0-0.12) 0 (0) 
  nsp7: Ser3580-Gln3662 (83) 0 (0) 0 (0)   1 (0.40) 0 (0) 
  nsp8: Ser3663-Gln3857 (195) 0 (0) 0 (0)   0 (0) 0 (0) 
  nsp9: Asn3858-Gln3965 (108) 0 (0) 0 (0)   0 (0) 0 (0) 
  nsp10: Ala3966-Gln4100 (135) 0-1 (0-0.25) 0 (0)   0-1 (0-0.25) 0 (0) 
  nsp12: Ser4101-Gln5027 (927) 0-6 (0-0.22) 0-1 (0-0.11)   23-27 (0.83-0.97) 0-1 (0-0.11) 
  nsp13: Ser5028-Gln5546 (519) 1-2 (0.06-0.12) 0 (0)   2-3 (0.12-0.19) 0 (0) 
  nsp14: Asn5547-Gln6141 (595) 0-3 (0-0.17) 0-1 (0-0.17)   1-2 (0.06-0.11) 0-1 (0-0.17) 
  nsp15: Gly6142-Gln6480 (339) 0-2 (0-0.20) 0-2 (0-0.59)   8-9 (0.79-0.88) 1-2 (0.29-0.59) 
  nsp16: Ala6481-Lys6781 (301) 0-1 (0-0.11) 0-1 (0-0.33)   12-13 (1.32-1.43) 1-2 (0.33-0.66) 
NA, Not applicable. 
*Nucleotides are numbered according to the sequence of US PEDV prototype isolate USA/IN19338/2013 (GenBank accession 
number KF650371). 
†Prototype isolates IN19338, IA49379, NC49469 and NC35140. 
‡S-INDEL-variant isolate IL20697. 
§Percentage nucleotide (nt) and amino acid (aa) differences were calculated at each gene or protein level. 
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Table 1. Continued 
Structural/accessory 
proteins             
Spike (20634-24794) S (1386) 5-19 (0.12-0.46) 3-10 (0.22-0.72)   151-156 (3.63-3.75) 59-65 (4.26-4.69) 
Spike 1 (20634-22847) S1 (738) 4-13 (0.18-0.59) 3-7 (0.41-0.95)   148-152 (6.68-6.86) 58-61 (7.86-8.27) 
Spike 2 (22848-24794) S2 (648) 0-6 (0-0.31) 0-3 (0-0.46)   3-8 (0.15-0.41) 1-4 (0.15-0.62) 
ORF3 (24794-25468) NS3B (224) 0-3 (0-0.44) 0-1 (0-0.45)   1-3 (0.15-0.44) 0-1 (0-0.45) 
Envelope (25449-25679) E (76) 0 -1 (0-0.43) 0-1 (0-1.31)   0-1 (0-0.43) 0-1 (0-1.31) 
Membrane (25687-26367) M (226) 0 (0) 0 (0)   0 (0) 0 (0) 
Nucleocapsid (26379-
27704) 
N (441) 
1-2 (0.07-0.15) 0-2 (0-0.45)   3-4 (0.23-0.30) 1-2 (0.23-0.45) 
3' UTR (27705-28038) N/A 0 (0) N/A   0 (0) N/A 
 
Table 2. Design of experiment in which 5-day-old pigs were inoculated with various PEDV isolates 
    No. pigs necropsied 
Group No. Piglets                 US PEDV Strain Inoculum 3 days p.i. 7 days p.i. 
G1 10 Prototype isolate USA/IN19338/2013 104 TCID50ml
-1; 10 ml 5 5 
G2 10 Prototype isolate USA/NC35140/2013 104 TCID50ml
-1; 10 ml 5 5 
G3 10 Prototype isolate USA/NC49469/2013 104 TCID50ml
-1; 10 ml 5 5 
G4 10 S-INDEL-variant isolate USA/IL20697/2014 104 TCID50ml
-1; 10 ml 5 5 
G5 10 Virus-negative culture medium 10 ml 5 5 
1
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Fig. 1. Phylogenetic analysis of the full-length genome and S1 portion nucleotide sequences. 
Three US prototype PEDV isolates obtained in this study (USA/NC35140/2013, 
USA/IA49379/2013 and USA/NC49469/2013) and two previous isolates evaluated in this 
study (US PEDV prototype isolate USA/IN19338/2013 and US S-INDEL-variant isolate 
USA/IL20697) are indicated with circles or a triangle, respectively. Forty-five PEDV 
sequences selected from GenBank were also included for analysis. The trees were 
reconstructed using the distance-based neighbour-joining (NJ) method (a, c) and the 
maximumlikelihood (ML) method (b, d) of the software MEGA6. The US prototype-like 
PEDVs are shown in blue type, with clade 1 and clade 2 indicated. The US S-INDEL-
variant-like PEDVs are shown in red type. Bars indicate nucleotide substitutions per site. 
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Fig. 1. continued 
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Fig. 2. Clinical assessment and virus shedding of 5-day-old pigs inoculated with US PEDV 
prototype and S-INDEL-variant isolates. (a) Mean diarrhoea scores over the course of 7 days 
p.i. See Methods for scoring system. (b) Mean daily weight gain (MDG). Statistical analyses 
on MDG were performed among groups from -1 to 3 days p.i. and from -1 to 7 days p.i., 
respectively. Virus shedding in rectal swabs (c) and sera (d) of inoculated pigs was 
determined by a quantitative PEDV N-gene-based real-time RT-PCR. The virus titres 
[log10(genomic copies ml
-1)] at each time point were the mean values of all available pigs 
(both PCR-positive and -negative pigs) in each group. Error bars indicate SE. In (d), viraemia 
levels among the groups were statistically analyzed at 3 and 7 days p.i., respectively. Labels 
without the same letters indicate significant differences, for example A and B have 
significant difference, but A and AB have no significant difference. 
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Fig. 3. Examination of gross lesions of inoculated pigs at 3 and 7 days p.i. necropsies. Mean 
scores of contents of small intestine, caecum and colon are shown in (a). Mean scores of 
lesions of the same tissues are shown in (b). The scoring criteria are described in Methods. 
Statistical analyses were performed on various inoculated groups, but each time on one tissue 
type and at one time point. Labels without the same letters indicate significant differences, as 
explained for Fig. 2. Error bars indicate SE. 
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Fig. 4. Representative microscopic lesions and immunohistochemistry (IHC) staining of 
inoculated pigs necropsied at 3 days p.i. H&E-stained tissue sections of small intestine 
(ileum) from the different inoculation groups (a–e). IHC-stained tissue sections of ileum (f–
j), caecum (k–o) and colon (p–t) from the different inoculation groups. All images are at 
×100 magnification. 
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Fig. 5. Mean villus height, crypt depth, villus/crypt ratio and IHC scores of pigs necropsied 
at 3 days p.i. Statistical analyses were performed on various inoculated groups, but each time 
on one tissue type. Labels without the same letters indicate significant differences, as 
explained for Fig. 2. Error bars indicate SE. 
 
155 
 
 
 
Fig. 6. Mean villus height, crypt depth, villus/crypt ratio and IHC scores of pigs necropsied 
at 7 days p.i. Statistical analyses were performed on various inoculated groups, but each time 
on one tissue type. In (d), IHC staining was performed on ileums. Labels without the same 
letters indicate significant differences, as explained for Fig. 2. Error bars indicate SE. 
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Supplemental Fig S1. Schematic diagrams of PEDV genome organization and putative 
functions of viral proteins. The PEDV entire genome organization is depicted (top). The 5’ 
leader, ORFs 1a and 1b encoding replicase polyproteins, spike (S), ORF3, envelope (E), 
membrane (M) and nucleocapsid (N) genes are shown, with the ribosomal frameshift site 
indicated. Predicted cleavage products (nsp1-nsp16) of the replicase polyproteins and 
putative functional domains are depicted (bottom). Nsp1 may possibly suppress the innate 
immune response and host protein synthesis. The exact function of nsp2 remains unclear. 
Nsp3 includes papain-like proteases (PL1pro and PL2pro, cleavage sites= white arrow) and 
adenosine diphosphate-ribose 1’’-phosphatase (ADRP, X domain) activity. The PL2pro is also 
an interferon antagonist. Nsp5 is the main protease or 3C-like protease (3CLpro, cleavage 
site= black arrow). Nsp3, nsp4 and nsp6 contain transmembrane domains (TM) and function 
as membrane anchor proteins. Nsp7 and nsp8 form a hexadecameric complex with a central 
channel for binding to the double-stranded RNA and initiating RNA synthesis. Nsp9 is a 
single-stranded RNA-binding protein (RBP). Nsp10 is a cofactor (activator) of nsp14 and 
nsp16. The nsp14 has 3’-5’ exonuclease (ExoN) at the N-terminal and 7-methyltransferase 
(7MT) at the C-terminal. The nsp16 acts as the 2’-O-methyltransferase (2’-O-MT). The 
interactions between nsp10, nsp14 and nsp16 plays a crucial role in replication fidelity and 
methylation of the virus. The nsp11 function is not fully understood yet. Nsp12 is the viral 
RNA-dependent RNA polymerase (RdRP). Nsp13 harbors a zinc-binding domain (ZBD) and 
viral helicase. Nsp13 also has NTPase and RNA 5’ triphosphatase activity. Nsp15 contains a 
motif known as nidoviral uridylate-specific endoribonuclease (NendoU). The S protein 
functions as the virus attachment protein interacting with the cell receptor. Additionally, the 
S protein is postulated to harbor neutralization epitopes and is also associated with viral 
virulence/attenuation. The M protein and E protein play a pivotal role in viral assembly. The 
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N protein binds to the viral genome RNA and packs into the nucleocapsid. The N protein has 
also been shown to antagonize interferon-β production. The accessory protein encoded by 
ORF3 may be associated with cell culture adaptation and may also have an influence on cell 
cycle and subcellular structure. 
 
  
Supplemental Table S1. PCR detection of PEDV RNA in various tissues at 3 DPI and 7 DPI from pigs inoculated with four PEDVs 
 
Abbreviations: DPI, days post inoculation; MLN, mesenteric lymph node; PCR, polymerase chain reaction; Ct, cycle threshold. 
* Rear leg muscle. †Mean Ct was mean Ct value of PCR-positive pigs (pigs with PCR Ct<45). 
ǂ Genomic copies/ml was geomean genomic copies per milliter of all pigs (both PCR-positive and negative pigs). Statistical analyses 
were performed on the same tissue types for G1-4 groups and different letters indicate significant differences. 
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CHAPTER 6. EVALUATION OF THE PATHOGENESIS DIFFERENCES AND 
TWO-WAY CROSS-PROTECTION EFFICACY OF THE U.S. PORCINE 
EPIDEMIC DIARRHEA VIRUS PROTOTYPE AND S-INDEL-VARIANT STRAINS 
IN WEANED PIGS 
 
Qi Chen, Phillip Gauger, Molly Stafne, Melisa Spadaro, Holly Salzbrenner, Joseph Thomas, 
Michael Welch, Paulo Arruda, Darin Madson, Luis Gimenez-Lirola, Drew Magstadt, Chong 
Wang, Yaxuan Sun, Ju Ji, Jianqiang Zhang 
 
A manuscript describing the work in this Chapter has been submitted to Virology for 
publication 
 
Abstract 
At least two genetically different porcine epidemic diarrhea virus (PEDV) strains 
(U.S. prototype strain [P-strain] and U.S. S-INDEL-variant strain [V-strain]) are currently 
circulating in U.S. swine. Previous studies have experimentally confirmed the V-strain is less 
pathogenic than the P-strain in neonates. The objectives of the current study were to evaluate 
the pathogenesis differences and cross-protection efficacy between two strains in weaned 
pigs. The results indicated P-strain was more virulent than V-strain in 3-week-old pigs; in 
contrast, V-strain had higher virulence than P-strain in 7-week-old pigs. P-strain 
immunization provided similar protection against P-strain and V-strain challenge; V-strain 
immunization provided protection against V-strain challenge and partial cross-protection 
against P-strain challenge. Immunization with either strain elicited robust serum antibodies. 
V-strain could potentially be a live virus vaccine candidate against porcine epidemic diarrhea 
and this warrants further studies. 
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Introduction 
Porcine epidemic diarrhea (PED) first appeared in the United Kingdom in the early 
1970s (Oldham, 1972). The causative agent, porcine epidemic diarrhea virus (PEDV), was 
first identified in 1977 in Belgium (classical PEDV CV777 strain) and was classified as a 
coronavirus (Pensaert and de Bouck, 1978). After epidemic and endemic infections in Europe 
in the 1970s-1990s, PEDV prevalence in European pigs became low and only sporadic PED 
outbreaks were observed (Jung and Saif, 2015; Lee, 2015). In Asia, PED epidemics first 
occurred in Japan in 1982 and then in South Korea and China (Kweon et al., 1993; Takahashi 
et al., 1983; Xuan et al., 1984). Later on, PED outbreaks in other Asian countries were also 
reported, for example, in Thailand in 2007 (Puranaveja et al., 2009), in Vietnam in 2009-
2010 (Duy et al., 2011), and in Taiwan in 2013-2014 (Lin et al., 2014). In North America, 
PED outbreaks were first reported in the U.S. in 2013 (Stevenson et al., 2013) and 
subsequently in Canada (Kochhar, 2014) and Mexico (Vlasova et al., 2014). After PED 
outbreaks in the U.S., PED epidemics recurred in South Korea, Japan and Taiwan (Choi et 
al., 2014; Lee and Lee, 2014; Lin et al., 2014; Suzuki et al., 2015; Van Diep et al., 2015). 
Since 2014, PED outbreaks have also been reported in a number of European countries 
including Germany, Belgium, France, Portugal, Italy, Austria, and Ukraine, etc. (Boniotti et 
al., 2016; Dastjerdi et al., 2015; Grasland et al., 2015; Mesquita et al., 2015; Stadler et al., 
2015; Steinrigl et al., 2015; Theuns et al., 2015).  
The PEDVs associated with the initial outbreak in the U.S. in April 2013 are highly 
virulent and are genetically similar to new PEDV variants identified in China since late 2010 
(Chen et al., 2014; Huang et al., 2013). In January 2014, novel U.S. PEDV variant strain 
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such as OH851 [GenBank # KJ399978] was identified (Wang et al., 2014). Compared to the 
U.S. PEDV strains originally identified in April 2013, the U.S. PEDV variant strains have 
characteristic insertions and deletions in the spike (S) gene and are also called the ‘S INDEL’ 
strain (Vlasova et al., 2014). There have been some discrepancies in the literatures regarding 
how to categorize different PEDV strains worldwide (Chen et al., 2014; Huang et al., 2013; 
Lee, 2015; Li et al., 2012; Sun et al., 2016; Sun et al., 2015; Vlasova et al., 2014; Wang et 
al., 2013; Wang et al., 2014). Before a consensus of describing different PEDV strains is 
reached, we have been using ‘U.S. PEDV prototype strain’ to refer to the U.S. PEDV strains 
originally identified in April 2013, and using ‘U.S. PEDV S-INDEL-variant strain’ to refer to 
the U.S. PEDV variant strains identified in January 2014 (Chen et al., 2016a; Chen et al., 
2016b).     
A number of U.S. PEDV prototype isolates and U.S. PEDV S-INDEL-variant isolates 
have been successfully isolated and grown in cell cultures (Chen et al., 2016a; Chen et al., 
2014; Chen et al., 2016b; Oka et al., 2014). Experimental infection studies have 
demonstrated that the U.S. PEDV S-INDEL-variant isolates overall had lower pathogenicity 
than the U.S. PEDV prototype isolates in conventional neonatal piglets at 3-4 days of age or 
5-6 days of age (Chen et al., 2016a; Lin et al., 2015a). However, experimental infection 
studies in pigs of different ages have also shown that the pathogenicity of the U.S. PEDV 
prototype isolates is age dependent (Jung et al., 2015; Madson et al., 2016; Madson et al., 
2014; Thomas et al., 2015). Pathogenesis of the U.S. PEDV S-INDEL-variant isolates in pigs 
of other ages has not been investigated.  
Another key question is whether or not there is cross-protection between U.S. PEDV 
prototype strains and U.S. PEDV S-INDEL-variant strains and this question is directly 
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related to strategies of developing a safe and efficacious vaccine against U.S. PEDVs. Some 
studies have demonstrated that antibodies against U.S. PEDV prototype strains and 
antibodies against U.S. PEDV S-INDEL-variant strains cross-reacted and cross-neutralized 
both strains in vitro (Chen et al., 2016b; Lin et al., 2015b). Two in vivo studies have also 
been performed to evaluate the cross-protection between two U.S. PEDV strains (Goede et 
al., 2015; Lin et al., 2015a). Goede et al (2015) demonstrated that sows exposed to a U.S. 
PEDV S-INDEL-variant strain 7 months previously could provide partial protection to 
newborn piglets challenged with a U.S. PEDV prototype strain. In Lin et al study (2015a), 
piglets at 3-4 days of age were inoculated with a U.S. PEDV S-INDEL-variant strain and 
then challenged with a U.S. PEDV prototype strain at 21-29 days post inoculation; partial 
protection was observed. These two in vivo studies have only evaluated one-way cross-
protection (U.S. S-INDEL-variant PEDV immunization against U.S. prototype PEDV 
challenge) in sow and piglet models. The two-way cross-protections between two U.S. 
PEDV strains have not been investigated.   
The objectives of the present study were 1) to evaluate the pathogenesis differences 
of U.S. prototype and U.S. S-INDEL-variant PEDV strains in 3-week-old and 7-week-old 
weaned pigs; 2) to examine the two-way cross-protection efficacy between two U.S. PEDV 
strains in weaned pigs.  
 
Materials and Methods 
Viruses and cells 
A U.S. PEDV prototype strain cell culture isolate USA/IN19338/2013 and a U.S. 
PEDV S-INDEL-variant strain cell culture isolate USA/IL20697/2014 were previously 
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isolated, propagated, and titrated in Vero cells (ATCC CCL-81) in our lab (Chen et al., 2014; 
Chen et al., 2016b). Both virus isolates used for pig inoculations in the present study were at 
cell culture passage 7 (P7), diluted to 104 TCID50/ml, and saved at -80°C upon use. In this 
study, the U.S. PEDV prototype isolate USA/IN19338/2013 was simplified as P-strain and 
the U.S. PEDV S-INDEL-variant isolate USA/IL20697/2014 was simplified as V-strain.  
Animal study design 
The animal study protocol was approved by the Iowa State University Institutional 
Animal Care and Use Committee (approval number 9-14-7872-S; approved on October 9, 
2014). Eighty-five pigs at 17 days of age were purchased from a conventional farm without 
PEDV outbreak history and delivered to the Iowa State University Laboratory Animal 
Resources facilities. All pigs were confirmed negative for PEDV, transmissible 
gastroenteritis virus (TGEV), and porcine deltacoronavirus (PDCoV) by virus-specific real-
time reverse-transcription PCRs (qRT-PCRs) on rectal swabs and negative for PEDV 
antibody by a virus-specific indirect fluorescent antibody (IFA) assay on serum samples at 
the Iowa State University Veterinary Diagnostic Laboratory (ISU VDL) following routine 
procedures. All pigs on arrival were administered an intramuscular injection of Excede® 
(Zoetis) per label instructions. 
Pigs were blocked by weight and then randomly divided into 7 groups with 15 or 10 
pigs per group (Table 1). Each group was housed in one room on a solid floor. After 4 days 
of acclimation (pigs were at 3 weeks of age), pigs were orogastrically inoculated with 10ml 
of virus-negative culture media (N), 10ml of PEDV P-strain isolate at 104 TCID50/ml, or 
10ml of V-strain virus isolate at 104 TCID50/ml on Day 0 (D0) of the study followed by a 2
nd 
inoculation on D28 (pigs were at 7 weeks of age). Seven groups were designated according 
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to 1st inoculation/2nd inoculation: P/V (15 pigs), V/V (15 pigs), N/V (15 pigs), P/P (10 pigs), 
V/P (10 pigs), N/P (10 pigs), and N/N (10 pigs, Table 1). On D4 (4 days after the 1st 
inoculation), five pigs from each of the P/V, V/V, and N/V groups were necropsied. On 6 
days after the 2nd inoculation (D34), five pigs randomly selected from each of the 7 groups 
were necropsied. The remaining 5 pigs per group were kept until 4 weeks after the 2nd 
inoculation (D56) to evaluate viral shedding duration and post-challenge antibody responses.  
Clinical parameters, including but not limited to vomiting, diarrhea, lethargy, 
appetite, dehydration, and depression, were recorded daily between D0 and D7, daily on 
D10, 12, 14, 21, daily between D28 and D34, and daily on D38, 40, 42, 49, and 56, with the 
criteria as previously described (Chen et al., 2016a). Weights were also measured on D0, 4, 
7, 14, 21, 28, 34, 42, 49, and 56. Rectal swabs were collected on D0, 2, 4, 7, 10, 14, 21, 28, 
30, 32, 34, 38, 42, 49 and 56 and were tested for fecal viral shedding by a PEDV N gene-
based quantitative real-time RT-PCR. Serum samples were collected on D0, 4, 7, 14, 21, 28, 
34, 42, 49 and 56 and were tested for presence of PEDV antibody by an IFA assay and virus 
neutralization (VN) assay with U.S. P-strain and V-strain as indicator viruses, respectively. 
Gross lesions and content characters of small intestines, ceca and colons were examined 
during necropsy. Distal jejunum, ileum, cecum, and colon tissues were collected from each 
pig and fixed with 10% buffered formalin (Thermo Fisher scientific, Waltham, 
Massachusetts, USA) immediately at necropsy on D4 and D34 for histopathology evaluation 
and immunohistochemistry (IHC). 
Pathogenesis comparisons of PEDV P-strain and V-strain were evaluated in pigs at 3 
weeks of age and 7 weeks of age, respectively. In addition to comparing clinical signs and 
virus shedding levels in fecal samples, five pigs necropsied on D4 from each of the P/V, V/V 
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and N/V groups were used to compare macroscopic and microscopic lesions of two PEDV 
strains in 3-week-old pigs; five pigs necropsied on D34 from each of the N/V, N/P and N/N 
groups were used to compare macroscopic and microscopic lesions of two PEDV strains in 
7-week-old pigs.  
To evaluate cross-protection efficacy, clinical signs and virus shedding levels in the 
N/N, N/V, V/V and P/V groups after the challenge on D28 as well as macroscopic and 
microscopic lesions of pigs necropsied on D34 from these groups were used to evaluate 
protection efficacy against the V-strain challenge; similar parameters in the N/N, N/P, V/P 
and P/P groups were used to evaluate protection efficacy against the P-strain challenge. 
PEDV N gene-based quantitative real-time RT-PCR (qRT-PCR) 
Nucleic acids were extracted from rectal swab samples (100 µl) using a MagMAX 
Pathogen RNA/DNA Kit (Thermo Fisher Scientific) and a Kingfisher-96 instrument (Thermo 
Fisher Scientific) following the instructions of the manufacturer.  Nucleic acids were eluted 
into 90 µl of Elution buffer. Five microliters of each RNA template was used in a 25 µl PCR 
reaction using the Path-ID™ Multiplex One-Step RT-PCR Kit (Thermo Fisher Scientific). 
Primers and probe sequences of the PEDV N gene-based qRT-PCR, and standard curve 
generation have been previously described (Lowe et al., 2014; Madson et al., 2014; Thomas 
et al., 2015; Zhang et al., 2016). Amplification reactions were performed on an ABI 7500 
Fast instrument (Thermo Fisher Scientific) with the following conditions: 1 cycle of 48°C for 
10 min, 1 cycle of 95°C for 10 min, and 45 cycles of 95°C for 15 sec and 60°C for 45 sec. 
Virus concentration (genomic copies per milliliter [gc/ml]) of each sample was calculated 
based on the standard curve. The mean PCR cycle threshold (Ct) values were calculated 
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based on PCR-positive samples (Ct<40), and the mean virus concentrations (gc/ml) were 
calculated based on all available pigs within each group. 
Gross pathology 
At necropsy, the small intestines, ceca, and colons were examined for gross lesions by 
veterinary pathologists blind to the treatment groups. Tissue lesions were categorized as 
normal, thin-walled, and/or gas-distended. The presence of thin-walled intestines or gas-
distended organs was numerated as 1 point, respectively; the presence of both thin-walled 
and gas-distended was numerated as 2 points. Contents of small intestine, cecum and colon 
were examined and scored with the criteria: 0 = Normal, 1 = liquid with some solids (semi-
watery), 2 = watery.  
Histopathology  
Hematoxylin and Eosin (H&E) staining was performed on cross sections of distal 
jejunum, ileum, cecum, and colon tissues from each pig and examined by a veterinary 
pathologist blinded to the treatment. Villus heights (VH) and crypt depths (CD) were 
measured from three representative villi and crypts of each distal jejunum and ileum cross 
sections using a computerized image system following previously described procedures 
(Madson et al., 2014). Villus height/crypt depth (VH/CD) ratio was calculated as the division 
of the average villus height by the average crypt depth of each tissue.  
Immunohistochemistry (IHC) 
Serial sections of distal jejunum, ileum, cecum, and colon were evaluated for 
presence of PEDV antigen by IHC using a PEDV-specific monoclonal antibody (BioNote, 
Hwaseong-si, Gyeonggi-do, Korea) as previously described (Madson et al., 2014). The IHC 
antigen detection in each tissue was semi-qualified as previously described (Chen et al., 
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2015) and assigned with a score following the criteria: 0 = no staining; 1 = approximately 1-
10% staining; 2 = approximately 10%-25% staining; 3 = approximately 25%-50% staining; 4 
= approximately 50%-100% staining.  
Indirect fluorescent antibody (IFA) assay 
Anti-PEDV IgG antibody in serum samples was tested by the U.S. PEDV prototype 
strain-based IFA (Pro IFA) and S-INDEL-variant strain-based IFA (Var IFA) assays using 
the U.S. PEDV P-strain (USA/IN19338/2013) and V-strain (USA/IL20697/2014) as 
indicator viruses, respectively. The indicator viruses used for IFA assays were the same 
passaged viruses as used for animal inoculation in this study. IFA procedures have been 
previously described (Thomas et al., 2015). An IFA titer of ≥ 40 was considered to be IFA 
antibody positive. 
Virus neutralization (VN) test 
Serum samples was tested by the U.S. PEDV prototype strain-based VN (Pro VN) 
and S-INDEL-variant strain-based VN (Var VN) assays using the U.S. PEDV P-strain 
(USA/IN19338/2013) and V-strain (USA/IL20697/2014) as indicator viruses, respectively. 
The indicated viruses used in VN assay were the same batches as used for animal inoculation 
in this study. The VN procedures have been previously described (Chen et al., 2016b; 
Thomas et al., 2015). The reciprocal of the highest serum dilution resulting in >90% 
reduction of fluorescent staining as compared to the negative serum control was considered 
as the neutralizing antibody titer of the serum sample. A VN titer of ≥8 was considered 
positive. 
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Statistical analyses 
A generalized linear mixed (GLIMMIX) model was used to analyze virus shedding 
titer Log10(gc/ml), IFA and VN antibody titers, clinical observation scores, pathological 
scores, villus heights, crypt depths, and villus/crypt ratio differences among groups with 
Statistical Analysis System (SAS) version 9.3 (SAS Institute, Cary, NC). During D0-D28 
(before the 2nd inoculation on D28), groups receiving the same inoculum at the 1st inoculation 
were categorized according to their treatment for analyses (e.g. the N/N, N/V and N/P groups 
were analyzed as negative treatment; the V/V and V/P groups were analyzed as V-strain 
treatment; the P/V and P/P groups were analyzed as P-strain treatment). IFA antibody titers 
were transferred to log2([IFA titer]/10), and VN antibody titers were transferred to log2(VN 
titer) prior to statistical analysis. P-value <0.05 was defined as statistically significant.  
 
Results 
Pathogenesis comparison 
During D0-D28 (after the 1st inoculation but before the 2nd inoculation), 7 groups of 
pigs were in 3 categories or treatments: P-strain inoculation (P/V and P/P groups), V-strain 
inoculation (V/V and V/P groups), and Negative culture medium inoculation (N/V, N/P, and 
N/N groups). These 3 treatments were compared to evaluate the pathogenesis differences of 
the U.S. PEDV P-strain and V-strain in 3-week-old pigs. After the 2nd inoculation on D28 
(pigs were 7-week-old at the 2nd inoculation), the N/V, N/P and N/N groups were compared 
to evaluate the pathogenesis differences of the U.S. PEDV P-strain and V-strain in 7-week-
old weaned pigs. 
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Clinical parameters 
Following the 1st inoculation (D0) of 3-week-old pigs, the two groups inoculated with 
the P-strain (P/V and P/P) developed semi-watery to watery diarrhea between D2 and D4; 
one group (V/P) inoculated with the V-strain had mild soft feces during D2-D4 and the other 
group (V/V) inoculated with the V-strain developed watery diarrhea from D5 to D7. For the 
other 3 groups (N/N, N/V and N/P) inoculated with virus-negative culture medium at the 1st 
inoculation, overall no diarrhea was observed up to D28. 
After the 2nd inoculation on D28 of 7-week-old pigs, the P-strain inoculated group 
(N/P) and negative group (N/N) did not have diarrhea while the V-strain inoculated group 
(N/V) developed watery diarrhea during D33-D38 (5-10 days post the 2nd inoculation).  
Depression or abnormal body conditions were not observed during D0-D28 in pigs 
inoculated with either PEDV strain, and weight did not show significant difference at any 
time point during D0-D28 between the two strains. 
Fecal virus shedding 
As shown in Fig 1 and Table 2, the Neg control pigs (N/N, N/V and N/P groups) did 
not shed any virus in rectal swabs during D0-D28 as tested by PEDV N gene-based qRT-
PCR. Among the P-strain-inoculated pigs (P/V and P/P groups), PEDV RNA was detected in 
rectal swab samples from 25/25, 25/25, 20/20, 20/20, 20/20, 13/20 and 13/20 pigs on D2, D4, 
D7, D10, D14, D21 and D28 with average Ct values of 18.5, 15.3, 21.6, 33.6, 32.4, 34.8 and 
34.2, respectively. Fecal shedding in the P-strain-inoculated pigs (P/V and P/P groups) 
reached the peak level on D4 and then gradually declined (Fig 1). Among the V-strain-
inoculated pigs (V/V and V/P groups), PEDV RNA was detected in rectal swab samples 
from 18/25, 25/25, 20/20, 20/20, 19/20, 12/20 and 6/20 pigs on D2, D4, D7, D10, D14, D21 
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and D28 with average Ct values of 30.4, 25.3, 23.0, 32.1, 25.7, 34.4 and 35.4, respectively. 
Fecal shedding in the V-strain-inoculated pigs (V/V and V/P groups) gradually increased in 
the first a few days and reached the peak level on D7 (Fig 1). Statistical analysis showed that 
3-week-old pigs inoculated with the P-strain (P/V and P/P groups) overall shed significantly 
higher amount of virus in feces than pigs inoculated with the V-strain (V/V and V/P groups) 
from D0-D28 (P=0.0396).  
After the 2nd inoculation on D28 of 7-week-old pigs, no any virus was detected from 
the N/N group in rectal swabs from D28 to D56 (Fig 1 and Table 2). For the N/V and N/P 
groups, PEDV N gene-based qRT-PCR positive pigs and the mean Ct values of the positive 
rectal swabs are summarized in Table 2. Fecal virus shedding in 7-week-old pigs inoculated 
with the V-strain (N/V group) or the P-strain (N/P group) gradually increased after 
inoculation and reached the peak levels on D38 (10 days post the 2nd inoculation) (Fig 1). 
The N/V group overall shed significantly higher levels of virus in rectal swabs than the N/P 
group during D28-D56 (P=0.0359) (Fig 1).  
Virus shedding in pigs that were at different ages but inoculated with the same virus 
strain was also compared. Three-week-old pigs inoculated with the P-strain shed 1.3× higher 
viruses in rectal swabs during 0 to 28 days post inoculation (mean titer of 4.84 log10[gc/ml]) 
than 7-week-old pigs inoculated with the same P-strain (mean titer of 3.54 log10[gc/ml]) per 
time-point. On the other hand, on average, 3-week-old pigs inoculated with the V-strain shed 
0.5× lower viruses per time-point during 0 to 28 days post inoculation (mean titer of 3.89 
log10[gc/ml]) than 7-week-old pigs inoculated with the same V-strain (mean titer of 4.38 
log10[gc/ml]). 
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Gross pathology 
Five pigs from each of the P-strain inoculation (P/V group), V-strain inoculation 
(V/V group), and Neg medium inoculation (N/V group) were necropsied on D4 (4 days post 
the 1st inoculation) to compare macroscopic and microscopic lesions caused by the P-strain 
and V-strain in 3-week-old pigs. The average content scores of small intestines, ceca, and 
colons were numerically higher in P-strain-inoculated pigs than in V-strain-inoculated pigs 
and negative control pigs but differences were not significant (Fig 2A). The average gross 
lesion scores in small intestines and ceca of the V-strain-inoculated pigs and negative control 
pigs were not significantly different, but were both significantly less severe than the P-strain-
inoculated pigs (Fig 2A).  
Five pigs necropsied from each of the N/N, N/V and N/P groups on D34 (6 days post 
the 2nd inoculation) were compared to evaluate the macroscopic and microscopic lesions 
caused by the P-strain and V-strain in 7-week-old pigs. Overall, the macroscopic pathological 
changes were minor in all three groups of pigs. The average content scores of small 
intestines, ceca, and colons from the P-strain-inoculated pigs were similar to those of the 
negative control pigs but were significantly lower than those of the V-strain-inoculated pigs 
(Fig 2B). The average gross lesion scores in small intestines were not significantly different 
among the P-strain, V-strain and Neg-inoculated pigs (Fig 2B); but the average gross lesion 
scores in ceca and colons of the V-strain-inoculated pigs were significantly higher than the P-
strain and Neg-inoculated pigs (Fig 2B). 
Histopathological lesions 
On D4, the villus-height-to-crypt-depth (VH/CD) ratios in distal jejunums and ileums 
of the P-strain-inoculated pigs were significantly lower than those of the V-strain-inoculated 
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pigs and the negative control pigs, suggesting that the villous atrophy caused by the P-strain 
was more severe than the V-strain in 3-week-old pigs (Fig 3A). Between the V-strain groups 
and negative control groups, the average VH/CD ratios in distal jejunums and ileums of 3-
week-old pigs were not significantly different (Fig 3A).  
On D34, in the 7-week-old pigs, the VH/CD ratios in distal jejunums and ileums were 
substantially lower in the N/V group than the N/N and N/P groups but the differences were 
not significant (Fig 4A).  
Immunohistochemistry 
On D4 (4 days post inoculation in 3-week-old pigs), the P-strain-inoculated pigs had 
respectively average IHC scores of 4 and 4 in distal jejunum and ileum, which were 
significantly higher than the V-strain-inoculated pigs that had average IHC scores of 1.4 and 
1.4 in distal jejunum and ileum, respectively (Fig 3B). PEDV IHC staining was also observed 
in cecum epithelia cells of 3 pigs (scores of 1, 1, and 2) and colon epithelia cells of 1 pig 
(score of 2) inoculated with the P-strain. PEDV IHC staining was not observed in ceca and 
colons of V-strain-inoculated pigs. PEDV IHC staining was not observed in any tissues 
(small intestine, cecum, and colon) of negative control pigs. 
On D34 (6 days post inoculation in 7-week-old pigs), distal jejunums and ileums of 
5/5 pigs in the N/V group, ceca of 2/5 pigs in the N/V group, and cecum of 1/5 pig in the N/P 
group were positive by PEDV IHC staining. The colons in the N/V group and the distal 
jejunums, ileums and colons in the N/P group were all negative by PEDV IHC staining. The 
N/V group had significantly higher average IHC scores in distal jejunums and ileums than 
the N/P and N/N groups (Fig 4B).  
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Cross-protection efficacy 
Following the 2nd inoculation on D28, the 7 groups (P/V, V/V, N/V, P/P, V/P, N/P 
and N/N) were compared to evaluate the effect of previous exposure (D0) on the outcomes of 
the subsequent challenge (D28). 
Clinical parameters 
After the 2nd inoculation (D28), watery diarrhea was observed only in the V/V and 
N/V groups between D33 and D38, and diarrhea was not observed in other groups. Abnormal 
body conditions and depression were not observed in any pigs during D28-D56, and 
significant difference in weight gain was not observed during D28-D56 among all groups. 
Fecal virus shedding 
Viral shedding levels in rectal swabs as determined by PEDV N gene-based qRT-
PCR were compared among 7 groups from D28-D56 (Fig 1 and Table 2). The N/N group 
remained PEDV PCR negative through D28-D56. For 3 groups challenged with the V-strain 
(N/V, P/V and V/V), the P/V and V/V groups overall shed similar amounts of virus during 
D28-D56 (P=0.9422), but both the P/V and V/V groups shed significantly lower amounts of 
virus compared to the N/V group (P<0.0001). For 3 groups challenged with the P-strain (N/P, 
V/P and P/P), the V/P and P/P groups shed significantly less amounts of virus than the N/P 
group during D28-D56 (P<0.0001), yet the V/P group, which shed sharply higher amount of 
virus on D34 than the other days, was shedding significantly more viruses than the P/P group 
from D28 to D56 (P=0.0001) (Fig 1).  
Gross pathology 
On D34, among the 3 groups challenged with the V-strain (N/V, P/V and V/V), the 
average content scores of cecum and colon, and the average gross lesion scores of colon in 
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the V/V and P/V groups were significantly lower than those in the N/V group, and these 
scores were not significantly different between the V/V and P/V groups (Fig 2B). The 
average gross lesion scores of cecum in the V/V group but not the P/V group was 
significantly lower than those in the N/V group. The average content scores and the average 
gross lesion scores of small intestine in the V/V and P/V groups were numerically lower than 
those in the N/V group, but were not statistically significant (Fig 2B). Among the 3 groups 
challenged with the P-strain (N/P, V/P and P/P), mild or no macroscopic pathological lesions 
were observed and there were no significant differences on the average content scores and 
the average gross lesion scores of any tissues (small intestine, cecum and colon) (Fig 2B). 
Histopathological lesions 
On D34, among the 3 groups challenged with the V-strain (N/V, P/V and V/V), both 
the V/V and P/V groups had numerically higher VH/CD ratios (higher VH/CD ratios indicate 
less severity in lesions) in distal jejunum and ileum than those in the N/V group; however, 
statistically significant differences of the VH/CD ratios were only observed in distal jejunum 
and ileum between the N/V and V/V groups, but not between the N/V and P/V groups (Fig 
4A). Among the 3 groups challenged with the P-strain (N/P, V/P and P/P), statistically 
significant differences were not observed in any histopathological measurement.  
Immunohistochemistry 
On D34, except distal jejunum, ileum, cecum in the N/V group and cecum of one pig 
in the N/P group, all other tissues and groups were PEDV IHC negative. The V/V and P/V 
groups both had significantly lower PEDV IHC scores in distal jejunum and ileum when 
compared to the N/V group; no significant difference in IHC scores was observed in any 
tissues between the V/V and P/V groups (Fig 4B). The PEDV IHC scores in distal jejunum, 
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ileum, cecum and colon were not significantly different among the N/P, P/P, and V/P groups 
(Fig 4B).  
Antibody responses 
The serum IFA antibody results (determined by Pro IFA assay and Var IFA assay) 
and VN antibody results (determined by Pro VN assay and Var VN assay) are summarized in 
Table 3, Fig 5 and Fig 6.  
After the 1st inoculation, some P-strain-inoculated 3-week-old pigs (P/V and P/P 
groups) started to develop IFA antibodies with low titers from D7 regardless of being tested 
by Pro IFA or Var IFA assays; in contrast, the V-strain-inoculated pigs (V/V and V/P groups) 
generally did not develop detectable IFA antibody until D14 (Table 3 and Fig 5A, B). In pigs 
inoculated with either PEDV P-strain or V-strain, geometric mean IFA antibody titers peaked 
on D21 during the period of D0-D28 (Fig 5A, B). During D0-D28, the P-strain-inoculated 
pigs (P/V and P/P groups) developed significantly higher IFA antibody titers than the V-
strain-inoculated pigs (V/V and V/P groups), regardless of being measured by Pro IFA or 
Var IFA assays (Fig 5C, D). After virus challenge on D28, naïve 7-week-old pigs inoculated 
with the V-strain (N/V group) or P-strain (N/P group) were PEDV antibody negative until 
D42 (14 days after the challenge) when IFA antibodies became detectable and were 
maintained through D56. It is noteworthy that only 1 out of 5 serum samples collected on 
D42 from the N/P group were PEDV antibody positive by IFA assays whereas 5 serum 
samples collected on D42 from the N/V group were all antibody positive by PEDV IFA 
assays (Table 3). All serum samples collected from the N/P and N/V groups on D49 and D56 
were PEDV antibody positive by IFA assays (Table 3). Overall, the geometric mean IFA 
antibody titers in the N/V group were numerically higher than those in the N/P group but the 
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differences were not statistically significant during D28-D56 (Fig 5C, D). After the 2nd 
inoculation on D28, PEDV IFA antibody titers in the V/V, V/P, P/V and P/P groups 
increased slightly and then fluctuated throughout the end of the study (Fig 5A, B). The 
geometric mean IFA antibody titers determined by the Pro IFA assay had no significant 
differences among the V/P, P/V and P/P groups during D28-D56 although the P/P group had 
significantly higher antibody titers than the V/V group (Fig 5C). However, the geometric 
mean IFA antibody titers determined by the Var IFA assay had no significant differences 
among the four groups (V/V, V/P, P/V and P/P) during D28-D56 (Fig 5D). The N/N group 
remained PEDV IFA antibody negative from D0-D56. 
After the 1st inoculation, 3-week-old pigs inoculated with the P-strain (P/V and P/P 
groups) or the V-strain (V/V and V/P groups) started to develop VN antibodies with low 
titers from D7 regardless of being tested by Pro VN or Var VN assays (Table 3 and Fig 6A, 
B). In pigs inoculated with either PEDV P-strain or V-strain, geometric mean VN antibody 
titers peaked on D21-D28 before the 2nd inoculation on D28 (Fig 6A, B). During D0-D28, the 
P-strain-inoculated pigs (P/V and P/P groups) developed significantly higher VN antibody 
titers than the V-strain-inoculated pigs (V/V and V/P groups) when tested by Pro VN assay 
(Fig 6C); however, the VN antibody titers determined by Var VN assay were not 
significantly different between the P-strain-inoculated pigs (P/V and P/P groups) and the V-
strain-inoculated pigs (V/V and V/P groups) (Fig 6D). After the 2nd inoculation on D28, a 
few pigs in the N/V and N/P groups became PEDV VN antibody positive with low titers on 
D34 but almost all pigs became VN antibody positive on D42 through D56 (Table 3 and Fig 
6A, B). Overall, the N/V group had significantly higher VN antibody titer than the N/P group 
during D28-D56 (Fig 6C, D). After the 2nd inoculation on D28, PEDV VN antibody titers in 
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the V/V, V/P, P/V and P/P groups increased slightly and then were maintained through D56 
(Fig 6A, B). The geometric mean VN antibody titers had no significant differences among 
the V/P, P/V and P/P groups during D28-D56 (Fig 6C, D). The N/N group remained PEDV 
VN antibody negative from D0-D56. 
 
Discussion 
At present, both U.S. PEDV prototype strain and U.S. PEDV S-INDEL-variant strain 
are circulating in U.S. swine although U.S. PEDV S-INDEL-variant strain is less frequently 
detected compared to U.S. PEDV prototype strain (Vlasova et al., 2014). In this study, ‘P-
strain’ and ‘V-strain’ were used to represent ‘U.S. PEDV prototype strain’ and ‘U.S. PEDV 
S-INDEL-variant strain’, respectively, for the sole purpose of simplifying descriptions and 
presentations of animal study design and research data. However, we have no intention to 
recommend wide use of the term ‘P-strain’ and ‘V-strain’ in other publications. Instead, we 
recommend to use the term ‘U.S. PEDV prototype strain’ and ‘U.S. PEDV S-INDEL-variant 
strain’ for clarity especially considering that currently there are some discrepancies regarding 
how to categorize different PEDV strains worldwide. It is important that the provenance of 
viruses is stated clearly in the literatures. 
In a previous study (Chen et al., 2016a), we have experimentally confirmed that naïve 
conventional neonatal piglets (5 days old, not housed with sows, manually fed with a mixture 
of Esbilac liquid milk replacer and yogurt) inoculated with a U.S. PEDV S-INDEL-variant 
isolate (USA/IL20697/2014) had significantly diminished clinical signs, virus shedding in 
feces, macroscopic and microscopic lesions and immunohistochemistry staining in small 
intestines when compared to pigs of the same age inoculated with each of the three U.S. 
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PEDV prototype isolates (USA/IN19338/2013, USA/NC35140/2013, and 
USA/NC49469/2013), clearly demonstrating that U.S. PEDV S-INDEL-variant strain is less 
pathogenic/virulent than U.S. PEDV prototype strain in neonates. In another study, Lin et al 
(2015a) compared pathogenesis of a U.S. PEDV prototype isolate (PC21A) and a U.S. PEDV 
S-INDEL-variant isolate (Iowa106) in 3-4-day-old piglets that were housed with dams and 
naturally suckled milk from dams. Their study also demonstrated that the S-INDEL Iowa106 
isolate overall had lower pathogenicity than the prototype isolate PC21A although the S-
INDEL Iowa106 isolate caused 75% mortality in one litter potentially due to the sow’s health 
issue that negatively impacted colostrum/milk production in that litter (Lin et al., 2015a). In 
the current study, for the first time, we experimentally compared pathogenesis of a P-strain 
isolate (USA/IN19338/2013) and a V-strain isolate (USA/IL20697/2014) in 3-week-old and 
7-week-old weaned pigs, respectively. In 3-week-old pigs, onset of diarrhea and fecal virus 
shedding in the P-strain-inoculated pigs were earlier than those in the V-strain-inoculated 
pigs; in addition, pigs inoculated with the P-train had higher virus loads shed in feces, more 
severe macroscopic and microscopic lesions in intestinal tissues, and higher IHC scores in 
small intestines when compared to pigs inoculated with the V-strain. These collectively 
suggest that the P-strain isolate IN19338/2013 is more pathogenic/virulent than the V-strain 
isolate IN20697/2014 in 3-week-old pigs, which is consistent with the features observed in 
neonatal piglets. Interestingly, in 7-week-old pigs, the V-strain inoculation led to more severe 
clinical diarrhea, higher levels of fecal virus shedding, more severe macroscopic and 
microscopic lesions and higher levels of IHC staining in intestinal tissues, compared to the P-
strain inoculation. These data suggest that the V-strain isolate IL20697/2014 is more 
pathogenic/virulent than the P-strain isolate IN19338/2013 under the conditions of this study, 
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which is opposite to the features observed in neonatal piglets and 3-week-old pigs. In the 
future, additional studies should be performed to further confirm this finding.  
This study was not designed to directly compare pathogenesis of the same virus strain 
in pigs at different ages. However, three-week-old pigs inoculated with the P-strain isolate 
IN19338/2013 appeared to have higher levels of fecal virus shedding and higher IHC scores 
than 7-week-old pigs inoculated with the same virus isolate (Fig 1A, Fig 3B, and Fig 4B). 
Additionally, the P-strain-inoculated 3-week-old pigs had significantly more severe 
macroscopic and histopathological lesions than the negative control pigs of the same age (Fig 
2A and Fig 3A); in contrast, macroscopic and histopathological lesions were not significantly 
different between the P-strain-inoculated 7-week-old pigs and the negative control pigs of the 
same age (Fig 2B and Fig 4A). These data would imply that the P-strain pathogenesis was 
overall milder in 7-week-old pigs than in 3-week-old pigs and lesion severities appear to be 
consistent with virus replication efficiency in pigs at the corresponding ages. In fact, the age-
dependent pathogenicity of U.S. PEDV prototype strains has also been experimentally 
demonstrated in previous studies in which the prototype strain caused more severe diseases 
in nursing/neonatal pigs than in 3-4-week-old weaned pigs (Jung et al., 2015; Madson et al., 
2016; Madson et al., 2014; Thomas et al., 2015). This study provides additional information 
on pathogenesis of U.S. PEDV prototype strain in 3- and 7-week-old pigs. The research data 
in the present study do not allow to clearly draw conclusions on the higher pathogenicity of 
the V-strain isolate IN20697/2014 in 7-week-old pigs than in 3-week-old pigs; but 
pathogenesis of this V-strain isolate in 7-week-old pigs is at least not less severe than in 3-
week-old pigs under the conditions of this study. Pathogenicity of S-INDEL PEDVs 
observed in the field has variations too. In the U.S., suckling piglets on the farm infected with 
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the S-INDEL variant strain OH851 showed minimal to no clinical signs and no piglets died 
(Wang et al., 2014). In Germany, one fattening farm and two sow farms experienced PED 
outbreak in 2014 caused by a U.S. S-INDEL-variant-like PEDV (99.4% nucleotide identity 
to the OH851 strain at the whole genome level) (Stadler et al., 2015). On the fattening farm, 
approximately 95% of all growing and finishing pigs developed diarrhea. On one sow farm, 
mortality ranged from 5.5% in suckling piglets to 8.8% in nursery pigs (Stadler et al., 2015). 
For a group of farrowing sows on another sow farm, 67.6% piglets died or had to be 
euthanized before weaning (Stadler et al., 2015). In France, PED outbreak occurred in a 
farrow-to-finish herd in December 2014 caused by a S-INDEL PEDV genetically very 
similar (99.9% nucleotide identity at the whole genome level) to Germany S-INDEL PEDV 
(Grasland et al., 2015). The mortality rate ranged 3.3-5.5% in the fattening building and 
reached 12% in piglets after 1 week and 25% at weaning in the farrowing building (Grasland 
et al., 2015). More studies are definitely needed to further investigate age-dependent 
pathogenicity of PEDV S-INDEL-variant strains in pigs of different ages.  
The U.S. PEDV prototype strains are more virulent than the U.S. S-INDEL-variant 
strains in neonatal piglets and 3-week-old weaned pigs. It is assumed that genetic differences 
especially in the S1 region between the two PEDV strains may be responsible for the 
observed pathogenic differences although that remains to be confirmed using a reverse 
genetics approach (Chen et al., 2016a). The U.S. PEDV prototype strain induces greater 
disease severity in neonatal piglets than in 3-4-week-old pigs (Jung et al., 2015; Madson et 
al., 2016; Madson et al., 2014; Thomas et al., 2015). Some possible explanations include: 1) 
an immature immune system in neonatal piglets (Saif, 2011; Stokes et al., 2001); 2) neonatal 
piglets are more vulnerable to dehydration and the electrolyte and fluid imbalance (Saif, 
181 
 
2011); 3) the intestinal villi of neonatal piglets are longer and may have more mature 
permissive enterocytes than weaned pigs (Tivey and Smith, 1989); 4) slower replacement of 
villous enterocytes (7-10 days) in neonatal pigs compared to 2-4 days in weaned pigs (Moon, 
1971).  In this study, it was observed that the U.S. S-INDEL-variant isolate was more 
virulent than the U.S. prototype PEDV. The mechanisms behind this observation are 
currently unknown. 
Another important question is whether there is cross-protection between the two U.S. 
PEDV strains. Two previous in vivo studies (Goede et al., 2015; Lin et al., 2015a) have 
demonstrated one-way cross-protection, namely U.S. S-INDEL-variant PEDV immunization 
can provide partial protection against U.S. prototype PEDV challenge in sow and piglet 
models. In this study, experiments were designed to evaluate two-way cross-protection 
between two U.S. PEDV strains in weaned pig models. To rule out any cross contamination 
possibly introduced during the animal study, rectal swabs collected on D4 and D14 from the 
P/V, P/P, V/V and V/P groups and rectal swabs collected on D32 (4 days after challenge on 
D28) from the P/V, V/V, N/V, P/P, V/P and N/P groups were also tested by a PEDV S gene-
based differential real-time RT-PCR. It was confirmed that the viruses recovered from the 
P/V and P/P group on D4 and D14 were the P-strain and the viruses recovered from the V/V 
and V/P group on D4 and D14 were the V-strain, all matching the respective virus in the 
original inocula on D0. On D32, the viruses recovered from the N/V, P/V and V/V groups 
were the V-strain and the viruses recovered from the N/P and V/P groups were the P-strain, 
matching the respective virus used for challenge on D28. For the V/V group, since pigs 
already stopped shedding virus in feces on D28 and D30 (Table 2), it is reasonable to assume 
that the V-strain virus detected on D32 was from the challenge on D28 instead of the leftover 
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virus from the 1st inoculation on D0. For the P/P group, 2 rectal swabs were PEDV N gene-
based qRT-PCR positive with Ct values over 36 and they were negative by the PEDV S 
gene-based differential RT-PCR. 
To evaluate cross-protection efficacy, the N/V, P/V and V/V groups were compared 
and the N/P, V/P and P/P groups were compared during D28-D56. Fecal virus shedding 
levels in the V/V and P/V groups were similar to each other but were significantly lower than 
that in the N/V group during D28-D56. The V/V and P/V groups had less severe macroscopic 
and microscopic lesions and significantly lower IHC scores when compared to the N/V group 
on D34 necropsy. These data suggest that immunization with either the V-strain or P-strain 
(1st inoculation on D0) provided efficient protection against the subsequent challenge with 
the V-strain on D28. Since the P-strain inoculation on D28 induced very mild lesions (the 
N/P group), there were no significant differences on macroscopic and microscopic lesions as 
well as IHC scores among the N/P, P/P and V/P groups on D34 necropsy. Thus, fecal virus 
shedding is the only parameter to evaluate protection efficacy among the N/P, P/P and V/P 
groups. As shown in Fig 1, both the P/P and the V/P groups had significantly lower virus 
load shed in feces than the N/P group during D28-D56, suggesting that immunization with 
either the P-strain or V-strain provided protection against the subsequent challenge with the 
P-strain. However, since the V/P group still shed significantly higher virus in feces than the 
P/P group during D28-D56, it was considered that the V-strain immunization provided partial 
protection against the P-strain challenge and not as efficient as protection provided by the P-
strain immunization against the P-strain challenge. A controlled study by immunizing 
pregnant sows with the V-strain and P-strain, respectively, followed by challenging newborn 
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pigs with the P-strain may be a better model to assess cross-protection efficacy against the P-
strain challenge.  
Previous studies have shown that the antibodies against U.S. prototype and S-INDEL-
variant PEDVs cross-react and cross-neutralize both strains in vivo (Chen et al., 2016b; Lin 
et al., 2015b). The results from this study corroborate such conclusions. In 3-week-old pigs, 
the P-strain inoculation (P/V and P/P groups) elicited significantly higher IFA antibody titers 
and similar VN antibody titers when compared to the V-strain inoculation (V/V and V/P 
groups) during D0-D28. In 7-week-old pigs, inoculation with the V-strain (N/V group) 
elicited numerically higher IFA antibody titers and significantly higher VN antibody titers 
than inoculation with the P-strain (N/P group) during D28-D56. Overall, either the P-strain or 
the V-strain can induce robust antibody responses in 3-week-old and 7-week-old pigs. After 
the 2nd inoculation on D28, PEDV IFA and VN antibody titers in the V/V, V/P, P/V and P/P 
groups increased slightly and then were maintained through D56. Based on Fig 1 and Fig 6, it 
appears that development of serum antibodies coincide with reduction of virus shedding in 
feces during D0-D56. However, it is impossible to conclude that the serum PEDV antibody 
provided protective immunity. For enteric pathogens such as PEDV, TGEV and rotavirus, it 
is generally thought that mucosal immunity is critical for protection (Chattha et al., 2015; 
Langel et al., 2016). In gilts and sows, sIgA antibody levels and PEDV neutralizing antibody 
titers in colostrum and milk are considered to be able to reflect mucosal and lactogenic 
immunity and may be a correlate for protective immunity against PEDV (Chattha et al., 
2015; Langel et al., 2016). In weaned pigs, it remains to be determined which antibody 
isotypes in which specimen matrix can better reflect mucosal immunity. 
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Vaccine strategies for PEDV are to orally vaccinate pigs to effectively induce 
protective mucosal and/or lactogenic immunity (Chattha et al., 2015; Langel et al., 2016; 
Song et al., 2015). Killed vaccines and subunit vaccines can be used as booster vaccines to 
enhance and maintain mucosal or lactogenic immunity (Langel et al., 2016). Since PED 
outbreaks in 2013, the U.S. has conditionally licensed two commercial PEDV vaccines: one 
is an alphavirus-based RNA particle vaccine developed by HarrisvaccinesTM; another one is 
an inactivated vaccine developed by Zoetis, Inc. Both vaccines are labeled for intramuscular 
administration to sows or gilts pre-farrowing. Currently, modified live virus vaccine for 
PEDV is not available in the U.S. yet. Two previous studies (Goede et al., 2015; Lin et al., 
2015a) and the current study demonstrate that U.S. PEDV S-INDEL-variant strain can 
provide at least partial protection against challenge with U.S. PEDV prototype strain. In 
addition, U.S. PEDV S-INDEL-variant strain is less pathogenic than U.S. PEDV prototype 
strain in neonatal pigs and is less concerned for being spread into neonates. Moreover, U.S. 
PEDV S-INDEL-variant strain appears to have greater replication efficiency than U.S. PEDV 
prototype strain in older pigs and may elicit better immune responses. Therefore, U.S. PEDV 
S-INDEL-variant strain could potentially be a live virus vaccine candidate against PEDV and 
is worth serious consideration and further investigation.      
In summary, this study demonstrated that U.S. PEDV prototype strain was more 
virulent than U.S. PEDV S-INDEL-variant strain in 3-week-old pigs; in contrast, U.S. PEDV 
S-INDEL-variant strain had higher virulence than U.S. PEDV prototype strain in 7-week-old 
pigs. Immunization with either strain elicited robust serum IFA and VN antibodies. 
Immunization with U.S. PEDV prototype strain provided similar protection against challenge 
with U.S. prototype strain or U.S. PEDV S-INDEL-variant strain. Immunization with U.S. 
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PEDV S-INDEL-variant strain provided efficient protection against challenge with U.S. 
PEDV S-INDEL-variant strain and provide at least partial cross-protection against U.S. 
prototype PEDV challenge. U.S. PEDV S-INDEL-variant strain could potentially be a live 
virus vaccine candidate against porcine epidemic diarrhea and this warrants further studies. 
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Table 1. Animal study design.  
Group Pigs 
Day0 (3-wk-age, 
inoculation) 
D4 
(Necropsy) 
D28 (7-wk-
age, 
Challenge) 
D34 
(Necropsy) 
D56 
(Necropsy) 
G1 P/V n=15 Prototype n=5 Variant n=5 n=5 
G2 V/V n=15 Variant n=5 Variant n=5 n=5 
G3 N/V n=15 Negative n=5 Variant n=5 n=5 
G4 P/P n=10 Prototype n=0 Prototype n=5 n=5 
G5 V/P n=10 Variant n=0 Prototype n=5 n=5 
G6 N/P n=10 Negative n=0 Prototype n=5 n=5 
G7 N/N n=10 Negative n=0 Negative n=5 n=5 
Notes: Pigs were inoculated on D0 and/or D28 with prototype (P) PEDV isolate 
USA/IN19338/2013, variant (V) isolate USA/IL20697/2014, or negative media (N). Groups 
were named with the treatment on D0/D28. Pigs were inoculated with 10 ml of 104 
TCID50/ml virus of either P-strain or V-strain PEDV. “n” = number of pigs. 
 
  
 
 
Table 2. PEDV N gene-based qRT-PCR results on rectal swabs collected from different groups at different time points 
Group Pigs D0 D2 D4 D7 D10 D14 D21 D28 D30 D32 D34 D38 D42 D49 D56 
G1 P/V n=15 0/15  
15/15* 
(18.8)§ 
15/15 
(14.9) 
10/10 
(22.6) 
10/10 
(33.7) 
10/10 
(33.1) 
4/10 
(37.6) 
5/10 
(36.4) 
1/10 
(36.7) 
4/10 
(36.4) 
6/10 
(36.6) 
3/5 
(37.1) 
0/5  
1/5 
(36.0) 
0/5 
G2 V/V n=15 0/15  
10/15 
(31.2) 
15/15 
(25.8) 
10/10 
(23.6) 
10/10 
(35.0) 
9/10 
(27.2) 
5/10 
(34.8) 
0/10  0/10 
8/10 
(35.4) 
7/10 
(32.5) 
4/5 
(35.6) 
2/5 
(37.1) 
0/5 0/5  
G3 N/V n=15 0/15  0/15 0/15 0/10 0/10 0/10 0/10 0/10 0/10 
10/10 
(23.3) 
10/10 
(19.4) 
5/5 
(15.7) 
5/5 
(26.0) 
3/5 
(29.1) 
2/5 
(38.4) 
G4 P/P n=10 0/10 
10/10 
(18.0) 
10/10 
(15.8) 
10/10 
(20.7) 
10/10 
(33.4) 
10/10 
(31.7) 
9/10 
(33.5) 
8/10 
(32.7) 
5/10 
(33.8) 
2/10 
(36.0) 
2/10 
(37.6) 
0/5 
1/5 
(38.1) 
0/5 0/5  
G5 V/P n=10 0/10 
8/10 
(29.5) 
10/10 
(24.5) 
10/10 
(22.5) 
10/10 
(29.2) 
10/10 
(24.4) 
7/10 
(34.1) 
6/10 
(35.4) 
7/10 
(35.5) 
5/10 
(32.0) 
10/10 
(29.4) 
2/5 
(36.0) 
2/5 
(32.3) 
3/5 
(35.1) 
0/5  
G6 N/P n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10  
1/10 
(34.9) 
10/10 
(31.4) 
10/10 
(30.36) 
5/5 
(25.9) 
5/5 
(27.1) 
5/5 
(28.6) 
1/5 
(37.0) 
G7 N/N n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/5 0/5 0/5 0/5 
* PEDV N gene-based qRT-PCR positive pigs among available pigs in that group. 
§ Average Ct values of the PEDV qRT-PCR-positive rectal swabs in that group at that time point. 
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Table 3. PEDV IFA and VN antibody results on sera collected from different groups at different time 
points 
Assay Group Pigs D0 D7 D14 D21 D28 D34 D42 D49 D56 
Pro IFA 
assay 
G1 P/V n=15 0/15* 3/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G2 V/V n=15 0/15  1/10 5/10 9/10 9/10 9/10 5/5 5/5 4/5 
G3 N/V n=15 0/15  0/10  0/10  0/10  0/10  0/10  5/5 5/5 5/5 
G4 P/P n=10 0/10 6/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G5 V/P n=10 0/10 0/10 8/10 9/10 9/10 7/10 4/5 4/5 4/5 
G6 N/P n=10 0/10 0/10 0/10 0/10 0/10 0/10 1/5 5/5 5/5 
G7 N/N n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/5 0/5 0/5 
Var IFA 
assay 
G1 P/V n=15 0/15* 2/10 9/10 10/10 10/10 10/10 5/5 5/5 5/5 
G2 V/V n=15 0/15  0/10 7/10 9/10 9/10 9/10 5/5 5/5 5/5 
G3 N/V n=15 0/15  0/10  0/10  0/10  0/10  0/10  5/5 5/5 5/5 
G4 P/P n=10 0/10 5/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G5 V/P n=10 0/10 0/10 8/10 9/10 8/10 9/10 5/5 5/5 5/5 
G6 N/P n=10 0/10 0/10 0/10 0/10 0/10 0/10 1/5 5/5 5/5 
G7 N/N n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/5 0/5 0/5 
Pro VN 
assay 
G1 P/V n=15 0/15§ 5/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G2 V/V n=15 0/15  3/10 9/10 10/10 10/10 10/10 5/5 5/5 5/5 
G3 N/V n=15 0/15  0/10  0/10  0/10  0/10  2/10 5/5 5/5 5/5 
G4 P/P n=10 0/10 9/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G5 V/P n=10 0/10 4/10 7/10 10/10 10/10 10/10 5/5 5/5 5/5 
G6 N/P n=10 0/10 0/10 0/10 0/10 0/10 3/10 5/5 5/5 5/5 
G7 N/N n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/5 0/5 0/5 
Var VN 
assay 
G1 P/V n=15 0/15§ 9/10 10/10 10/10 10/10 10/10 5/5 5/5 5/5 
G2 V/V n=15 0/15  8/10 10/10 10/10 10/10 10/10 5/5 5/5 4/5 
G3 N/V n=15 0/15  0/10  0/10  0/10  0/10  0/10 5/5 5/5 5/5 
G4 P/P n=10 0/10 7/10 9/10 10/10 10/10 10/10 5/5 5/5 5/5 
G5 V/P n=10 0/10 7/10 10/10 10/10 10/10 10/10 5/5 4/5 4/5 
G6 N/P n=10 0/10 0/10 0/10 0/10 0/10 1/10 4/5 5/5 5/5 
G7 N/N n=10 0/10 0/10 0/10 0/10 0/10 0/10 0/5 0/5 0/5 
* PEDV IFA antibody positive (titer ≥ 40) pigs among available pigs in that group at that 
time point.  
§ PEDV VN antibody positive (titer ≥ 8) pigs among available pigs in that group at that time 
point. 
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Fig 1. Fecal virus shedding titers. A) Fecal virus shedding titers at each time point of each 
group with upper standard error bars shown. B) Statistical analyses of overall virus shedding 
titers from D0 to D28 and from D28 to D56, respectively. The 2nd inoculation (challenge) 
was conducted on D28. During D0-D28, the N/N, N/V and N/P groups received the same 
inoculum and were analyzed as the same treatment, similarly for the V/V and V/P groups, 
and P/V and P/P groups. Different letters indicate statistically significant difference in virus 
shedding amount between groups. 
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Fig 2. Examination of gross lesions of inoculated pigs at D4 and D34 necropsies. Mean 
scores of contents of small intestine, cecum, and colon as well as the mean gross lesion 
scores of small intestine, cecum and colon are shown in (A) for D4 necropsy and in (B) for 
D34 necropsy. Standard error bars are shown. Statistical analyses were performed on various 
inoculation groups, but each time on one tissue. Labels without the same letters indicate 
significant differences, for example A and B have significant difference but A and AB have 
no significant difference. Yellow highlights are statistical analysis of the V-strain-challenged 
pigs, and green highlights are statistical analysis of the P-strain-challenged pigs. 
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Fig 3. Mean villus height/crypt depth ratio and immunohistochemistry scores of pigs 
necropsied on D4. A) Group mean of villus height/crypt depth ratios of distal jejunum and 
ileum. B) Group mean of PEDV IHC scores in distal jejunum, ileum, cecum, and colon. 
Standard error bars shown. Different letters indicate statistically significant difference 
between groups. 
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Fig 4. Mean villus height/crypt depth ratio and immunohistochemistry scores of pigs 
necropsied on D34. A) Group mean of villus height/crypt depth ratios of distal jejunum and 
ileum. B) Group mean of PEDV IHC scores in distal jejunum, ileum, cecum, and colon. 
Standard error bars shown. Labels without the same letters indicate significant differences, as 
explained for Fig 2. Yellow highlights are statistical analysis of the V-strain-challenged pigs, 
and green highlights are statistical analysis of the P-strain-challenged pigs. 
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Fig 5. Serum IFA antibody titers against PEDVs. A) Group mean of serum IFA antibody 
titers tested by the PEDV P-strain-based IFA (Pro IFA) assay. B) Group mean of serum IFA 
antibody titers tested by the PEDV V-strain-based IFA (Var IFA) assay. Standard error bars 
are shown. C) Statistical analysis of Pro IFA antibody titers. D) Statistical analysis of Var 
IFA antibody titers. Different letters indicate statistically significant differences between 
groups. The 2nd inoculation (challenge) was conducted on D28. During D0-D28, the N/N, 
N/V and N/P groups were inoculated with same virus and were analyzed as the same 
treatment, similarly for the V/V and V/P groups, and the P/V and P/P groups. During D28-
D56, PEDV IFA antibody titers were compared between the N/V and N/P group, and among 
the V/V, V/P, P/V and P/P groups. 
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Fig 6. Serum VN antibody titers against PEDVs. A) Group mean of serum VN antibody 
titers tested by the PEDV P-strain-based VN (Pro VN) assay. B) Group mean of serum VN 
antibody titers tested by the PEDV V-strain-based (Var VN) assay. Standard error bars are 
shown. C) Statistical analysis of Pro VN antibody titers. D) Statistical analysis of Var VN 
antibody titers. Different letters indicate statistically significant differences between groups. 
The 2nd inoculation (challenge) was conducted on D28. During D0-D28, the N/N, N/V and 
N/P groups were inoculated with same virus and were analyzed as the same treatment, 
similarly for the V/V and V/P groups, and the P/V and P/P groups. During D28-D56, PEDV 
VN antibody titers were compared between the N/V and N/P group, and among the V/V, 
V/P, P/V and P/P groups. 
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CHAPTER 7. GENERAL CONCLUSIONS 
 
PEDV remains highly prevalent in U.S. and Asian swine and is spreading to more and 
more countries in the world. The virus is continuing to evolve worldwide. Vaccines that are 
able to effectively control the spread and reduce losses associated with PEDV are still 
indispensable.  
The research in this dissertation successfully isolated and characterized multiple 
PEDVs of the two major strains (U.S. PEDV prototype strain and U.S. S-INDEL-variant 
strain) circulating in the U.S. between 2013 and 2016. Pathogenesis comparison in 5-day-old 
neonatal pigs and weaned pigs at 3-week old and 7-week old demonstrated that U.S. 
prototype strain was more virulent in 5-day-old neonatal pigs and 3-week-old weaned pig, as 
compared to U.S. S-INDEL-variant strain. In contrast, U.S. S-INDEL-variant strain showed 
higher virulence in 7-week-old infected pigs than U.S. prototype strain of PEDV, although 
the lesions and clinical diseases from both strains were mild. In addition, we showed the 
cross-reacting capacities between two U.S. PEDV strains in vitro and cross-protection 
efficacy between two strains in vivo.  
Overall, cell adapted PEDV isolates obtained from this dissertation can be applied to 
vaccine development, diagnostic assay development and evaluation, and animal study 
challenge materials. Indeed, these PEDV isolates have been utilized in the development and 
evaluation of multiple diagnostic assays as described in this dissertation. 
Additionally, based on the cross-protecting efficacy between the two U.S. PEDV 
strains, it is predicted that PEDV live attenuated vaccine with one current U.S. strain is 
sufficient to protect against infection and reduce diseases of both strains. On the other hand, 
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in terms of pathogenicity, U.S. S-INDEL-variant strain is of lower virulence in neonatal pigs, 
which is associated with lower mortalities in neonatal pigs, as compared to U.S. prototype 
strain. U.S. S-INDEL-variant strain caused mild diseases in older pigs. From the safety 
prospect, U.S. S-INDEL-variant strain can be a better option for a live vaccine candidate. 
Therefore, U.S. S-INDEL-variant strain could potentially be a safe and effective PEDV live 
virus vaccine candidate against PED and this warrants further studies. 
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